Aamir UB, Wernery U, Ilyushina N, et al. Characterization of avian H9N2 influenza viruses from United Arab Emirates 2000 to 2003. Virology 2007 Apr 25;361(1):45-55 [Abstract]

Abbas MA, Spackman E, Fouchier R, et al. H7 avian influenza virus vaccines protect chickens against challenge with antigenically diverse isolates. Vaccine 2011 Oct 6;29(43):7424-9 [Abstract]

Abbas MA, Spackman E, Swayne DE, et al. Sequence and phylogenetic analysis of H7N3 avian influenza viruses isolated from poultry in Pakistan 1995-2004. Virol J 2010 Jun 24;7:137 [Abstract]

Abbate R, Di Giuseppe G, Marinelli P, et al. Knowledge, attitudes, and practices of avian influenza, poultry workers, Italy. Emerg Infect Dis 2006 Nov;12(11):1762-5 [Full text]

Abbott A. Chicken flu races through Dutch poultry farms. Nature 2003 Mar 20;422(6929):247 [Full text]

Abdel-Moneim AS, Abdel-Ghany AE, Shany SAS. Isolation and characterization of highly pathogenic avian influenza virus subtype H5N1 from donkeys. J Biomed Sci 2010 Apr 14;17:25 [Abstract]

Abdel-Moneim AS, Afifi MA, El-Kady MF. Genetic drift evolution under vaccination pressure among H5N1 Egyptian isolates. Virol J 2011 Jun 8;8:283 [Abstract]

Abdelwhab EM, Grund C, Aly MM, et al. Multiple dose vaccination with heterologous H5N2 vaccine: immune response and protection against variant clade 2.2.1 highly pathogenic avian influenza H5N1 in broiler breeder chickens. Vaccine 2011 Aug 26;29(37):6219-25 [Abstract]

Abdelwhab EM, Hafez HM. An overview of the epidemic of highly pathogenic H5N1 avian influenza virus in Egypt: epidemiology and control challenges. Epidemiol Infect 2011 May;139(5):647-57 [Abstract]

Abt M, de Jonge J, Laue M, et al. Improvement of H5N1 influenza vaccine viruses: influence of internal gene segments of avian and human origin on production and hemagglutinin content. Vaccine 2011 Jul 18;29(32):5153-62 [Abstract]

Achenbach JE, Bowen RA. Transmission of avian influenza A viruses among species in an artificial barnyard. PLoS ONE 2011 Mar 31;6(3):e17643 [Full text]

Adar Y, Singer Y, Levi R, et al. A universal epitope-based influenza vaccine and its efficacy against H5N1. Vaccine 2009 Mar 26;27(15):2099-107 [Abstract]

Adisasmito W, Chan PKS, Lee N, et al. Effectiveness of antiviral treatment in human influenza A(H5N1) infections: analysis of a global patient registry. J Infect Dis 2010 Oct 15;202(8):1154-60 [Abstract]

Aditama TY, Samaan G, Kusriastuti R, et al. Avian influenza H5N1 transmission in households, Indonesia. PLoS ONE 2012 Jan 4;7(1):e29971 [Full text]

Aditama TY, Samaan G, Kusriastuti R, et al. Risk factors for cluster outbreaks of avian influenza A H5N1 infection, Indonesia. Clin Infect Dis 2011 (published online Oct 19) [Abstract]

Ahmed SSU, Ersboll AK, Biswas PK, et al. Ecological determinants of highly pathogenic avian influenza (H5N1) outbreaks in Bangladesh. PLoS ONE 2012 Mar 21;7(3):e33938 [Full text]

Ahmed SSU, Ersboll AK, Biswas PK, et al. Spatio-temporal magnitude and direction of highly pathogenic avian influenza (H5N1) outbreaks in Bangladesh. PLoS ONE 2011 Sep 9;6(9):e24324 [Full text]

Aiki-Raji CO, Aguilar PV, Kwon YK, et al. Phylogenetics and pathogenesis of early avian influenza viruses (H5N1), Nigeria. Emerg Infect Dis 2008 Nov;14(11):1753-5 [Full text]

Al-Azemi A, Bahl J, Al-Zenki S, et al. Avian influenza A virus (H5N1) outbreaks, Kuwait, 2007. Emerg Infect Dis 2008 Jun;14(6):958-62 [Full text]

Aldridge JR Jr, Moseley CE, Boltz DA, et al. TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection. Proc Natl Acad Sci 2009 Mar 31;106(13):5306-11 [Abstract]

Alexander DJ. Should we change the definition of avian influenza for eradication purposes? Avian Dis. 2003;47(3 Suppl):976-81 [Abstract]

Alibek K, Liu G. Biodefense shield and avian influenza. (Letter) Emerg Infect Dis 2006 May;12(5):873-5 [Full text]

Altiok E, Taylan F, Yenen OS, et al. Mutations in influenza A virus (H5N1) and possible limited spread, Turkey, 2006. Emerg Infect Dis 2008 Mar;14(3):491-2 [Full text]

Aly MM, Arafa A, Hassan MK. Epidemiological findings of outbreaks of disease caused by highly pathogenic H5N1 avian influenza virus in poultry in Egypt during 2006. Avian Dis 2008 Jun;52(2):269-77 [Abstract]

American Council on Science and Health. Avian influenza, or bird flu: what you need to know. Mar 2006 [Full text]

Amonsin A, Choatrakol C, Lapkuntod J, et al. Influenza virus (H5N1) in live bird markets and food markets, Thailand. Emerg Infect Dis 2008 Nov;14(11):1739-42 [Full text]

Amonsin A, Lapkuntod J, Suwannakarn K, et al. Genetic characterization of 2008 reassortant influenza A virus (H5N1), Thailand. Virol J 2010 Sep 16;7:233 [Abstract]

Ao Z, Patel A, Tran K, et al. Characterization of a trypsin-dependent avian influenza H5N1-pseudotyped HIV vector system for high throughput screening of inhibitory molecules. Antiviral Res 2008 Jul;97(1):12-18 [Abstract]

Apisarnthanarak A, Erb S, Stephenson I, et al. Seroprevalence of anti-H5 antibody among Thai health care workers after exposure to avian influenza (H5N1) in a tertiary care center. Clin Infect Dis 2004 Jan 15;40(2):e16-8 [Full text]

Apisarnthanarak A, Kitphati R, Thongphubeth K, et al. Atypical avian influenza (H5N1). Emerg Infect Dis 2004 Jul;10(7):1321-4 [Full text]

Apisarnthanarak A, Mundy LM. Antiviral therapy for avian influenza virus (H5N1) infection at 2 Thai medical centers: survey findings and implications for pandemic preparedness. Infect Control Hosp Epidemiol 2008 Dec;29(12):1185-8 [Abstract]

Apisarnthanarak A, Puthavathana P, Kitphati R, et al. Avian influenza H5N1 screening of intensive care unit patients with community-acquired pneumonia. Emerg Infect Dis 2006 Nov;12(11):1766-9 [Full text]

Apisarnthanarak A, Warren DK, Fraser VJ. Issues relevant to the adoption and modification of hospital infection-control recommendations for avian influenza (H5N1 infection) in developing countries. Clin Infect Dis 2007 Nov 15;45(10):1338-42 [Abstract]

Areechokchai D, Jiraphongsa C, Laosiritaworn Y, et al. Investigation of avian influenza (H5N1) outbreak in humans: Thailand, 2004. MMWR 2006 Apr 28;55(Suppl 1):3-6 [Full text]

Arizona Department of Health Services. Modern Methods for Influenza Detection and Sub-typing [PowerPoint presentation]

Arsnoe DM, Ip HS, Owen JC. Influence of body condition on influenza A virus infection in mallard ducks: experimental infection data. PLoS ONE 2011 Aug 16;6(8):222633 [Full text]

Arzey GG, Kirkland PD, Arzey KE, et al. Influenza virus A (H10N7) in chickens and poultry abattoir workers, Australia. Emerg Infect Dis 2012 (published online Apr 2) [Full text]

ASTHO. Nature's terrorist attack: pandemic influenza. Preparedness planning for state health officials. Nov 2002 [Full text]

Atmar RL, Keitel WA, Patel SM, et al. Safety and immunogenicity of nonadjuvanted and MF59-adjuvanted influenza A/H9N2 vaccine preparations. Clin Infect Dis 2006 Nov 1;43(9):1135-42 [Abstract]

Atmar RL, Keitel WA, Quarles JM, et al. Evaluation of age-related differences in the immunogenicity of a G9 H9N2 influenza vaccine. Vaccine 2011 Oct 19;29(45):8066-72 [Abstract]

Auewarakul P, Sangsiriwut K, Chaichoune K, et al. Surveillance for reassortant virus by multiplex reverse transcription-PCR specific for eight genomic segments of avian influenza A H5N1 viruses. J Clin Microbiol 2007 May;45(5):1637-9 [Abstract]

Auewarakul P, Suptawiwat O, Kongchanagul A, et al. An avian influenza H5N1 virus that binds to a human-type receptor. J Virol 2007 Sep;81(18):9950-5 [Abstract]

Ayora-Talavera G, Shelton H, Scull MA, et al. Mutations in H5N1 influenza virus hemagglutinin that confer binding to human tracheal airway epithelium. PLoS One 2009 Nov 18;4(11):e7836 [Full text]

Ayyalasomayajula S, DeLaurentis DA, Moore GE, et al. A network model of H5N1 avian influenza transmission dynamics in domestic cats. Zoonoses Public Health 2008 Jul 9;55(8-10):497-506 [Abstract]

Balicer RD, Reznikovich S, Berman E, et al. Multifocal avian influenza (H5N1) outbreak. Emerg Infect Dis 2007 Oct;13(10):1601-3 [Full text]

Balkhy H. Avian influenza: the tip of the iceberg. Ann Thorac Med 2008 Oct-Dec;3(4):154-7 [Full text]

Bansal S, Pourbohloul B, Meyers LA. A comparative analysis of influenza vaccination programs. PLoS Med 2006 Oct;3(10):e387 [Full text]

Banzhoff A, Gasparini R, Laghi-Pasini F, et al. MF59-adjuvanted H5N1 vaccine induced immunologic memory and heterotypic antibody responses in non-elderly and elderly adults. PLoS ONE 2009 Feb 6;4(2):e4384 [Full text]

Baras B, Stittelaar KJ, Kuiken T, et al. Longevity of the protective immune response induced after vaccination with one or two doses of AS03A-adjuvanted split H5N1 vaccine in ferrets. Vaccine 2011 Mar 3;29(11):2092-9 [Abstract]

Baras B, Stittelaar KJ, Simon JH, et al. Cross-protection against lethal H5N1 challenge in ferrets with an adjuvanted pandemic influenza vaccine. PLoS ONE 2008 Jan 2;3(1):e1401 [Full text]

Barbazan P, Thitithanyanont A, Misse D, et al. Detection of H5N1 avian influenza virus from mosquitoes collected in an infected poultry farm in Thailand. Vector Borne Zoonotic Dis 2008 Feb;8(1):105-110 [Abstract]

Barber MRW, Aldridge JR Jr, Webster RG, et al. Association of RIG-I with innate immunity of ducks to influenza. Proc Natl Acad Sci 2010 Mar 30;107(13):5913-8 [Abstract]

Barennes H, Harimanana AN, Lorvongseng S, et al. Paradoxical risk perception and behaviours related to avian flu outbreak and education campaign, Laos. BMC Infect Dis 2010 Oct 12;10(1):294 [Abstract]

Barennes HM, Martinez-Aussel B, Vongphrachanh P, et al. Avian influenza risk perceptions, Laos. (Letter) Emerg Infect Dis 2007 Jul;13(7):1126-8 [Full text]

Barral M, Alvarez V, Juste R, et al. First case of highly pathogenic H5N1 avian influenza virus in Spain. BMC Vet Res 2008 Dec 10;4:50 [Abstract]

Barrett R, Brown PJ. Stigma in the time of influenza: social and institutional responses to pandemic emergencies. J Infect Dis 2008 Feb 15;197(S1):S34-7 [Abstract]

Bartlett JG. Planning for avian influenza. Ann Intern Med 2006 Jul 18;145(2):141-4 [Full text]

Baskin CR, Bielefeldt-Ohmann H, Tumpey TM, et al. Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus. Proc Natl Acad Sci 2009 Mar 3;106(9):3455-60 [Full text]

Basler CF, Aguilar PV. Progress in identifying virulence determinants of the 1918 H1N1 and Southeast Asian H5N1 influenza viruses. Antiviral Res 2008 Sep;78(3):166-78 [Abstract]

Basuno E, Yusdja Y, Ilham N. Socio-economic impacts of avian influenza outbreaks on small-scale producers in Indonesia. Transbound Emerg Dis 2010 Apr;57(1-2):7-10 [Abstract]

Bataille A, van der Meer F, Stegeman A, et al. Evolutionary analysis of inter-farm transmission dynamics in a highly pathogenic avian influenza epidemic. PLoS Pathog 2011 Jun 23;7(6):e1002094 [Full text]

Baumer A, Feldmann J, Renzullo S, et al. Epidemiology of avian influenza virus in wild birds in Switzerland between 2006 and 2009. Avian Dis 2010 Jun;54(2):875-84 [Abstract]

Beach RH, Fred Kuchler F, Leibtag E, et al. The effects of avian influenza news on consumer purchasing behavior: a case study of Italian consumers' retail purchases. Econ Res Rep 2008 Aug 29 (report no. ERR-65) [Full text]

Beato MS, Toffan A, De Nardi R, et al. A conventional, inactivated oil emulsion vaccine suppresses shedding and prevents viral meat colonisation in commercial (Pekin) ducks challenged with HPAI H5N1. Vaccine 2007 May 16;25(20):4064-72 [Abstract]

Beigel J, Bray M. Current and future antiviral therapy of severe seasonal and avian influenza. Antiviral Res 2008 Apr;78(1):91-102 [Abstract]

Beigel JH, Voell J, Huang CY, et al. Safety and immunogenicity of multiple and higher doses of an inactivated influenza A/H5N1 vaccine. J Infect Dis 2009 Aug 15;200(4):501-8 [Abstract]

Belmaker I, Lyandres M, Bilenko N, et al. Adherence with oseltamivir chemoprophylaxis among workers exposed to poultry during avian influenza outbreaks in southern Israel. Int J Infect Dis 2009 Mar;13(2):261-5 [Abstract]

Belser JA, Blixt O, Chen LM, et al. Contemporary North American influenza H7 viruses possess human receptor specificity: implications for virus transmissibility. Proc Natl Acad Sci 2008 May 27;105(21):7558-63 [Full text]

Belser JA, Lu X, Maines TR, et al. Pathogenesis of avian influenza (H7) virus infection in mice and ferrets: enhanced virulence of Eurasian H7N7 viruses isolated from humans. J Virol 2007 Oct;81(20):11139-47 [Abstract]

Belser JA, Lu X, Szretter KJ, et al. DAS181, a novel sialidase fusion protein, protects mice from lethal avian influenza H5N1 virus infection. J Infect Dis 2007 Nov 15;196(10):1493-9 [Abstract]

Belshe RB, Frey SE, Graham I, et al. Safety and immunogenicity of influenza A H5 subunit vaccines: effect of vaccine schedule and antigenic variant. J Infect Dis 2011 Mar 1;203(5):666-73 [Abstract]

Benitez MA. Hong Kong's health policies focus on containing avian influenza. Lancet 2003 Jan 25;361(9354):318 [Full text]

Bentley RA, Ormerod P. A rapid method for assessing social versus independent interest in health issues: a case study of 'bird flu' and 'swine flu'. Soc Sci Med 2010 Aug;71(3):482-5 [Abstract]

Bernstein DI, Edwards KM, Dekker CL, et al. Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adults. J Infect Dis 2008 Mar 1;197(suppl 2):667-75 [Abstract]

Bertelsen MF, Klausen J, Holm E, et al. Serological response to vaccination against avian influenza in zoo-birds using an inactivated H5N9 vaccine. Vaccine 2007 May 30;25(22):4345-9 [Abstract]

Bertran K, Busquets N, Abad FX, et al. Highly (H5N1) and low (H7N2) pathogenic avian influenza virus infection in falcons via nasochoanal route and ingestion of experimentally infected prey. PLoS ONE 2012 Mar 9;7(3):e32107 [Full text]

Bi J, Deng G, Dong J, et al. Phylogenetic and molecular characterization of H9N2 influenza isolates from chickens in northern China from 2007-2009. PLoS ONE 2010 Sep 29;5(9):e13063 [Full text]

Biswas PK, Christensen JP, Ahmed SSU, et al. Avian influenza outbreaks in chickens, Bangladesh. Emerg Infect Dis 2008 Dec;14(12):1909-12 [Full text]

Bodewes R, Kreijtz JHCM, Geelhoed-Mieras MM, et al. Vaccination against seasonal influenza A/H3N2 reduces the induction of heterosubtypic immunity against influenza A/H5N1 in ferrets. J Virol 2011 Mar;85(6):2695-702 [Abstract]

Boender GJ, Hagenaars TJ, Bouma A, et al. Risk maps for the spread of highly pathogenic avian influenza in poultry. PLoS Comp Biol 2007 Apr;3(4):e71 [Full text]

Bogner P, Capua I, Cox, NJ, et al. A global initiative on sharing avian flu data. Nature 2006 Aug 31;442:981 [Full text]

Boltz DA, Douangngeun B, Sinthasak S, et al. H5N1 influenza viruses in Lao People's Democratic Republic. Emerg Infect Dis 2006 Oct;12(10):1593-5 [Full text]

Boltz DA, Rehg JE, McClaren J, et al. Oseltamivir prophylactic regimens prevent H5N1 influenza morbidity and mortality in a ferret model. J Infect Dis 2008 May 1;197(9):1315-23 [Abstract]

Boon ACM, Sandbulte MR, Seiler P, et al. Role of terrestrial wild birds in ecology of influenza A virus (H5N1). Emerg Infect Dis 2007 Nov;13(11):1720-4 [Full text]

Bos MEH, te Beest DE, van Boven M, et al. High probability of avian influenza virus (H7N7) transmission from poultry to humans active in disease control on infected farms. J Infect Dis 2010 May 1;201(9):1390-6 [Abstract]

Bose ME, Littrell JC, Patzer AD, et al. The influenza primer design resource: a new tool for translating influenza sequence data into effective diagnostics. Influenza Other Resp Viruses 2008 Jan;2(1):23-31 [Abstract]

Bosman A, Meijer A, Koopmans M. Final analysis of Netherlands avian influenza outbreaks reveals much higher levels of transmission to humans than previously thought. Eurosurveillance Weekly 2005 Jan 6;10(1):pii=2616 [Full text]

Bouma A, Claassen I, Natih K, et al. Estimation of transmission parameters of H5N1 avian influenza virus in chickens. PLoS Pathog 2009 Jan 30;5(1):e1000281 [Full text]

Bourouiba L, Wu UJ. Spatial dynamics of bar-headed geese migration in the context of H5N1. J R Soc Interface 2010 Nov 6;7(52):1627-39 [Abstract]

Bouvier NM. The science of security versus the security of science. (Perspective) J Infect Dis 2012 (published online Mar 27) [Abstract]

Boyce W. Earth monitoring: vigilance is not enough. Nature 2007 Dec 6;450(7171):791-2 [Full text]

Breban R, Drake JM, Stallknecht DE, et al. The role of environmental transmission in recurrent avian influenza epidemics. PLoS Comput Biol 2009 Apr 10;5(4):e1000346 [Full text]

Bresson JL, Perrone C, Launay O, et al. Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial. Lancet 2006 May 20;367(9523):1657-64 [Abstract]

Brett AS, Zuger A. The run on Tamiflu: should physicians prescribe on demand? (Perspective) N Engl J Med 2005 Dec 22;353(24):2636-7 [Full text]

Bright RA, Carter DM, Crevar CJ, et al. Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle. PLoS ONE 2008 Jan 30;3(1):e1501 [Full text]

Bright RA, Medina M, Xu X, et al. Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern. Lancet 2005 Oct 1;366(9492):1175-81 [Abstract]

Brown C, Horstick O, Naville F, et al. Avian influenza outbreaks in the WHO European region and public health actions. Eurosurveillance Weekly 2005 Oct 27;10(10):pii=2820 [Full text]

Brown C, Paget J, Meijer A. Avian influenza: current situation in southeast Asia and impact on Europe. Eurosurveillance Weekly 2005 Jan 20 [Full text]

Brown JD, Stallknecht DE, Beck JR, et al. Susceptibility of North American ducks and gulls to H5N1 highly pathogenic avian influenza viruses. Emerg Infect Dis 2006 Nov;12(11):1663-70 [Full text]

Brown JD, Stallknecht DE, Swayne DE. Experimental infection of swans and geese with highly pathogenic avian influenza virus (H5N1) of Asian lineage. Emerg Infect Dis 2008 Jan;14(1):136-42 [Full text]

Brown JD, Stallknecht DE, Swayne DE. Experimental infections of herring gulls (Larus argentatus) with H5N1 highly pathogenic avian influenza viruses by intranasal inoculation of virus and ingestion of virus infected chicken meat. Avian Pathol 2008 Aug;37(4):393-7 [Abstract]

Brown JN, Palermo RE, Baskin CR, et al. Macaque proteome response to highly pathogenic avian influenza and 1918 reassortant influenza virus infections. J Virol 2010 Nov;84(22):12058-68 [Abstract]

Brownstein JS, Wolfe CJ, Mandl KD. Empirical evidence for the effect of airline travel on inter-regional influenza spread in the United States. PLoS Med 2006 Oct;3(10):e401 [Full text]

Buchy P, Fourment M, Mardy S, et al. Molecular epidemiology of clade 1 influenza A viruses (H5N1), southern Indochina Peninsula, 2004-2007. Emerg Infect Dis 2009 Oct;15(10):1641-4 [Full text]

Buchy P, Vong S, Chu S, et al. Kinetics of neutralizing antibodies in patients naturally infected by H5N1 virus. PLoS ONE 2010 May 27;5(5):e10864 [Full text]

Budd A, Alleva L, Alsharifi M, et al. Increased survival after gemfibrozil treatment of severe mouse influenza. Antimicrob Agents Chemother 2007 Aug;51(8):2965-8 [Abstract]

Bui HH, Peters B, Assarsson E, et al. Ab and T cell epitopes of influenza A virus, knowledge and opportunities. Proc Natl Acad Sci 2007 Jan 2;104(1):246-51 [Abstract]

Bui VN, Ogawa H, Xininigen. H4N8 subtype avian influenza virus isolated from shorebirds contains a unique PB1 gene and causes severe respiratory disease in mice. Virology 2011 (published online Dec 20) [Abstract]

Bulach D, Halpin R, Spiro D, et al. Molecular analysis of H7 avian influenza viruses from Australia and New Zealand: genetic diversity and relationships -- 1976 to 2007. J Virol 2010 Oct;84(19):9957-66 [Abstract]

Butler D. Q&A: Siti Fadilah Supari. Nature 2007 Dec 20;450(7173):1137 [Full text]

Butt AM, Siddique S, Idrees M, et al. Avian influenza A (H9N2): computational molecular analysis and phylogenetic characterization of viral surface proteins isolated between 1997 and 2009 from the human population. Virol J 2010 Nov 15;7:319 [Abstract]

Cagle C, To TL, Nguyen T, et al. Pekin and Muscovy ducks respond differently to vaccination with a H5N1 highly pathogenic avian influenza (HPAI) commercial inactivated vaccine. Vaccine 2011 Sep 2;29(38):6549-57 [Abstract]

Cai Y, Song H, Ye J, et al. Improved hatchability and efficient protection after in ovo vaccination with live-attenuated H7N2 and H9N2 avian influenza viruses. Virol J 2011 Jan 21;8:31 [Abstract]

Call SA, Vollenweider MA, Hornung CA, et al. Does this patient have influenza? JAMA 2005 Feb 23;293(8):987-97 [Abstract]

Cameron CM, Cameron MJ, Bermejo-Martin JF, et al. Gene expression analysis of host innate immune responses during lethal H5N1 infection in ferrets. J Virol 2008 Nov;82(22):11308-17 [Abstract]

Campitelli L, Di Martino A, Spagnolo D, et al. Molecular analysis of avian H7 influenza viruses circulating in Eurasia in 1999-2005: detection of multiple reassortant virus genotypes. J Gen Virol 2008 Jan;89(1):48-59 [Abstract]

Cappelle J, de Almeida RS, Fofana B, et al. Circulation of avian influenza viruses in wild birds in Inner Niger Delta, Mali. Influenza Other Respi Viruses 2011 (published online Dec 15) [Abstract]

Capua I, Alexander DJ. Avian influenza in birds: a challenge and opportunity for the poultry veterinarian. Poult Sci 2009 Apr;88(4):842-6 [Abstract]

Capua I, Alexander DJ. Avian influenza: recent developments. Avian Pathol. 2004 Aug;33(4):393-404 [Abstract]

Capua I, Alexander DJ. Ecology, epidemiology and human health implications of avian influenza viruses: why do we need to share genetic data? Zoonoses Publ Health 2008 Feb;55(1):2-15 [Abstract]

Capua I, Marangon S. Control and prevention of avian influenza in an evolving scenario. Vaccine 2007 Jul 26;25(30):5645-52 [Abstract]

Capua I, Marangon S. Control of avian influenza in poultry. Emerg Infect Dis 2006 Sep;12(9):1319-24 [Full text]

Capua I, Marangon S. The use of vaccination to combat mutiple introductions of notifiable avian influenza viruses of the H5 and H7 subtypes between 2000 and 2006 in Italy. Vaccine 2007 Jun 28;25(27):4987-95 [Abstract]

Cardona C, Slemons R, Perez D. The prevention and control of avian influenza: the avian influenza coordinated agriculture project. Poult Sci 2009 Apr;88(4):837-41 [Abstract]

Cardona CJ, Xing Z, Sandrock CE, et al. Avian influenza in birds and mammals. Comp Immunol Microbiol Infect Dis 2009 Jul;32(4):255-73 [Abstract]

Carlson CM, Turpin EA, Moser LA, et al. Transforming growth factor-beta: activation by neuraminidase and role in highly pathogenic H5N1 influenza pathogenesis. PLoS Pathog 2010 Oct 7;6(10):e1001136 [Full text]

Carter NJ, Plosker GL. Prepandemic influenza vaccine H5N1 (split virion, inactivated, adjuvanted) (Prepandrix): a review of its use as an active immunization against influenza A subtype H5N1 virus. BioDrugs 2008;22(5):279-82 [Abstract]

Casadevall A, Shenk T. Mammalian-transmissible H5N1 virus: containment level and case fatality ratio. (Editorial) mBio 2012 Mar 6;3(2):e00054 [Full text]

Cattoli G, Fusaro A, Monne I, et al. Evidence for differing evolutionary dynamics of A/H5N1 viruses among countries applying or not applying avian influenza vaccination in poultry. Vaccine 2011 Nov 21;29(50):9368-75 [Abstract]

Cattoli G, Milani A, Temperton N, et al. Antigenic drift in H5N1 avian influenza in poultry is driven by mutations in major antigenic sites of the hemagglutinin molecule analogous to human influenza. J Virol 2011 Sep;85(17):8718-24 [Abstract]

Cattoli G, Monne I, Fusaro A, et al. Highly pathogenic avian influenza virus subtype H5N1 in Africa: a comprehensive phylogenetic analysis and molecular characterization of isolates. PLoS ONE 2009 Mar 17;4(3):e4842 [Full text]

Cattoli G, Terregino C. New perspectives in avian influenza diagnosis. Zoonoses Publ Health 2008 Feb;55(1):24-8 [Abstract]

CDC. Avian influenza (bird flu) [Full text]

CDC. Avian Influenza A Viruses [Webpage]

CDC. Cases of influenza A (H5N1): Thailand, 2004. MMWR 2004 Feb 13;53(5):100-3 [Full text]

CDC. Clinical description & lab diagnosis of influenza. [Webpage]

CDC. Guidelines and recommendations: interim guidance about avian influenza (H5N1) for U.S. citizens living abroad. Outbreak notice updated Jan 13, 2011 [Full text]

CDC. Human infection with avian influenza A (H5N1) virus: advice for travelers. Outbreak notice updated Nov 3, 2008 [Full text]

CDC. Interim guidance for airline cleaning crew, maintenance crew, and baggage/package and cargo handlers for airlines returning from areas affected by avian influenza A (H5N1). Mar 13, 2006 [Full text]

CDC. Interim guidance for airline flight crews and persons meeting passengers arriving from areas with avian influenza (updated). Published Feb 18, 2004; updated frequently [Web page]

CDC. Interim guidance for protection of persons involved in U.S. avian influenza outbreak disease control and eradication activities. Feb 17, 2004 [Full text]

CDC. Interim guidance for states conducting avian mortality surveillance for West Nile virus (WNV) and/or highly pathogenic H5N1 avian influenza virus. Released Aug 23, 2006 [Full text]

CDC. Interim recommendations for infection control in health-care facilities caring for patients with known or suspected avian influenza. May 21, 2004 [Webpage]

CDC. Interim recommendations for persons with possible exposure to avian influenza during outbreaks among poultry in the United States. Feb 24, 2004 [Web page]

CDC. Key facts about avian influenza (bird flu) and avian influenza A (H5N1) virus. Updated Dec 28, 2005 [Full text]

CDC. New laboratory assay for diagnostic testing of avian influenza A/H5 (Asian lineage). MMWR 2006 Feb 3;55(Early release):1 [Full text]

CDC. Outbreak notice: Human infection with avian influenza A (H5N1) virus: advice for travelers. Published Sep 23, 2005; updated frequently [Full text]

CDC. Traveler's health: Illness and injury abroad [Webpage]

CDC. Traveler's health: Traveler's health kit [Webpage]

CDC. Travelers' Health [Webpage]

CDC. Updated interim guidance for laboratory testing of persons with suspected infection with avian influenza A (H5N1) virus in the United States. Jun 7, 2006 [Full text]

Ceyhan M, Yildirim I, Ferraris O, et al. Serosurveillance study on transmission of H5N1 virus during a 2006 avian influenza epidemic. Epidemiol Infect 2010 Sep;138(9):1274-80 [Abstract]

Chaichoune K, Wiriyarat W, Thitithanyanont A, et al. Indigenous sources of 2007 -2008 H5N1 influenza outbreaks in Thailand. J Gen Virol 2009 Jan;90(1):216-22 [Abstract]

Chakrabarti AK, Pawar SD, Cherian SS, et al. Characterization of the influenza A H5N1 viruses of the 2008-09 outbreaks in India reveals a third introduction and possible endemicity. PLoS One 2009 Nov 16;4(11):e7846 [Abstract]

Chakrabarti AK, Vipat VC, Mukherjee S, et al. Host gene expression profiling in influenza A virus-infected lung epithelial (A549) cells: a comparative analysis between highly pathogenic and modified H5N1 viruses. Virol J 2010 Sep 9;7:219 [Abstract]

Chan MC, Cheung CY, Chui WH, et al. Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respir Res 2005 Nov 11;6(1):135 [Full text]

Chan PK. Outbreak of avian influenza A (H5N1) virus infection in Hong Kong in 1997. Clin Infec Dis 2002;34:Suppl 2:S58-S64 [Abstract]

Chan RWY, Yuen KM, Yu WCL, et al. Influenza H5N1 and H1N1 virus replication and innate immune responses in bronchial epithelial cells are influenced by the state of differentiation. PLoS ONE 2010 Jan 15;5(1):e8713 [Full text]

Chandrasekaran A, Srinivasan A, Raman R, et al. Glycan topology determines human adaptation of avian H5N1 virus hemagglutinin. Nat Biotechnol 2008 Jan;26(1):107-13 [Abstract]

Chang H, Huang C, Wu J, et al. A single dose of DNA vaccine based on conserved H5N1 subtype proteins provides protection against lethal H5N1 challenge in mice pre-exposed to H1N1 influenza virus. Virol J 2010 Aug 21;7(1):197 [Abstract]

Charlton B, Crossley B, Hietala S. Conventional and future diagnostics for avian influenza. Comp Immunol Microbiol Infect Dis 2009 Jul;32(4):341-50 [Abstract]

Chen CY, Liu KJ, Tsai CP, et al. Baculovirus as an avian influenza vaccine vector: differential immune responses elicited by different vector forms. Vaccine 2010 Nov 10;28(48):7644-54 [Abstract]

Chen GW, Chang SC, Mok CK, et al. Genomic signatures of human versus avian influenza A viruses. Emerg Infect Dis 2006 Sep;12(9):1353-60 [Full text]

Chen H, Deng G, Li Z, et al. The evolution of H5H1 influenza viruses in ducks in southern China. Proc Natl Acad Sci 2004 Jul 13;101(28):10452-7 [Full text]

Chen H, Smith GJ, Li KS, et al. Establishment of multiple sublineages of H5N1 influenza virus in Asia: implications for pandemic control. Proc Natl Acad Sci 2006 Feb 21;103(8):2845-50 [Abstract]

Chen H, Smith GJ, Zhang SY, et al. Avian flu: H5N1 virus outbreak in migratory waterfowl. Nature 2005 Jul 14;436(7048):191-2 [First paragraph]

Chen J, Chen SCY, Stern P, et al. Genetic strategy to prevent influenza virus infections in animals. J Infect Dis 2008 Feb 15;197(S1):S25-8 [Abstract]

Chen J, Yang Z, Chen Q, et al. Characterization of H5N1 influenza A viruses isolated from domestic green-winged teal. Virus Genes 2008 Sep 30;38(1):66-73 [Abstract]

Chen JM, Chen JW, Dai JJ, et al. A survey of human cases of H5N1 avian influenza reported by the WHO before June 2006 for infection control. Am J Infect Control 2007 Jun;35(5);351-3 [Abstract]

Chen LM, Blixt O, Stevens J, et al. In vitro evolution of H5N1 avian influenza virus toward human-type receptor specificity. Virology (published online Nov 5) [Abstract]

Chen LM, Davis CT, Zhou H, et al. Genetic compatibility and virulence of reassortants derived from contemporary avian H5N1 and human H3N2 influenza A viruses. PLoS Pathog 2008 May 23;4(5):e1000072 [Full text]

Chen MW, Cheng TJR, Huang Y, et al. A consensus-hemagglutinin-based DNA vaccine that protects mice against divergent H5N1 influenza viruses. Proc Natl Acad Sci 2008 Sep 9;105(36):13538-43 [Abstract]

Chen PS, Tsai FT, Lin CK, et al. Ambient influenza and avian influenza virus during dust storm days and background days. Environ Health Perspect 2010 Sep;118(9):1211-6 [Abstract]

Chen X, Smith GJD, Zhou B, et al. Avian influenza A (H5N1) infection in a patient in China, 2006. Influenza Other Resp Viruses 2007 Sep/Nov;1(5-6):207-13 [Full text]

Chen Y, Luo W, Song H, et al. Mimotope ELISA for detection of broad spectrum antibody against avian H5N1 influenza virus. PLoS ONE 2011 Sep 2;6(9):e24144 [Full text]

Chen Y, Luo W, Wu WL, et al. Humanized antibodies with broad-spectrum neutralization to avian influenza. Antiviral Res 2010 Jul;87(1):81-4 [Abstract]

Chen Y, Qin K, Wu WL, et al. Broad cross-protection against H5N1 avian influenza virus infection by means of monoclonal antibodies that map to conserved viral epitopes. J Infect Dis 2009 Jan 1;199(1):49-58 [Abstract]

Chen Y, Xu F, Fan X, et al. Evaluation of a rapid test for detection of H5N1 avian influenza. J Virol Methods 2008 Dec;154(1-2):213-5 [Abstract]

Chen Y, Zhong G, Wang G, et al. Dogs are highly susceptible to H5N1 avian influenza virus. Virology 2010 Sep 15;405(1):15-9 [Abstract]

Chen Z, Kim L, Subbarao K, et al. The 2009 pandemic H1N1 virus induces anti-neuraminidase (NA) antibodies that cross-react with the NA of H5N1 viruses in ferrets. Vaccine 2012 (published online Feb 11) [Abstract]

Chen Z, Santos C, Aspelund A, et al. Evaluation of live attenuated influenza A virus H6 vaccines in mice and ferrets. J Virol 2009 Jan;83(1):65-72 [Abstract]

Cheng LS, Amaro RE, Xu D, et al. Ensemble-based virtual screening reveals potential novel antiviral compounds for avian influenza neuraminidase. J Med Chem 2008 Jul 10;51(13):3878-94 [Abstract]

Cheng VCC, Chan JFW, Wen X, et al. Infection of immunocompromised patients by avian H9N2 influenza A virus. J Infect 2011 May;62(5):394-9 [Abstract]

Cheng X, Eisenbraun M, Xu Q, et al. H5N1 vaccine-specific B cell responses in ferrets primed with live attenuated seasonal influenza vaccines. PLoS ONE 2009 Feb 11;4(2):e4336 [Full text]

Cheng X, Wu C, He J, et al. Serological and genetic characterization analyses of a highly pathogenic influenza virus (H5N1) islolated from an infected man in Shenzhen. J Med Virol 2008 Apr 21;80(6):1058-64 [Abstract]

Cheung C-L, Rayner JM, Smith GJD, et al. Distribution of amantadine-resistant H5N1 avian influenza variants in Asia. J Infect Dis Jun 15 2006;193(12):1626-9 [Abstract]

Cheung CL, Vijaykrishna D, Smith GJD, et al. Establishment of influenza A virus (H6N1) in minor poultry species in Southern China. J Virol 2007 Oct;81(19):10402-12 [Abstract]

Choi YK, Ozaki H, Webby RJ, et al. Continuing evolution of H9N2 influenza viruses in southeastern China. J Virol 2004 Aug;78(16):8609-14 [Abstract]

Chotpitayasundondh T, Thisyakorn U, Pancharoen C, et al. Safety, humoral and cell mediated immune responses to two formulations of an inactivated, split-virion influenza A/H5N1 vaccine in children. PLoS ONE 2008 Dec 29;3(12):e4028 [Full text]

Chotpitayasunondh T, Ungchusak K, Hanshaoworakul W, et al. Human disease from influenza A (H5N1), Thailand, 2004. Emerg Infect Dis 2005 Feb;11(2):201-9 [Full text]

Christian MD, Hawryluck L, Wax RS, et al. Development of a triage protocol for critical care during an influenza pandemic. CMAJ 2006 Nov 21;175(11):1377-81 [Full text]

Chutinimitkul S, Bhattarakosol P, Srisuratanon S, et al. H5N1 influenza A virus and infected human plasma. (Letter) Emerg Infect Dis 2006 Jun;12(6):1041-3 [Full text]

Chutinimitkul S, Songserm T, Amonsin A, et al. New strain of influenza A virus (H5N1), Thailand. (Letter) Emerg Infect Dis 2007 Mar;13(3):506-7 [Full text]

Chutinimitkul S, van Riel D, Munster VJ, et al. In vitro assessment of attachment pattern and replication efficiency of H5N1 influenza A viruses with altered receptor specificity. J Virol 2010 Jul;84(13):6825-33 [Abstract]

Cinatl J Jr, Michaelis M, Doerr HW. The threat of avian influenza A (H5N1). Part IV: development of vaccines. Med Microbiol Immunol 2007 Dec;196(4):213-25 [Abstract]

Coetzee N, Edeghere O, Afza M, et al. Limiting worker exposure to highly pathogenic avian influenza A (H5N1): a repeat survey at a rendering plant processing infected poultry carcasses in the UK. BMC Public Health 2011 Aug 5;11:626 [Abstract]

Coiras MT, Perez-Brena P, Garcia ML, et al. Simultaneous detection of influenza A, B, and C viruses, respiratory syncytial virus, and adenoviruses in clinical samples by multiplex reverse transcription nested-PCR assay. J Med Virol 2003 Jan;69(1):132-44 [Abstract]

Collins PJ, Haire LF, Lin YP, et al. Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants. Nature 2008 Jun 26;453(7199):1258-61 [Abstract]

Collins RA, Ko LS, Fung KY, et al Rapid and sensitive detection of avian influenza virus subtype H7 using NASBA. Biochem Biophys Res Commun 2003 Jan 10;300(2):507-15 [Abstract]

Comin A, Stegeman A, Marangon S, et al. Evaluating surveillance strategies for the early detection of low pathogenicity avian influenza infections. PLoS ONE 2012 Apr 24;7(4):e35956 [Full text]

Conenello GM, Zamarin D, Perrone LA, et al. A single mutation in the PB1-F2 of H5N1 (HK/97) and 1918 influenza A viruses contributes to increased virulence. PLoS Pathog 2007 Oct 5;3(10):e141 [Full text]

Cong Y, Wang G, Guan Z, et al. Reassortant between human-like H3N2 and avian H5 subtype influenza A viruses in pigs: a potential public health risk. PLoS ONE 2010 Sep 7;5(9):e12591 [Full text]

Coombes R. Hunting down the H5N1 virus. BMJ 2007 Feb 17;342(7589):342-3 [Abstract]

Cornelissen LAHM, de Vries RP, de Boer-Luijtze EA, et al. A single immunization with soluble recombinant trimeric hemagglutinin protects chickens against highly pathogenic avian influenza virus H5N1. PLoS ONE 2010 May 14;5(5):e10645 [Full text]

Corti D, Suguitan AL Jr, Pinna D, et al. Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine. J Clin Invest 2010 May 3;120(5):1663-73 [Full text]

Costa TP, Brown JD, Howerth EW, et al. Homo- and heterosubtypic low pathogenic avian influenza exposure on H5N1 highly pathogenic avian influenza virus infection in wood ducks (Aix sponsa). PLoS ONE 2011 Jan 6;6(1):e15987 [Full text]

Couacy-Hymann, Danho T, Keita D, et al. The first specific detection of a highly pathogenic avian influenza virus (H5N1) in Ivory Coast. Zoonoses Public Health 2009 Feb;56(1):10-5 [Abstract]

Cox RJ, Madhun AS, Hauge S, et al. A phase I clinical trial of a PER.C6 cell grown influenza H7 virus vaccine. Vaccine 2009 Mar 18;27(13):1889-97 [Abstract]

Cox RJ, Pedersen G, Madhun AS, et al. Evaluation of a virosomal H5N1 vaccine formulated with Matrix M adjuvant in a phase I clinical trial. Vaccine 2011 Oct 19;29(45):8049-59 [Abstract]

Crevar CJ, Ross TM. Elicitation of protective immune responses using a bivalent H5N1 VLP vaccine. Virol J 2008 Oct 28;5(1):131 [Abstract]

Crofts J, Paget J, Karcher F. H5N1 avian influenza virus: human cases reported in southern China. Eurosurveillance Weekly 2003 Feb 9;7(9):pii=2169 [Full text]

Crowe BA, Bruhl P, Gerencer M, et al. Evaluation of the cellular immune responses induced by a non-adjuvanted inactivated whole virus A/H5N1/VN/1203 pandemic influenza vaccine in humans. Vaccine 2010 Dec 16;29(2):166-73 [Abstract]

Cui S, Tong G. A chromatographic strip test for rapid detection of one lineage of the H5 subtype of highly pathogenic avian influenza. J Vet Diagn Invest 2008 Sep;20(5):567-71 [Abstract]

Curran MS, Ellis JS, Wreghitt TG, et al. Establishment of a UK National Influenza H5 Laboratory Network. J Med Microbiol 2007 Oct;56(10):1263-7 [Full text]

Daidoji T, Koma T, Du A, et al. H5N1 avian influenza virus induces apoptotic cell death in mammalian airway epithelial cells. J Virol 2008 Nov;82(22):11294-307 [Abstract]

Dalla Pozza M, Ceolin C, Marangon S. Emergency response following suspicion of an avian influenza outbreak. Zoonoses Publ Health 2008 Feb;55(1):50-3 [Abstract]

Dawson ED, Moore CL, Smagala JA, et al. MChip: a tool for influenza surveillance. Anal Chem 2006 Nov 15;78(22):7610-5 [Abstract]

De Clercq E. Antiviral agents active against influenza A viruses. Nature Rev Drug Disc 2006 Dec;5(12):1015-25 [Abstract]

De Jong MD, Simmons CP, Thanh TT, et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. (Letter) Nat Med 2006 Oct:12(10):1203-7 [Abstract]

De Jong MD, Thanh TT, Khank TH, et al. Oseltamivir resistance during treatment of influenza A (H5N1) infection. N Engl J Med 2005 Dec 22;353(24):2667-72 [Full text]

De Jong MD, Van Cam B, Qui PT, et al. Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma. N Engl J Med 2005 Feb 17;352:686-91 [Abstract]

De Vleeschauwer A, Atanasova K, Van Borm S, et al. Comparative pathogenesis of an avian H5N2 and a swine H1N1 influenza virus in pigs. PLoS ONE 2009 Aug 17;4(8):e6662 [Full text]

de Wit E, Kawaoka Y, de Jong MD, et al. Pathogenicity of highly pathogenic avian influenza virus in mammals. Vaccine 2008 Sep 12;26(suppl 4):D54-8 [Full text]

de Zwart O, Veldhuijzen IK, Elam G, et al. Avian influenza risk perception, Europe and Asia. Emerg Infect Dis 2007 Feb;13(2):290-3 [Full text]

DEFRA (UK Dept for Environment, Food and Rural Affairs). H5N1 highly pathogenic avian influenza outbreak, Holton, Suffolk, February 2007: lessons to be learned report. Released Oct 11, 2007 (but dated Aug 3) [Full text]

DEFRA (UK Dept for Environment, Food and Rural Affairs). Highly pathogenic avian influenza H5N1 in wild swans in Dorset. Epidemiology report released Jan 30, 2008 [Full text]

DEFRA (UK Dept for Environment, Food and Rural Affairs). Outbreak of Highly Pathogenic H5N1 Avian Influenza in Suffolk in January 2007: A Report of the Epidemiological Findings by the National Emergency Epidemiology Group, Defra. Released Apr 19, 2007 [Full text]

Delogu M, De Marco MA, Trani LD, et al. Can preening contribute to influenza A virus in wild waterbirds? PLoS ONE 2010 Jun 25;5(6):e11315 [Full text]

Dent JE, Kao R, Kiss IZ, et al. Contact structures in the poultry industry in Great Britain: exploring transmission routes for a potential avian influenza virus epidemic. BMC Vet Res 2008 Jul 23;4:27 [Abstract - with link to full text]

Desvaux S, Marx N, Ong S, et al. Highly pathogenic avian influenza virus (H5N1) outbreak in captive wild birds and cats, Cambodia. Emerg Infect Dis 2009 Mar;15(3):475-8 [Full text]

Deyde VM, Xu X, Bright RA, et al. Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide. J Infect Dis 2007 Jul 15;196(2):249-57 [Full text]

Di Giuseppe G, Abbate R, Albano L, et al. A survey of knowledge, attitudes and practices towards avian influenza in an adult population of Italy. BMC Infect Dis 2008 Mar 17;8:36 [Abstract, with link to full text]

DiNapoli JM, Yang L, Suguitan A Jr, et al. Immunization of primates with a Newcastle disease virus-vectored vaccine via the respiratory tract induces a high titer of serum neutralizing antibodies against highly pathogenic avian influenza. J Virol 2007 Nov;81(21):11560-8 [Abstract]

Ding H, Tsai C, Zhou F, et al. Heterosubtypic antibody response elicited with seasonal influenza vaccine correlates partial protection against highly pathogenic H5N1 virus. PLoS ONE 2011 Mar 25;6(3):e17821 [Full text]

Dinh PN, Long HT, Tien NTK, et al. Risk factors for human infection with avian influenza A H5N1, Vietnam, 2004. Emerg Infect Dis 2006 Dec;12(12):1841-7 [Full text]

Dishman H, Stallknecht D, Cole D, et al. Duck hunters' perceptions of risk for avian influenza, Georgia, USA. Emerg Infect Dis 2010 Aug;16(8):1279-81 [Full text]

Dogan N, Ozkan B, Boga I, et al. A successful treatment of avian influenza infection in Turkey. J Trop Pediatr 2009 Aug;55(4):268-71 [Abstract]

Doherty PC, Kelso A. Toward a broadly protective influenza vaccine. (Commentary) J Clin Invest 2008 Oct 1;118(10):3273-5 [Full text]

Doherty PC, Thomas PG. Dangerous for ferrets: lethal for humans? (Commentary) BMC Biol 2012 Feb 20;10:10 [Abstract]

Dolberg F. Emergency regional support for post-avian influenza rehabilitation. From FAO. Feb 2005 [Full text]

Donahue JG, Coleman LA, Bender J, et al. Prospective study of avian influenza infection in backyard poultry flocks and flock handlers in Wisconsin. Vector Borne Zoonotic Dis 2011 Sep;11(9):1293-7 [Abstract]

Dong G, Luo J, Zhang H, et al. Phylogenetic diversity and genotypical complexity of H9N2 influenza A viruses revealed by genomic sequence analysis. PLoS ONE 2011 Feb 28;6(2):e17212 [Full text]

Dong G, Xu C, Wang C, et al. Reassortant H9N2 influenza viruses containing H5N1-like PB1 genes isolated form black-billed magpies in southern China. PLoS ONE 2011 Sep 29;6(9):e25808 [Full text]

Driskell EA, Jones CA, Stallknecht DE, et al. Avian influenza virus isolates from wild birds replicate and cause disease in a mouse model of infection. Virology 2010 Apr 10;399(2):280-9 [Full text]

Du L, Leung VHC, Zhang X, et al. A recombinant vaccine of H5N1 HA1 fused with foldon and human IgG Fc induced complete cross-clade protection against divergent H5N1 Viruses. PLoS ONE 2011 Jan 27;6(1):e16555 [Full text]

Du N, Zhou J, Lin X, et al. Differential activation of NK cells by influenza A pseudotype H5N1 and 1918 and 2009 pandemic H1N1 viruses. J Virol 2010 Aug;84(15):7822-31 [Abstract]

Du QS, Wang SQ, Chou KC. Analogue inhibitors by modifying oseltamivir based on the crystal neuraminidase structure for treating drug-resistant H5N1 virus. Biochem Biophys Res Comm 2007 Oct 19;362(2):525-31 [Abstract]

Duan L, Bahl J, Smith GJD, et al. The development and genetic diversity of H5N1 influenza virus in China, 1996-2006. Virology 2008 Oct 25;380(2):243-254 [Abstract]

Duan L, Campitelli L, Fan XH, et al. Characterization of low-pathogenic H5 subtype influenza viruses from Eurasia: implications for the origin of highly pathogenic H5N1 viruses. J Virol 2007 Jul;81(14):7529-39 [Abstract]

Ducatez MF, Bahl J, Griffin Y, et al. Feasibility of reconstructed ancestral H5N1 influenza viruses for cross-clade protective vaccine development. Proc Natl Acad Sci 2011 Jan 4;108(1):349-54 [Abstract]

Ducatez MF, Olinger CM, Owoade AA, et al. Avian flu: multiple introductions of H5N1 in Nigeria. (Brief Communications) Nature 2006 Jul 6;442(7098):37 [Full text]

Ducatez MF, Olinger CM, Owoade AA, et al. Molecular and antigenic evolution and geographical spread of H5N1 highly pathogenic avian influenza viruses in western Africa. J Gen Virol 2007 Aug;88(8):2297-306 [Abstract]

Ducatez MF, Tarnagda Z, Tahita MC, et al. Genetic characterization of HPAI (H5N1) viruses from poultry and wild vultures, Burkina Faso. Emerg Infect Dis 2007 Apr;13(4):611-3 [Full text]

Dudley J. Age-specific infection and death rates for human A(H5N1) avian influenza in Egypt. (Rapid communications) Eurosurveill 2009 May 7;14(18):pi=19198 [Full text]

Dudley JP. Mammalian-transmissible highly pathogenic H5N1 influenza: epidemiological context. (Commentary) mBio 2012 Apr 3;3(2):e00071-12 [Abstract]

Dugan VG, Chen R, Spiro DJ, et al. The evolutionary genetics and emergence of avian influenza viruses in wild birds. PLoS Pathog 2008 May 30;4(5):e1000076 [Full text]

Dugan VG, Dunham EJ, Jin G, et al. Phylogenetic analysis of low pathogenicity H5N1 and H7N3 influenza A virus isolates recovered from sentinel, free flying, wild mallards at one study site during 2006. Virology 2011 Aug 15;417(1):98-105 [Abstract]

Duwe S, Schweiger B. A new and rapid genotypic assay for the detection of neuraminidase inhibitor resistant influenza A viruses of subtype H1N1, H3N2, and H5N1. J Virol Method 2008 Nov;153(2):134-41 [Abstract]

Eames KTD, Webb C, Thomas K, et al. Assessing the role of contact tracing in a suspected H7N2 influenza A outbreak in humans in Wales. BMC Infect Dis 2010 May 28;10(141) [Abstract]

ECDC. Ferrets as experimental models of influenza in humans. Mar 7, 2012 [Full text]

Economist staff. Bird flu in Asia: coming home to roost? Economist 2007 (published online Jan 25) [Full text]

Editorial team. Avian influenza A/(H7N2) outbreak in the United Kingdom. Eurosurveillance Weekly 2007 May 31;12(5):pii=3206 [Full text]

Edwards JC, Kang J, Silenas R. Promoting regional disaster preparedness among rural hospitals. J Rural Health 2008 Summer;24(3):321-5 [Abstract]

Edwards S. OFFLU network on avian influenza. Emerg Infect Dis 2006 Aug;12(8):1287-8 [Full text]

EFSA (European Food Safety Authority). Animal health and welfare aspects of avian influenza and the risk of its introduction into the EU poultry holdings--scientific opinion of the Panel on Animal Health and Welfare. Report released May 7, 2008 [Full text]

EFSA (European Food Safety Authority). EFSA publishes scientific report on avian influenza and food safety. Oct 26, 2005 [Press release]

Eggert D, Thomas C, Spackman E, et al. Characterization and efficacy determination of commercially available Central American H5N2 avian influenza vaccines for poultry. Vaccine 2010 Jun 23;28(29):4609-15 [Full text]

Ehrlich HJ, Muller M, Fritsch S, et al. A cell culture (Vero)-derived H5N1 whole-virus vaccine induces cross-reactive memory responses. (Brief report) J Infect Dis 2009 Oct 1;200(7):1113-8 [Abstract]

Ehrlich HJ, Muller M, Oh HML, et al. A clinical trial of a whole-virus H5N1 vaccine derived from cell culture. N Engl J Med 2008 Jun 12;358(24):2573-84 [Full text]

Eichelberger M, Golding H, Hess M, et al. FDA/NIH/WHO public workshop on immune correlates of protection against influenza A viruses in support of pandemic vaccine development, Bethesda, Maryland, US, December 10-11, 2007. Vaccine 2008 Aug 12;26(34):4299-303 [Abstract]

Ekiert DC, Bhabha G, Elsliger MA, et al. Antibody recognition of a highly conserved influenza virus epitope. Science 2009 Apr 10;324(5924):246-51 [Abstract]

El-Sayed A, Awad W, Fayed A, et al. Avian influenza prevalence in pigs, Egypt. (Letter) Emerg Infect Dis 2010 Apr;16(4):726-7 [Full text]

Ellis JS, Smith JW, Braham S, et al. Design and validation of an H5 TaqMan real-time one-step reverse transcription-PCR and confirmatory assays for diagnosis and verification of influenza A virus H5 infections in humans. J Clin Microbiol 2007 May;45(5):1535-43 [Abstract]

Ellis TM, Dyrting KC, Wong CW, et al. Analysis of H5N1 avian influenza infections from wild bird surveillance in Hong Kong from January 2006 to October 2007. Avian Pathol 2009 Apr;38(2):107-19 [Abstract]

Enserink M. Influenza: tense meeting produces some hope for flu-sharing deal. Science 2007 Nov 30;318(5855):1361 [Abstract]

Epstein S. T-cell immune responses and asymptomatic H5N1 influenza infection. (Editorial) J Infect Dis 2011 (published online Nov 11) [Abstract]

Escorcia M, Carrillo-Sanchez K, March-Mifsut S, et al. Impact of antigenic and genetic drift on the serologic surveillance of H5N2 avian influenza viruses. BMC Vet Res 2010 Dec 20;6:57 [Abstract]

Escorcia M, Vazquez L, Mendez ST, et al. Avian influenza: genetic evolution under vaccination pressure. Virol J 2008 Jan 24;5:15 [Abstract]

European Centre for Disease Prevention and Control Influenza Team. H5N1 infections in cats: public health implications. Eurosurveillance Weekly 2006 Apr 13;11(4):pii=2942 [Full text]

European Centre for Disease Surveillance and Control. Highly pathogenic avian influenza A/H5N1--update and overview of 2006. Eurosurveillance Weekly 2006 Dec 21;11(12):E061221.1 [Full text]

European Commission. Timeline of actions by the EC on avian influenza and human flu pandemic preparedness. Aug 25, 2005 [Full text]

Eurosurveillance Editorial Team. Preventing introduction and spread of avian influenza among bird flocks in Europe: recommendations by European Animal Health Panel. Eurosurveillance Weekly 2005 Sep 29;10(9):pii=2799 [Full text]

Fang LQ, de Vlas SJ, Liang S, et al. Environmental factors contributing to the spread of H5N1 avian influenza in mainland China. PLoS ONE 2008 May 28;3(5):e2268 [Full text]

FAO. Approaches to controlling, preventing and eliminating H5N1 highly pathogenic avian influenza in endemic countries. FAO Animal Production and Health paper No. 171. Report released Apr 12, 2011 [Full text]

FAO. Avian influenza background. Animal Health Special Report (Includes map of poultry density in Southeast Asia) [Web page]

FAO. Avian influenza in cats should be closely monitored. Recommendations released Feb 8, 2007 [Full text]

FAO. Bird flu situation in Indonesia critical. Report released Mar 18, 2008 [Full text]

FAO. Coping with risks posed by avian influenza and other infections diseases. (Situation update 77) FAO AIDE News 2011 May 10:1-8 [Full text]

FAO. Enhancing control of highly pathogenic avian influenza in developing countries through compensation: issues and good practice. Nov 27, 2006 [Full text]

FAO. H5N1 in cats. Mar 7, 2006 [Full text]

FAO. Risk factors of highly pathogenic avian influenza outbreaks in domestic poultry. (Situation update 69) FAO AIDE News 2010 Sep 2:1-3 [Full text]

FAO. Understanding avian influenza. Overview released Apr 7, 2008 [Full text]

Farnsworth ML, Miller RS, Pedersen K, et al. Environmental and demographic determinants of avian influenza viruses in waterfowl across the contiguous United States. PLoS ONE 2012 Mar 12;7(3):e32729 [Full text]

Farrar J. H5N1 surveillance: shift expertise to where it matters. (Commentary) Nature 2012 Mar 28;483:534-5 [Full text]

Fasina FO, Bisschop SP, Joannis TM, et al. Molecular characterization and epidemiology of the highly pathogenic avian influenza in H5N1 in Nigeria. Epidemiol Infect 2009 Apr;137(4):456-63 [Abstract]

Fasina FO, Bisschop SP, Webster RG. Avian influenza H5N1 in Africa: an epidemiological twist. Lancet Infect Dis 2007 Nov;7(11):696-7 [Full text]

Fasina FO, Bisschop SPR, Ibironke AA, et al. Avian influenza risk perception among poultry workers, Nigeria. (Letter) Emerg Infect Dis 2009 Apr;15(4):616-7 [Full text]

Fasina FO, Ifende VI, Ajibade. Avian influenza A(H5N1) in humans: lessons from Egypt. Euro Surveill 2010 Jan 28;15(4):pii=19473 [Full text]

Fasina FO, Meseko AC, Joannis TM, et al. Control versus no control: options for avian influenza H5N1 in Nigeria. Zoonoses Public Health 2007 Jun;54(5):173-6 [Abstract]

Fazekas G, Martosne-Mendi R, Jankovics I, et al. Cross-reactive immunity to clade 2 strains of influenza virus A subtype H5N1 induced in adults and elderly patients by Fluval, a prototype pandemic influenza virus vaccine derived by reverse genetics, formulated with a phosphate adjuvant, and directed to clade 1 strains. Clin Vaccine Immunol 2009 Apr;16(4):437-43 [Abstract]

FDA. FDA approves first U.S. vaccine for humans against the avian influenza virus H5N1. Apr 17, 2007, press release [Full text]

Fedson DS. Confronting an influenza pandemic with inexpensive generic agents: can it be done? Lancet Infect Dis 2008 Sep;8(9):571-6 [Abstract]

Fedson DS. Confronting the next influenza pandemic with anti-inflammatory and immunomodulatory agents: why they are needed and how they might work. Influenza Other Resp Viruses 2009 Jun 12;3(4):129-42 [Abstract]

Fereidouni SR, Werner O, Starick E, et al. Avian influenza virus monitoring in wintering waterbirds in Iran, 2003-2007. Virol J 2010 Feb;7:43 [Abstract]

Ferguson N. Poverty, death, and a future influenza pandemic. Lancet 2006 Dec 23;368(9554);2187-8 [Full text]

Ferro PJ, Budke CM, Peterson MJ, et al. Multiyear surveillance for avian influenza virus in waterfowl from wintering grounds, Texas Coast, USA. Emerg Infect Dis 2010 Aug;16(8):1224-30 [Full text]

Fidler DP. Negotiating equitable access to influenza vaccines: global health diplomacy and the controversies surrounding avian influenza H5N1 and pandemic influenza H1N1. PLoS Med 2010 May 4;7(5):e1000247 [Full text]

Fiebig L, Soyka J, Buda S, et al. Avian influenza A(H5N1) in humans: new insights from a line list of World Health Organization confirmed cases, September 2006 to August 2010. Euro Surveill 2011 Aug 11;16(32):pii=19941 [Full text]

Fielding R, Bich TH, Quang LN, et al. Live poultry exposures, Hong Kong and Hanoi, 2006. Emerg Infect Dis 2007 Jul;13(7):1065-7 [Full text]

Fielding R, Lam WW, Ho EY, et al. Avian influenza risk perception, Hong Kong. Emerg Infect Dis 2005 May;11(5):677-82 [Full text]

Finkelstein DB, Mukatira S, Mehta PK, et al. Persistent host markers in pandemic and H5N1 influenza viruses. J Virol 2007 Oct;81(19):10292-9 [Abstract]

Flint PL. Applying the scientific method when assessing the influence of migratory birds on the dispersal of H5N1. Virol J 2007 Dec 4;4:132 [Abstract]

Forrest HL, Khalenkov AM, Govorkova EA, et al. Single- and multiple-clade influenza A H5N1 vaccines induce cross protection in ferrets. Vaccine 2009 Jun 24;27(31):4187-95 [Abstract]

Fouchier RA, Schneeberger PM, Rozendaal FW, et al. Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc Natl Acad Sci USA 2004 Feb 3;101(5):1356-61 [Abstract]

Fouchier RAM, Herfst S, Osterhaus ADME. Restricted data on influenza H5N1 virus transmission. (Commentary) Science 2012 (published online Jan 19) [Full text]

Fouchier RAM, Munster V, Wallensten A, et al. Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J Virol 2005 Mar;79(5):2814-22 [Abstract]

Fox A, Horby P, Ha NH, et al. Influenza A H5N1 and HIV co-infection: case report. BMC Infect Dis 2010 Jun 14;10(1):167 [Abstract]

Fritz R, Sabarth N, Kiermayr S, et al. A vero cell-derived whole-virus H5N1 vaccine effectively induces neuraminidase-inhibiting antibodies. J Infect Dis 2011 (published online Nov 16) [Abstract]

FSSCC (Financial Services Sector Coordinating Council for Critical Infrastructure Protection and Homeland Security). Statement on preparations for "avian flu." Jan 24, 2006 [Full text]

Fusaro A, Joannis T, Monne I, et al. Introduction into Nigeria of a distinct genotype of avian influenza virus (H5N1). Emerg Infect Dis 2009 Mar;15(3):445-7 [Full text]

Fusaro A, Monne I, Salviato A, et al. Phylogeography and evolutionary history of reassortant H9N2 viruses with potential human health implications. J Virol 2011 Aug;85(16):8413-21 [Abstract]

Gabriel G, Herwig A, Klenk HD. Interaction of polymerase subunit PB2 and NP with importin alpha1 is a determinant of host range of influenza A virus. PLoS Pathog 2008 Feb 1;4(2):e11 [Full text]

Gaglia MA Jr, Cook RL, Kraemer KL, et al. Patient knowledge and attitudes about avian influenza in an internal medicine clinic. Publ Health 2008 May;122(5):462-70 [Abstract]

Gaidet N, Cappelle J, Takekawa JY, et al. Potential spread of highly pathogenic avian influenza H5N1 by wildfowl: dispersal ranges and rates determined from large-scale satellite telemetry. J Appl Ecol 2010 Oct;47(5):1147-57 [Abstract]

Gaidet N, Caron A, Cappelle J, et al. Understanding the ecological drivers of avian influenza virus infection in wildfowl: a continental-scale study across Africa. Proc R Soc B 2011 (published online Sep 14) [Abstract]

Gaidet N, Caron A, Cappelle J, et al. Understanding the ecological drivers of avian influenza virus infection in wildfowl: a continental-scale study across Africa. Proc R Soc B Biol Sci 2011 (published online Sep 14) [Abstract]

Gaidet N, Cattoli G, Hammoumi S, et al. Evidence of infection by H5N2 highly pathogenic avian influenza viruses in healthy wild waterfowl. PLoS Pathog 2008 Aug 15;4(8):e1000127 [Abstract]

Gaidet N, Dodman T, Caron A, et al. Avian influenza viruses in water birds, Africa. Emerg Infect Dis 2007 Apr;13(4):626-9 [Full text]

Gaidet N, Newman SH, Hagemeijer W, et al. Duck migration and past influenza A (H5N1) outbreak areas. (Letter) Emerg Infect Dis 2008 Jul;14(7):1164-5 [Full text]

Gall A, Hoffmann B, Harder T, et al. Design and validation of a microarray for detection, hemagglutinin subtyping, and pathotyping of avian influenza viruses. J Clin Microbiol 2009 Feb;47(2):327-34 [Abstract]

Gall-Recule GL, Briand FX, Schmitz A, et al. Double introduction of highly pathogenic H5N1 avian influenza virus into France in early 2006. Avian Pathol 2008 Feb;37(1):15-23 [Abstract]

Galli G, Medini D, Borgogni E, Zedda L, et al. Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of productive antibody levels. Proc Natl Acad Sci 2009 Mar 10;106(10):3877-82 [Abstract]

Galsworthy SJ, ten Bosch QA, Hoye BJ, et al. Effects of infection-induced migration delays on the epidemiology of avian influenza in wild mallard populations. PLoS ONE 2011 Oct 18;6(10):e26118 [Full text]

Gambaryan AS, Matrosovich TY, Philipp J, et al. Receptor-binding profiles of H7 subtype influenza viruses in different host species. J Virol 2012 (published online Feb 15) [Abstract]

Gambotto A, Barrat-Boyes SM, de Jong MD, et al. Human infection with highly pathogenic H5N1 influenza virus. Lancet 2008 Apr 25;371(9622):1464-75 [Abstract]

GAO (US Government Accountability Office). Avian influenza: USDA has taken important steps to prepare for outbreaks, but better planning could improve response. Released Jun 11, 2007 [Full text]

GAO (US Government Accountability Office). Veterinarian workforce: actions are needed to ensure sufficient capacity for protecting public and animal health. GAO-09-178. Released Feb 18, 2009 [Full text]

Gao R, Gao Y, Wen L, et al. Development and implementation of the quality control panel of RT-PCR and real-time RT-PCR for avian influenza A (H5N1) surveillance network in mainland China. BMC Infect Dis 2011 Mar 16;11:36 [Abstract]

Gao W, Soloff AD, Lu X, et al. Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization. J Virol 2006 Feb;80(4):1959-64 [Abstract]

Gao Y, Zhang Y, Shinya K, et al. Identification of amino acids in HA and PB2 critical for the transmission of H5N1 avian influenza viruses in a mammalian host. PLoS Pathog 2009 Dec 24;5(12):e1000709 [Full text]

Garcia-Sastre A, Whitley RJ. Lessons learned from reconstructing the 1918 influenza pandemic. J Infect Dis 2006 Nov 1;194(suppl 2):S127-32 [Abstract]

Garcia-Sastre A. Working safely with H5N1 viruses. (Commentary) mBio 2012 Mar 6;3(2):e00049 [Full text]

Garigliany MM, Habyarimana A, Lambrecht B, et al. Influenza A strain-dependent pathogenesis in fatal H1N1 and H5N1 subtype infections of mice. Emerg Infect Dis 2010 Apr;16(4):595-603 [Full text]

Garske T, Clarke P, Ghani AC. The transmissibility of highly pathogenic avian influenza in commercial poultry in industrialized countries. PLoS One 2007 Apr;2(4):e349 [Full text]

Gasink LB, Linkin DR, Fishman NO, et al. Stockpiling drugs for an avian influenza outbreak: examining the surge in osteltamivir prescriptions during heightened media coverage of the potential for a worldwide pandemic. Infect Control Hosp Epidemiol 2009 Apr;30(4):370-6 [Abstract]

Gauthier-Clerc M, Lebarbenchon C, Thomas F. Recent expansion of highly pathogenic avian influenza H5N1: a critical review. Ibis 2007 April;149(2):202-14 [Abstract]

Gayer M, Watson JT, Connolly MA. Displaced populations and pandemic influenza. Lancet Infect Dis 2006 Dec;6(12):755-6 [Full text - Free registration required]

Ge E, Haining R, Li CP, et al. Using knowledge fusion to analyze avian influenza H5N1 in East and Southeast Asia. PLoS ONE 2012 May 17;7(5):e29617 [Full text]

Ge J, Deng D, Wen Z, et al. Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses. J Virol 2007 Jan;81(1):150-8 [Abstract]

Geeraedts F, Goutagny N, Hornung V, et al. Superior immunogenicity of inactivated whole virus H5N1 influenza vaccine is primarily controlled by Toll-like receptor signalling. PLoS Pathog 2008 Aug 29;4(8):e1000138 [Full text]

Ghabili K, Shoja MM, Kamran P. Avian influenza knowledge, medical students, Iran. (Letter) Emerg Infect Dis 2008 Apr;14(4):672-3 [Full text]

Ghedin E, Fitch A, Boyne A, et al. Mixed infection and the genesis of influenza diversity. J Virol 2009 Sep;83(17):8832-41 [Abstract]

Giannecchini S, Clausi V, Trani LD, et al. Molecular adaptation of an H7N3 wild duck influenza virus following experimental multiple passages in quail and turkey. J Virol 2010 Dec;408(2):167-73 [Abstract]

Giese M, Harder TC, Teifke JP, et al. Experimental infection and natural contact exposure of dogs with avian influenza virus (H5N1). Emerg Infect Dis 2008 Feb;14(2):308-10 [Full text]

Gilbert M, Chaitaweesub P, Parakamawongsa T, et al. Free-grazing ducks and highly pathogenic avian influenza, Thailand. Emerg Infect Dis 2006 Feb;12(2):227-34 [Full text]

Gilbert M, Xiao X, Domenech J, et al. Anatidae migration in the western Palearctic and spread of highly pathogenic avian influenza H5N1 virus. Emerg Infect Dis 2006;12(11):1650-6 [Full text]

Gilbert M, Xiao X, Pfeiffer DU, et al. Mapping H5N1 highly pathogenic avian influenza risk in Southeast Asia. Proc Natl Acad Sci 2008 Mar 25;105(12):4769-74 [Full text]

Giles BM, Crevar CJ, Carter DM, et al. A computationally optimized hemagglutinin virus-like particle vaccine elicits broadly reactive antibodies that protect nonhuman primates from H5N1 infection. J Infect Dis 2012 (published online Mar 23) [Abstract]

Giles BM, Ross TM. A computationally optimized broadly reactive antigen (COBRA) based H5N1 VLP vaccine elicits broadly reactive antibodies in mice and ferrets. Vaccine 2011 Apr 5;29(16):3043-54 [Abstract]

Gill JS, Webby R, Gilchrist MJ, et al. Avian influenza among waterfowl hunters and wildlife professionals. Emerg Infect Dis 2006 Aug;12(8):1284-6 [Full text]

Gillard P, Caplanusi A, Knuf M, et al. An assessment of prime-boost vaccination schedules with AS03A- adjuvanted prepandemic H5N1 vaccines: a randomized study in European adults. Influenza Other Respi Viruses 2012 (published online Mar 9) [Abstract]

Gillim-Ross L, Santos C, Chen Z, et al. Avian influenza H6 viruses productively infect and cause illness in mice and ferrets. J Virol 2008 Nov;82(21):10854-63 [Abstract]

Gillim-Ross L, Subbarao K. Can immunity induced by the human influenza virus N1 neuraminidase provide some protection from avian influenza H5N1 viruses (Perspectives). PLoS Med 2007 Feb;4(2):e91 [Full text]

Gilsdorf A, Boxall N, Gasimov B, et al. Two clusters of human infection with influenza A/H5N1 virus in the Republic of Azerbaijan, February-March 2006. Eurosurveillance Monthly 2006 May;11(5):pii=620 [Full text]

Gioia C, Castilletti C, Tempestilli M, et al. Cross-subtype immunity against avian influenza in persons recently vaccinated for influenza. Emerg Infect Dis 2008 Jan;14(1):121-8 [Full text]

Giriputro S, Agus R, Sulastri S, et al. Clinical and epidemiological features of patients with confirmed avian influenza presenting to Sulianti Saroso Infectious Diseases Hospital, Indonesia, 2005-2007. Ann Acad Med Singapore 2008 Jun;37(6):454-7 [Full text]

Glezen WP. Emerging infections: pandemic influenza. Epidemiol Rev 1996;18(1):64-76 [Full text]

Globig A, Baumer A, Revilla-Fernandez S, et al. Ducks as sentinels for avian influenza in wild birds. Emerg Infect Dis 2009 Oct;15(10):1633-6 [Full text]

Globig A, Staubach C, Beer M, et al. Epidemiological and ornithological aspects of outbreaks of highly pathogenic avian influenza virus H5N1 of Asian lineage in wild birds in Germany, 2006 and 2007. Transbound Emerg Dis 2009 Apr;56(3):57-72 [Abstract]

Goji NA, Nolan C, Hill H, et al. Immune responses of healthy subjects to a single dose of intramuscular inactivated influenza A/Vietnam/1203/2004 (H5N1) vaccine after priming with an antigenic variant. J Infect Dis 2008 Sep 1;198(5):635-41 [Abstract]

Gonzales JL, Stegeman JA, Koch G, et al. Rate of introduction of a low pathogenic avian influenza virus infection in different poultry production sectors in the Netherlands. Influenza Other Respi Viruses 2012 (published online Feb 29) [Abstract]

Gonzalez-Reiche AS, Morales-Betoulle ME, Alvarez D, et al. Influenza A viruses from wild birds in Guatemala belong to the North American lineage. PLoS ONE 2012 Mar 13;7(3):e32873 [Full text]

Govorkova EA, Ilyushina NA, Boltz DA, et al. Efficacy of oseltamivir therapy in ferrets inoculated with different clades of H5N1 influenza virus. Antimicrob Agents Chemother 2007 Apr;51(4);1414-24 [Abstract]

Govorkova EA, Ilyushina NA, Marathe BM, et al. Competitive fitness of oseltamivir-sensitive and -resistant highly pathogenic H5N1 influenza viruses in a ferret model. J Virol 2010 Aug;84(16):8042-50 [Abstract]

Govorkova EA, Ilyushina NA, McClaren JL, et al. Susceptibility of highly pathogenic H5N1 influenza viruses to the neuraminidase inhibitor oseltamivir differs in vitro and in a mouse model. Antimicrob Agents Chemother 2009 Jul 1;53(7):3088-96 [Abstract]

Govorkova EA, Rehg JE, Krauss S, et al. Lethality to ferrets of H5N1 influenza viruses isolated from humans and poultry in 2004. J Virol 2005 Feb;79(4):2191-8 [Abstract]

Govorkova EA, Webby RJ, Humberd J, et al. Immunization with reverse-genetics-produced H5N1 influenza vaccine protects ferrets against homologous and heterologous challenge. J Infect Dis 2006 Jul 15;194(2):159-67 [Full text - See also Hampson below]

Goyal SM, Jindal N, Chander Y, et al. Isolation of mixed subtypes of influenza A virus from a bald eagle (Haliaeetus leucocephalus). Virol J 2010 Jul 28;7:174 [Abstract]

Graiver DA, Topliff CL, Kelling CL, et al. Survival of the avian influenza virus (H6N2) after land disposal. Environ Sci Technol 2009 Jun 15;43(11):4063-7 [Abstract]

Gray GC, Baker WS. The importance of including swine and poultry workers in influenza vaccination programs. Clin Pharmacol Ther 2007 Dec;82(6):638-41 [Abstract]

Gray GC, Kayali G. Facing pandemic influenza threats: the importance of including poultry and swine workers in preparedness plans. Poult Sci 2009 Apr;88(4):880-5 [Abstract]

Gray GC, McCarthy T, Capuano AW, et al. Evidence for avian influenza A infections among Iowa's agricultural workers. Influenza Other Resp Viruses 2008 Mar;2(2):61-9 (published online Apr 7) [Abstract]

Green MD, Nettey H, Wirtz RA. Determination of oseltamivir quality by colorimetric and liquid chromatographic methods. Emerg Infect Dis 2008 Apr;14(4):552-6 [Full text]

Grund C, Abdelwhab EM, Arafa AS, et al. Highly pathogenic avian influenza virus H5N1 from Egypt escapes vaccine-induced immunity but confers clinical protection against a heterologous clade 2.2.1 Egyptian isolate. Vaccine 2011 Jul 26;29(33):5567-73 [Abstract]

Gu J, Xie Z, Gao Z, et al. H5N1 infection of the respiratory tract and beyond: a molecular pathology study. Lancet 2007 Sep 29;370(9593):1137-45 [Full text]

Gu M, Lie W, Cao Y, et al. Novel reassortant highly pathogenic avian influenza (H5N5) viruses in domestic ducks, China. Emerg Infect Dis 2011 Jun;17(6):1060-3 [Full text]

Guan Y, Chen H, Li KS, et al. A model to control the epidemic of H5N1 influenza at the source. BMC Infect Dis 2007 Nov 13;7:132 [Abstract]

Guan Y, Shortridge KF, Krauss S, et al. Emergence of avian H1N1 influenza viruses in pigs in China. J Virol 1996 Nov;70(11):8041-6 [Full text]

Guan Y, Webby R, Capua I, et al. H5N1: how to track a flu virus. (Commentary) Nature 2012 Mar 28;483:535-6 [Full text]

Guo Y, Rumschlag-Booms E, Wang J, et al. Analysis of hemagglutinin-mediated entry tropism of H5N1 avian influenza. Virol J 2009 Apr 2;6:39 [Abstract]

Guralnik M, Rosenbloom RA, Petteruti MP, et al. Limitations of current prophylaxis against influenza virus infection. Am J Ther 2007 Sep-Oct;14(5):449-54 [Abstract]

Gutierrez RA, Sorn S, Nicholls JM, et al. Eurasian tree sparrows, risk for H5N1 virus spread and human contamination through Buddhist ritual: an experimental approach. PLoS ONE 2011 Dec 2;6(12):e28609 [Full text]

Gyarmati P, Conze T, Zohari S, et al. Simultaneous genotyping of all hemagglutinin and neuraminidase subtypes of avian influenza viruses by use of padlock probes. J Clin Microbiol 2008 May;46(5):1747-51 [Abstract]

Hadzhiolova T, Pavlova S, Kotseva R. Laboratory investigation of the first suspected human cases of infection with avian influenza A(H5N1) virus in Bulgaria. Eurosurveillance 2008 Jul 24;13(30):pii=18938 [Full text]

Hall IM, Gani R, Hughes HE, et al. Real-time epidemic forecasting for pandemic influenza. Epidemiol Infect 2007 Apr;135(3):372-85 [Abstract]

Hall JS, Bentler KT, Landolt G, et al. Influenza infection in wild raccoons. Emerg Infect Dis 2008 Dec;14(12):1842-8 [Full text]

Hall JS, Krauss S, Franson JC, et al. Avian influenza in shorebirds: experimental infection of ruddy turnstones (Arenaria interpres) with avian influenza virus. Influenza Other Respi Viruses 2012 (published online Apr 12) [Abstract]

Hammouda A, Pearce-Duvet J, Chokri MA, et al. Prevalence of influenza A antibodies in yellow-legged gull (Larus michahellis) eggs and adults in southern Tunisia. Vector Borne Zoonotic Dis 2011 Dec 6;11(12):1583-90 [Abstract]

Hampson AW, Mackenzie JS. The influenza viruses. Med J Aust 2006 Nov 20;185(10 suppl):S39-43 [Full text]

Hampson AW. Ferrets and the challenges of H5N1 vaccine formulation. (Commentary) J Infect Dis 2006 Jul 15;194(2):143-5 [Full text - See also Govorkova above]

Han Y, Hou G, Jiang W, et al. A survey of avian influenza in tree sparrows in China in 2011. PLoS ONE 2012 Apr 4;7(4):e33092 [Full text]

Hansbro PM, Warner S, Tracey JP, et al. Surveillance and analysis of avian influenza viruses, Australia. Emerg Infect Dis 2010 Dec;16(12):1896-904 [Full text]

Hanshaoworakul W, Simmerman JM, Narueponjirakul U, et al. Severe human influenza infections in Thailand: oseltamivir treatment and risk factors for fatal outcome. PLoS ONE 2009 Jun 25;4(6):e6051 [Full text]

Hanson BJ, Boon AC, Lim AP, et al. Passive immunoprophylaxis and therapy with humanized monoclonal antibody specific for influenza A H5 hemagglutinin in mice. Respiratory Res 2006 Oct 14;7:126 [Full text]

Harder TC, Teuffert J, Starick E, et al. Highly pathogenic avian influenza virus (H5N1) in frozen duck carcasses, Germany, 2007. Emerg Infect Dis 2009 Feb;15(2):272-9 [Full text]

Harvey R, Nicolson C, Johnson RE, et al. Improved haemagglutinin antigen content in H5N1 candidate vaccine viruses with chimeric haemagglutinin molecules. Vaccine 2010 Nov 23;28(50):8008-14 [Abstract]

Hatta M, Hatta Y, Kim JH, et al. Growth of H5N1 influenza A viruses in the upper respiratory tract of mice. PLoS Pathog 2007 Oct 5;3(10):e133 [Full text]

Hayashi T, Chaichoune K, Patchimasiri T, et al. Differential host gene responses in mice infected with two highly pathogenic avian influenza viruses of subtype H5N1 isolated from wild birds in Thailand. J Virol 2011 Mar 30;412(1):9-18 [Abstract]

Hayden F, Croisier A. Transmission of avian influenza viruses to and between humans. (Commentary) J Infect Dis 2005 Oct 15;192(8):1311-4 [Full text - See also Puzelli below]

Hayden FG, Cote KM, Douglas RG Jr. Plaque inhibition assay for drug susceptibility testing of influenza viruses. Antimicrob Agents Chemother 1980 May;17(5):865-70 [Full text]

Hayden FG, Pavia AT. Antiviral management of seasonal and pandemic influenza. J Infect Dis 2006 Nov 1;194(suppl 2):S119-26 [Abstract]

Hayman A, Comely S, Lackenby A, et al. NS1 proteins of avian influenza A viruses can act as antagonists of the human alpha/beta interferon response. J Virol 2007 Mar;81(5):2318-27 [Abstract]

Haynes JR, Dokken L, Wiley JA, et al. Influenza-pseudotyped Gag virus-like particle vaccines provide broad protection against highly pathogenic avian influenza challenge. Vaccine 2009 Jan 22;27(4):530-41 [Abstract]

He G, Qiao J, Dong C, et al. Amantadine-resistance among H5N1 avian influenza viruses isolated in Northern China. Antiviral Res 2008 Jan;77(1):72-6 [Abstract]

He Q, Velumani S, Du Q, et al. Detection of H5 avian influenza viruses by antigen-capture enzyme-linked immunosorbent assay using H5-specific monoclonal antibody. Clin Vaccine Immunol 2007 May;14(5):617-23 [Abstract]

He X, Zhou J, Bartlam M, et al. Crystal structure of the polymerase PAC-PB1N complex from an avian influenza H5N1 virus. Nature 2008 Aug 28;454:1123-6 [Abstract]

Health Canada. Avian influenza: British Columbia (update). Infectious Diseases News Briefs. Apr 8, 2004 [Full text]

Heiny AT, Miotto O, Srinivasan KN, et al. Evolutionarily conserved protein sequences of influenza A viruses, avian and human, as vaccine targets. PLoS ONE 2007 Nov 21;2(11):e1190 [Full text]

Henaux V, Samuel MD, Dusek RJ, et al. Presence of avian influenza viruses in waterfowl and wetlands during summer 2010 in California: are resident birds a potential reservoir? PLoS ONE 2012 Feb 6;7(2):e31471 [Full text]

Henauz V, Samuel MD, Bunck CM. Model-based evaluation of highly and low pathogenic avian influenza dynamics in wild birds. PLoS ONE 2010 Jun 23;5(6):e10997 [Full text]

Henning J, Pfeiffer DU, Vu LT. Risk factors and characteristics of H5N1 highly pathogenic avian influenza (HPAI) post-vaccination outbreaks. Vet Res 2008 Dec 12;40(3):15 [Abstract]

Henning J, Wibawa H, Morton J, et al. Scavenging ducks and transmission of highly pathogenic avian influenza, Java, Indonesia. Emerg Infect Dis 2010 Aug;16(8):1244-50 [Full text]

Herfst S, Osterhaus DME, Fouchier RAM. The future of research and publication on altered H5N1 viruses. (Perspective) J Infect Dis 2012 (published online Mar 27) [Abstract]

Herrmann B, Larsson C, Zweygberg BW. Simultaneous detection and typing of influenza viruses A and B by a nested reverse transcription-PCR: comparison to virus isolation and antigen detection by immunofluorescence and optical immunoassay (FLU OIA). J Clin Microbiol 2001 Jan;39(1):134-8 [Full text]

HHS. Pandemic influenza plan. Released Nov 2, 2005 [Links to overview and full text]

Hickman D, Hossain MJ, Song H, et al. An avian live attenuated master backbone for potential use in epidemic and pandemic influenza vaccines. J Gen Virol 2008 Nov;89(11):2682-90 [Full text]

Hien ND, Ha NH, Van NT, et al. Human infection with highly pathogenic avian influenza virus (H5N1) in northern Vietnam, 2004-2005. Emerg Infect Dis 2009 Jan;15(1):19-23 [Full text]

Hien TT, Liem NT, Dung NT, et al. Avian influenza A (H5N1) in 10 patients in Vietnam. N Engl J Med 2004 Mar 18;350(12):1179-88 [Abstract]

Higgs ES, Hayden FG, Chotpitayasunondh T, et al. The Southeast Asian Influenza Clinical Research Network: development and challenges for a new multilateral research endeavor. Antiviral Res 2008 Apr;78(1):64-68 [Abstract]

Hill AW, Guralnick RP, Wilson MJC, et al. Evolution of drug resistance in multiple distinct lineages of H5N1 avian influenza. Infect Genet Evol 2009 Mar;9(2):169-78 [Abstract]

Hill NJ, Takekawa JY, Cardona CJ, et al. Cross-seasonal patterns of avian influenza virus in breeding and wintering migratory birds: a flyway perspective. Vector Borne Zoonotic Dis 2011 (published online Oct 13) [Abstract]

Hinjoy S, Puthavathana P, Laosiritaworn Y, et al. Low frequency of infection with avian influenza virus (H5N1) among poultry farmers, Thailand, 2004. Emerg Infect Dis 2008 Mar;14(3):499-501 [Full text]

Ho HT, Qiang HL, He F, et al. Rapid detection of H5N1 subtype influenza viruses by antigen-capture enzyme-linked immunosorbent assay using H5 and N1 specific monoclonal antibodies. Clin Vaccine Immunol 2009 May;16(5):726-32 [Abstract]

Hoa LK, Hiep LV, Be LV. Development of pandemic influenza vaccine production capacity in Viet Nam. Vaccine 2011 Jul 1;29(suppl 1):A34-6 [Abstract]

Hoelscher MA, Garg S, Bangari DS, et al. Development of adenoviral-vector-based pandemic influenza vaccine against antigenetically distinct human H5N1 strains in mice. Lancet 2006 Feb 11;367(9509):475-81 [Abstract]

Hoelscher MA, Singh N, Garg S, et al. A broadly protective vaccine against globally dispersed clade 1 and clade 2 H5N1 influenza viruses. J Infect Dis 2008 Apr 15;197(8):1185-8 [Abstract]

Hoffmann B, Harder T, Starick E, et al. Rapid and highly sensitive pathotyping of avian influenza A H5N1 virus by using real-time reverse transcription-PCR. J Clin Microbiol 2007 Feb;45(2):600-3 [Abstract]

Holman DH, Wang D, Raja NU, et al. Multi-antigen vaccines based on complex adenovirus vectors induce protective immune responses against H5N1 avian influenza viruses. Vaccine 2008 May 19;26(21):2627-39 [Abstract]

Hooker C, King C, Leask J, et al. Journalists' views about reporting avian influenza and a potential pandemic: a qualitative study. Influenza Other Respi Viruses 2011 (published online Dec 17) [Abstract]

Hoper D, Kalthoff D, Hoffman B, et al. Highly pathogenic avian influenza subtype H5N1 escaping neutralization: more than HA variation. J Virol 2011 (published online Nov 16) [Abstract]

Horby P, Sudoyo H, Viprakasit V, et al. What is the evidence of a role for host genetics in susceptibility to influenza A/H5N1? Epidemiol Infect 2010 Mar 18:1-9 [Abstract]

Horimoto T, Maeda K, Murakami S, et al. Highly pathogenic avian influenza virus infection in feral raccoons, Japan. Emerg Infect Dis 2011 Apr;17(4):714-7 [Full text]

Horimoto T, Murakami S, Muramoto Y, et al. Enhanced growth of seed viruses for H5N1 influenza vaccines. Virology 2007 Sep 15;366(1):23-7 [Abstract]

Horm SV, Gutierrez RA, Sorn S, et al. Environment: a potential source of animal and human infection with influenza A (H5N1) virus. Influenza Other Respi Viruses 2012 (published online Feb 17) [http://onlinelibrary.wiley.com/doi/10.1111/j.1750-2659.2012.00338.x/abstract]

Horm VS, Gutierrez RA, Nicholls JM, et al. Highly pathogenic influenza A(H5N1) virus survival in complex artificial aquatic biotopes. PLoS ONE 2012 Apr 13;7(4):e34160 [Full text]

Horthongkham N, Srihtrakul T, Athipanyasilp N, et al. Specific antibody response of mice after immunization with COS-7 cell derived avian influenza virus (H5N1) recombinant proteins. J Immune Based Ther Vaccines 2007 Oct;5(1):10 (published online Oct 3) [Abstract]

Hoschler K, Gopal R, Andres N, et al. Cross-neutralization of antibodies elicited by an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine in healthy adults against H5N1 clade 2 strains. Influenza Other Resp Viruses 2007 Sep/Nov;1(5-6):199-206 [Full text]

Hossain MJ, Hickman D, Perez DR. Evidence of expanded host range and mammalian-associated genetic changes in a duck H9N2 influenza virus following adaptation in quail and chickens. PLoS ONE 2008 Sep 9;3(9):e3170 [Full text]

Hourfar MK, Themann A, Eickmann M, et al. Blood screening for influenza. Emerg Infect Dis 2007 Jul;13(7):1081-3 [Full text]

Hoye BJ, Fouchier RA, Klaassen M. Host behaviour and physiology underpin individual variation in avian influenza virus infection in migratory Bewick's swans. Proc Royal Soc 2011 (published online Jul 6) [Abstract]

Hoye BJ, Munster VJ, Nishiura H, et al. Surveillance of wild birds for avian influenza virus. Emerg Infect Dis 2010 Dec;16(12):1827-34 [Full text]

Hsu JL, Liu KE, Huang MH, et al. Consumer knowledge and risk perceptions of avian influenza. Poult Sci 2008 Aug;87(8):1526-34 [Abstract]

Hu AY, Weng TC, Tseng YF, et al. Microcarrier-based MDCK cell culture system for the production of influenza H5N1 vaccines. Vaccine 2008 Oct 23;26(45):5736-40 [Abstract]

Hu H, Voss J, Zhang G, et al. A human antibody recognizing a conserved epitope of H5 hemagglutinin broadly neutralizes highly pathogenic avian influenza H5N1 viruses. J Virol 2012 (published online Jan 11) [Abstract]

Hu J, Zhao K, Liu X, et al. Two highly pathogenic avian influenza H5N1 viruses of clade 2.3.2.1 with similar genetic background but with different pathogenicity in mice and ducks. Transbound Emerg Dis 2012 (published online Apr 12) [Abstract]

Hu X, Liu D, Wang M, et al. Clade 2.3.2 avian influenza virus (H5N1), Qinghai Lake region, China 2009-2010. Emerg Infect Dis 2011 Mar;17(3):560-2 [Full text]

Huai Y, Xiang N, Zhou L, et al. Incubation period for human cases of avian influenza A (H5N1) infection, China. (Letter) Emerg Infect Dis 2008 Nov;14(11):1819-20 [Full text]

Huang K, Bahl J, Fan XH, et al. Establishment of an H6N2 influenza virus lineage in domestic ducks in southern China. J Virol 2010 Jul;84(14):6978-86 [Abstract]

Huang K, Zhu H, Fan X, et al. Establishment and lineage replacement of H6 influenza viruses in domestic ducks in southern China. J Virol 2012 (published online Mar 21) [Abstract]

Hulse-Post DJ, Franks J, Boyd K, et al. Molecular changes in the polymerase genes (PA and PB1) associated with high pathogenicity of H5N1 influenza virus in mallard ducks. J Virol 2007 Aug;81(16):8515-24 [Abstract]

Hulse-Post DJ, Sturm-Ramirez KM, Humberd J, et al. Role of domestic ducks in the propagation and biological evolution of highly pathogenic H5N1 influenza viruses in Asia. Proc Natl Acad Sci 2005 Jul 26;102(30):10682-7 [Abstract]

Humberd J, Boyd K, Webster RG. Emergence of influenza A virus variants after prolonged shedding from pheasants. J Virol 2007 Apr;81(8):4044-51 [Abstract]

Hung LH, Tsai PC, Wang CH, et al. Immunoadjuvant efficacy of plasmids with multiple copies of a CpG motif coadministrated with avian influenza vaccine in chickens. Vaccine 2011 Jun 24;29(29-30):4668-75 [Abstract]

Huo X, Zu R, Qi X, et al. Seroprevalence of avian influenza A (H5N1) virus among poultry workers in Jiangsu Province, China: an observational study. BMC Infect Dis 2012 Apr 18;12:93 [Abstract]

Hurt AC, Holien JK, Barr IG. In vitro generation of neuraminidase inhibitor resistance in A(H5N1) influenza viruses. Antimcicrob Agents Chemother 2009 Oct;53(10):4433-40 [Abstract]

Hurt AC, Lowther S, Middleton D, et al. Assessing the development of oseltamivir and zanamivir resistance in A(H5N1) influenza viruses using a ferret model. Antivir Res 2010 Sep;87(3):361-6 [Full text]

Hurtado TR. Human influenza A (H5N1): a brief review and recommendations for travelers. Wilderness Environ Med 2006 Dec;17(4):276-81 [Abstract]

Hwang SD, Shin JS, Ku KB, et al. Protection of pregnant mice, fetuses and neonates from lethality of H5N1 influenza viruses by maternal vaccination. Vaccine 2010 Apr 9;28(17):2957-64 [Full text]

Ichinohe T, Tamura SI, Kawaguchi A, et al. Cross-protection against H5N1 influenza virus infection is afforded by intranasal inoculation with seasonal trivalent inactivated influenza vaccine. J Infect Dis 2007 Nov 1;196(9):1313-20 [Abstract]

Iglesias I, Perez AM, Sanchez-Vizcaino JM. Reproductive ratio for the local spread of highly pathogenic avian influenza in wild bird populations of Europe, 2005-2008. Epidemiol Infect 2011 Jan;139(1):99-104 [Abstract]

Ikeno D, Kimachi K, Ibaragi K, et al. Differences in the priming effect of various clades/subclades of inactivated H5N1 vaccine for booster injection with heterologous clades of vaccine strains. Vaccine 2011 May 31;29(24):4156-61 [Abstract]

Ilyushina NA, Govorkova EA, Gray TE, et al. Human-like receptor specificity does not affect the neuraminidase-inhibitor susceptibility of H5N1 viruses. PLos Pathog 2008 Apr 11;4(4):e1000043 [Full text]

Ilyushina NA, Govorkova EA, Russell CJ, et al. Contribution of H7 haemagglutinin to amantadine resistance and infectivity of influenza virus. J Gen Virol 2007 Apr;88(4):1266-74 [Abstract]

Ilyushina NA, Hay A, Yilmaz N, et al. Oseltamivir-ribavirin combination therapy for highly pathogenic H5N1 influenza virus infection in mice. Antimicrob Agents Chemother 2008 Nov;52(11):3889-97 [Abstract]

Ilyushina NA, Seiler JP, Rehg JE, et al. Effect of neuraminidase inhibitor-resistant mutations on pathogenicity of Clade 2.2 A/Turket/15/06 (H5N1) influenza virus in ferrets. PloS Pathog 2010 May 27;6(5):e1000933 [Full text]

Imai H, Shinya K, Takano R, et al. The HA and NS genes of human H5N1 influenza A virus contribute to high virulence in ferrets. PLoS Pathog 2010 Sep 16;6(9):e1001106 [Full text]

Imai M, Watanabe T, Hatta M, et al. Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. (Letter) Nature 2012 (published online May 2) [Full text]

Imai Y, Kuba K, Neely GG, et al. Identification of oxidative stress and toll-like receptor 4 signalling as a key pathway of acute lung injury. Cell 2008 Apr 18;133(2):235-49 [Abstract]

Imperiale MJ, Hanna MG. Biosafety considerations of mammalian-transmissible H5N1 influenza. (Commentary) mBio 2012 Mar 6;3(2):e00043 [Full text]

India Press Information Bureau. A vison and road map. Document released at the close of 3-day international conference on avian flu. Dec 6, 2007 [Full text]

Indriani R, Samaan G, Gultom A, et al. Environmental sampling for avian influenza virus A (H5N1) in live-bird markets, Indonesia. Emerg Infect Dis 2010 Dec 12;16(12):1889-95 [Full text]

Influenza Team, ECDC. Highly pathogenic avian influenza A/H5N1 in birds within the EU--implications for public health. Euro Surveill 2007 Jul 5;12(7):pii=3230 [Full text]

Influenza team, ECDC. Low pathogenicity avian influenzas and human health. Eurosurveillance Weekly 2007 May 31;12(5):pii=3209 [Full text]

Influenza team, ECDPC. Outbreaks of highly pathogenic avian influenza (A/H5N1) in commercial poultry in Hungary and the UK--public health implications? Eurosurveillance Weekly 2007 Feb 15;12(2):E070215.3 [Full text]

Inglesby TV, Cicero A, Henderson DA. The risk of engineering a highly transmissible H5N1 virus. (Editorial) Biosecur Bioterror 2011 (published online Dec 16) [Abstract]

Inoue K. Highly pathogenic avian flu, Japan. (Letter) Emerg Infect Dis 2004 Jul;10(7):1327-8 [Full text]

Ip HS, Flint PL, Franson JC, et al. Prevalence of influenza A viruses in wild migratory birds in Alaska: patterns of variation in detection at a crossroads of intercontinental flyways. Virol J 2008 Jun 4;5(1):71 [Abstract]

Isbarn I, Bucknow R, Himmelreich A, et al. Inactivation of avian influenza virus by heat and high hydrostatic pressure. J Food Prot 2007 Mar;70(3):667-73 [Abstract]

Isoda N, Sakoda Y, Kishida N, et al. Potency of an inactivated avian influenza vaccine prepared from a non-pathogenic H5N1 reassortant virus generated between isolates from migratory ducks in Asia. Arch Virol 2008;153(9):1685-92 [Abstract]

Itoh Y, Ozaki H, Tsuchiya H, et al. A vaccine prepared from a non-pathogenic H5N1 avian influenza virus strain confers protective immunity against highly pathogenic avian influenza virus infection in cynomolgus macaques. Vaccine 2008 Jan 24;26(4):562-72 [Abstract]

Iwami S, Suzuki T, Takeuchi Y. Paradox of vaccination: is vaccination really efective against avian flu epidemics? PLoS ONE 2009 Mar 18;4(3):e4915 [Full text]

Jackson S, Van Hoeven N, Chen LM, et al. Reassortant between avian H5N1 and human H3N2 influenza viruses in ferrets: a public health risk assessment. J Virol 2009 Aug;83(16):8131-40 [Abstract]

Jadhao SJ, Achenbach J, Swayne DE, et al. Development of Eurasian H7N7/PR8 high growth reassortant virus for clinical evaluation as an inactivated pandemic influenza vaccine. Vaccine 2008 Mar 25;26(14):1742-50 [Abstract]

James CM, Foong YY, Mansfield JP, et al. Use of tetanus toxoid as a differentiating infected from vaccinated animals (DIVA) strategy for sero-surveillance of avian influenza virus vaccination in poultry. Vaccine 2007 Aug 1;25(31):5892-901 [Abstract]

Jang H, Boltz D, Sturm-Ramirez K, et al. Highly pathogenic H5N1 influenza virus can enter the central nervous system and induce neuroinflammation and neurodegeneration. Proc Natl Acad Sci 2009 Aug 18;106(33):14063-8 [Abstract]

Jang YH, Byun YH, Lee YJ, et al. Cold-adapted pandemic 2009 H1N1 influenza live vaccine elicits cross-reactive immune responses against seasonal and H5 influenza A viruses. J Virol 2012 (published online Mar 21) [Abstract]

Jarhult JD, Muradrasoli S, Wahlgren J, et al. Environmental levels of the antiviral oseltamivir induce development of resistance mutation H274Y in influenza A/H1N1 virus in mallards. PLoS ONE 2011 Sep 12;6(9):e24742 [Full text]

Jayawardena S, Cheung CY, Barr I, et al. Loop-mediated isothermal amplification for influenza A (H5N1) virus. Emerg Infect Dis 2007 Jun;13(6):899-901 [Full text]

Jennings LC, Monto AS, Chan PKS, et al. Stockpiling prepandemic influenza vaccines: a new cornerstone of pandemic preparedness plans. Lancet Infect Dis 2008 Oct;8(10):650-8 [Abstract]

Jia B, Shi J, Li Y, et al. Pathogenicity of Chinese H5N1 highly pathogenic avian influenza viruses in pigeons. Arch Virol 2008 Oct;153(10):1821-6 [Abstract]

Jiang H, Yang H, Kapczynski DR. Chicken interferon alpha pretreatment reduces virus replication of pandemic H1N1 and H5N9 avian influenza viruses in lung cell cultures from different avian species. Virol J 2011 Sep 22;8:447 [Abstract]

Jiao P, Tian G, Li Y, et al. A single-amino-acid substitution in the NS1 protein changes the pathogenicity of H5N1 avian influenza viruses in mice. J Virol 2008 Feb;82(3):1146-54 [Abstract]

Jin R, Lv Z, Chen Q, et al. Safety and immunogenicity of H5N1 influenza vaccine based on baculovirus surface display system of Bombyx mori. PLoS ONE 2008 Dec 12;2(12):e3933 [Full text]

Joannis TM, Meseko CA, Okadokun AT, et al. Serologic and virologic surveillance of avian influenza in Nigeria, 2006-7. Eurosurveillance 2008 Oct 16;13(42):pii=19007 [Full text]

Jones JC, Turpin EA, Bultmann H, et al. Inhibition of influenza virus infection by a novel antiviral peptide that targets viral attachment to cells. J Virol 2006 Dec;80(24):11960-7 [Abstract]

Jonges M, Bataille A, Enserink R, et al. Comparative analysis of avian influenza virus diversity in poultry and humans during a highly pathogenic avian influenza A(H7N7) outbreak. J Virol 2011 Oct;85(20):10598-604 [Abstract]

Joseph T, McAuliffe J, Lu B, et al. Evaluation of replication and pathogenicity of avian influenza A subtype viruses in a mouse model. J Virol 2007 Oct;81(19):10558-66 [Abstract]

Jourdain E, Gauthier-Clerc M, Bicout D, et al. Bird migration routes and risk for pathogen dispersion into western Mediterranean wetlands. Emerg Infect Dis 2007 Mar;13(3):362-72 [Full text]

Jourdain E, Gunnarsson G, Wahlgren J, et al. Influenza virus in a natural host, the mallard: experimental infection data. PLoS One 2010 Jan 28;5(1):8935 [Full text]

Kalthoff D, Breithaupt A, Teifke JP, et al. Highly pathogenic avian influenza virus (H5N1) in experimentally infected adult mute swans. Emerg Infect Dis 2008 Aug;14(8):1267-70 [Full text]

Kalthoff D, Giritch A, Geisler K, et al. Immunization with plant-expressed hemagglutinin protects chickens from lethal HPAIV H5N1 challenge infection. J Virol 2010 Nov;84(22):12002-10 [Abstract]

Kalthoff D, Hoffmann B, Harder T, et al Experimental infection of cattle with highly pathogenic avian influenza virus (H5N1). Emerg Infect Dis 2008 Jul;14(7):1132-4 [Full text]

Kamiyama Y, Adachi K, Handharyani E, et al. Protection from avian influenza H5N1 virus infection with antibody-impregnated filters. Virol J 2011 Feb 8;8:54 [Abstract]

Kanamori S, Jimba M. Compensation for avian influenza cleanup. (Letter) Emerg Infect Dis 2007 Feb;13(2):341-2 [Full text]

Kandeel A, Manoncourt S, Kareem ABE, et al. Zoonotic transmission of avian influenza virus (H5N1), Egypt, 2006-2009. Emerg Infect Dis 2010 Jul;16(7):1101-7 [Full text]

Kandun IN, Tresnaningsih E, Purba WH, et al. Factors associated with case fatality of human H5N1 virus infections in Indonesia: a case series. Lancet 2008 Aug 30;372(9640):744-9 [Abstract]

Kandun IN, Wibisono H, Sedyaningsih ER, et al. Three Indonesian clusters of H5N1 virus infection in 2005. N Engl J Med 2006 Nov 23;355(21):2186-94 [Full text]

Kang SM, Yoo DG, Lipatov AS, et al. Induction of long-term protective immune responses by influenza H5N1 virus-like particles. PLoS ONE 2009 Mar 2;4(3):e4667 [Abstract]

Kang XP, Jiang T, Li YQ et al. A duplex real-time RT-PCR assay for detecting H5N1 avian influenza virus and pandemic H1N1 influenza virus. Virol J 2010 Jun 2;7:113 [Abstract]

Karesh WB, Cook RA, Gilbert M, et al. Implications of wildlife trade on the movement of avian influenza and other infectious diseases. J Wildl Dis 2007 Jul;43(3 suppl):S55-9 [Abstract]

Karron RA, Callahan K, Luke C, et al. A live attenuated H9N2 influenza vaccine is well tolerated and immunogenic in healthy adults. J Infect Dis 2009 Mar 1;199(5):711-6 [Abstract]

Karron RA, Talaat K, Luke C, et al. Evaluation of two live attenuated cold-adapted H5N1 influenza virus vaccines in healthy adults. Vaccine 2009 Aug 6;27(36):4953-60 [Abstract]

Kash JC, Tumpey TM, Proll SC, et al. Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature 2006 Oct5;443(7111):578-81 [Abstract]

Kashyap AK, Steel J, Oner AF, et al. Combinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategies. Proc Natl Acad Sci 2008 Apr 22;105(16):5986-91 [Abstract]

Katz JM, Veguilla V, Belser JA, et al. The public health impact of avian influenza viruses. Poult Sci 2009 Apr;88(4):872-9 [Abstract]

Kaverin NV, Rudneva IA, Govorkova EA, et al. Epitope mapping of the hemagglutinin molecule of a highly pathogenic H5N1 influenza virus by using monoclonal antibodies. J Virol 2007 Dec;81(23):12911-7 [Abstract]

Kawaoka Y. H5N1: Flu transmission work is urgent. (Commentary) Nature 2012 (published online Jan 25) [Abstract]

Kayali G, El-Shesheny R, Kutkat MA, et al. Continuing threat of influenza (H5N1) virus circulation in Egypt. Emerg Infect Dis 2011 Dec;17(12):2306-8 [Full text]

Kayali G, Ortiz EJ, Chorazy ML, et al. Evidence of previous avian influenza infection among US turkey workers. Zoonoses Public Health 2009 Apr 8;57(4):265-72 [Abstract]

Kayali G, Webby RJ, Ducatez MF, et al. The epidemiological and molecular aspects of influenza H5N1 viruses at the human-animal interface in Egypt. PLoS ONE 2011 Mar 21;6(3):e17730 [Full text]

Kaye D, Pringle CR. Avian influenza viruses and their implication for human health. Clin Infect Dis 2005 Jan 1;40(1):108-12 [Full text]

Keawcharoen J, Oraveerakul K, Kuiken T, et al. Avian influenza H5N1 in tigers and leopards. Emerg Infect Dis 2004 Dec;10(12):2189-91 [Full text]

Keawcharoen J, van den Broak J, Bouma A, et al. Wild birds and increased transmission of highly pathogenic avian influenza (H5N1) among poultry, Thailand. Emerg Infect Dis 2011 Jun;17(6):1016-22 [Full text]

Keawcharoen J, van Riel D, van Amerongen G, et al. Wild ducks as long-distance vectors of highly pathogenic avian influenza virus (H5N1). Emerg Infect Dis 2008 Apr;14(4):600-7 [Full text]

Kerkhove MDV, Mumford E, Mounts AW, et al. Highly pathogenic avian influenza (H5N1): pathways of exposure at the animal-human interface, a systematic review. PLoS ONE 2011 Jan 24;6(1):e14582 [Full text]

Kessler N, Ferraris O, Palmer K, et al. Use of the DNA flow-thru chip, a three-dimensional biochip, for typing and subtyping of influenza viruses. J Clin Microbiol. 2004 May;42(5):2173-85 [Full text]

Khalenkov A, Perk S, Panshin A, et al. Modulation of the severity of highly pathogenic H5N1 influenza in chickens previously inoculated with Israeli H9N2 influenza viruses. Virology 2009 Jan 5;383(1):32-8 [Abstract]

Khuntirat BP, Yoon IK, Blair PJ, et al. Evidence for subclinical avian influenza virus infections among rural Thai villagers. Clin Infect Dis 2011 Oct 15;53(8):e107-16 [Abstract]

Khurana S, Sasono P, Fox A, et al. H5N1-serodetect EIA and rapid test: a novel differential diagnostics assay for serodiagnosis of H5N1 infections and surveillance. J Virol 2011 Dec;85(23):12455-63 [Abstract]

Khurana S, Suguitan AL Jr, Rivera Y, et al. Antigenic fingerprinting of H5N1 avian influenza using convalescent sera and monoclonal antibodies reveals potential vaccine and diagnostic targets. PLoS Med 2009 Apr 21;6(4):e1000049 [Full text]

Khurana S, Wu J, Verma N, et al. H5N1 virus-like particle vaccine elicits cross reactive neutralizing antibodies in humans that preferentially bind to oligomeric form of influenza hemagglutinin. J Virol 2011 Nov;85(21):10945-54 [Abstract]

Kilpatrick AM, Chmura AA, Gibbons DW, et al. Predicting the global spread of H5N1 avian influenza. Proc Natl Acad Sci 2006 Dec 19;103(51):19368-73 [Abstract]

Kim HR, Lee YJ, Park CK, et al. Highly pathogenic avian influenza (H5N1) outbreaks in wild birds and poultry, South Korea. Emerg Infect Dis 2012 (published online Feb 20) [Full text]

Kim JH, Lo FK, Cheuk KK, et al. Knowledge of avian influenza (H5N1) among poultry workers, Hong Kong, China. Emerg Infect Dis 2011 Dec;17(12):2319-21 [Full text]

Kim JK, Negovetich NJ, Forrest HL, et al. Ducks: the "trojan horses" of H5N1 influenza. Influenza Other Resp Viruses 2009 Jul;3(4):121-8 [Abstract]

Kim T, Hwang W, Zhang A, et al. Multi-agent modeling of the South Korean avian influenza epidemic. BMC Infect Dis 2010 Aug 10;10:236 [Abstract]

Kimble B, Nieto GR, Perez DR. Characterization of influenza virus sialic acid receptors in minor poultry species. Virol J 2010 Dec 9;7:365 [Abstract]

Kimble JB, Sorrell E, Shao H, et al. Compatibility of H9N2 avian influenza surface genes and 2009 pandemic H1N1 internal genes for transmission in the ferret model. Proc Natl Acad Sci 2011 Jul 19;108(29):12084-8 [Abstract]

Kishida N, Sakoda Y, Shiromoto M, et al. H2N5 influenza virus isolates from terns in Australia: genetic reasssortants between those of the Eurasian and American lineages. Virus Genes 2008 Aug;37(1):16-21 [Abstract]

Kiso M, Kubo S, Ozawa M, et al. Efficacy of the new neuraminidase inhibitor CS-8958 against H5N1 influenza viruses. PLoS Pathog 2010 Feb 26;6(2):e1000786 [Full text]

Kiso M, Takahashi K, Sakai-Tagawa Y, et al. T-705 (favipiravir) activity against lethal H5N1 influenza A viruses. Proc Natl Acad Sci 2010 Jan 12;107(2):882-7 [Abstract]

Kiss I, Gyarmati P, Zohari S, et al. Molecular characterization of highly pathogenic H5N1 avian influenza viruses isolated in Sweden in 2006. Virol J 2008 Oct 6;5:113 [Abstract]

Kistner O, Howard MK, Spruth M, et al. Cell culture (Vero) derived whole virus (H5N1) vaccine based on wild-type virus strain induces cross-protective immune responses. Vaccine 2007 Aug 10;25(32):6028-36 [Abstract]

Kitphati R, Pooruk P, Lerdsamran H, et al. Kinetics and longevity of antibody response to influenza A H5N1 infection in humans. Clin Vaccine Immunol 2009 Jul;16(7):978-81 [Abstract]

Kleijn D, Munster VJ, Ebbinge BS, et al. Dynamics and ecological consequences of avian influenza virus infection in greater white-fronted geese in their winter staging areas. Proc Biol Sci 2010 Jul 7;277(1690):2041-8 [Abstract]

Kleinman AM, Bloom BR, Saich A, et al. Avian and pandemic influenza: a biosocial approach. J Infect Dis 2008 Feb 15;197(S1):S1-S3 [Abstract]

Koehler AV, Pearce JM, Flint PL, et al. Genetic evidence of intercontinental movement of avian influenza in a migratory bird: the northern pintail (Anas acuta). Mol Ecol 2008 Nov;17(21):4754-62 [Abstract]

Koh GCH, Yee WT, Kwing CS, et al. Avian influenza: a global threat needing a global solution. (Commentary) Asia Pacific Fam Med 2008 Nov 13;7:5 [Abstract]

Kohls A, Hafez KM, Harder T, et al. Avian influenza virus risk assessment in falconry. Virol J 2011 Apr 23;8:187 [Abstract]

Komar N, Olsen B. Avian influenza virus (H5N1) mortality surveillance. (Letter) Emerg Infect Dis 2008 Jul;14(7):1176-7 [Full text]

Kongchanagul A, Suptawiwat O, Kanrai P, et al. Positive selection at the receptor-binding site of haemagglutinin H5 in viral sequences derived from human tissues. J Gen Virol 2008 Aug;89(8):1805-10 [Full text]

Koopmans M, Wilbrink B, Conyn M, et al. Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands. Lancet 2004 Feb 21;363(9409):587-93 [Abstract]

Koopmans M, Wilbrink B, Conyn M, et al. Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands. Lancet 2004 Feb 21;363(9409):587-93 [Abstract]

Korteweg C, Gu J. Pathology, molecular biology, and pathogenesis of avian influenza A (H5N1) infection in humans. Am J Pathol 2008 May;172(5):1155-70 [Abstract]

Kotwal GJ. Genetic diversity-independent neutralization of pandemic viruses (eg, HIV), potentially pandemic (eg, H5N1 strain of influenza) and carcinogenic (eg, HBV and HCV) viruses, and possible agents of bioterrorism (variola) by enveloped virus neutralizing compounds (EVNCs). Vaccine 2008 Jun 6;26(24):3055-8 [Abstract]

Kou Z, Lei FM, Yu J, et al. New genotype of avian influenza H5N1 viruses isolated from tree sparrows in China. J Virol 2005 Dec;79(24):15460-6 [Abstract]

Kowachi S, Luong ST, Shigematsu M, et al. Risk parameters of fulminant acute respiratory distress syndrome and avian influenza (H5N1) infection in Vietnamese children. J Infect Dis 2009 Aug 15;200(4):510-5 [Abstract]

Kraemer JD, Gostin LO. The limits of government regulation of science. (Commentary) Science 2012 (published online Jan 19) [Full text]

Krauss S, Obert CA, Franks J, et al. Influenza in migratory birds and evidence of limited intercontinental virus exchange. PLoS Pathog 2007 Nov 9;3(11):e167 [Full text]

Krauss S, Pryor SP, Raven G, et al. Respiratory tract versus cloacal sampling of migratory ducks for influenza A viruses: are both ends relevant? Influenza Other Respi Viruses 2012 (published online Mar 28) [Abstract]

Kreijtz JH, de Mutsert G, van Baalen CA, et al. Cross-recognition of avian H5N1 influenza virus by human cytotoxic T-lymphocyte populations directed to human influenza A virus. J Virol 2008 Jun;82(11):5161-66 [Abstract]

Kreijtz JH, Osterhaus AS, Rimmelzwaan GF. Vaccination strategies and vaccine formulations for epidemic and pandemic influenza. Hum Vaccines 2009 Mar;5(3):13-22 [Abstract]

Kreijtz JH, Suezer Y, de Mutsert G, et al. Recombinant modified vaccinia virus Ankara expressing the hemagglutinin gene confers protection against homologous and heterologous H5N1 influenza virus infections in macaques. J Infect Dis 2008 Feb 1;199(3):405-13 [Abstract]

Kreijtz JH, Suezer Y, van Amerongen G, et al. Recombinant modified vaccinia virus Ankara-based vaccine induces protective immunity in mice against infection with influenza virus H5N1. J Infect Dis 2007 Jun 1;195(11):1598-606 [Abstract]

Krenn BM, Egorov A, Romanovskaya-Romanko E, et al. Single HA2 mutation increases the infectivity and immunogenicity of a live attenuated H5N1 intranasal influenza vaccine candidate lacking NS1. PLoS ONE 2011 Apr 7;6(4):e18577 [Full text]

Kuiken T, Fouchier R, Rimmelzwaan G, et al. Feline friend or potential foe? Nature 2006 Apr 6;440:741-2 [Full text]

Kuiken T, Holmes EC, McCauley J, et al. Host species barriers to influenza virus infections. (Perspective) Science 2006 Apr 21;312(5772):394-7 [Full text]

Kuiken T, Rimmelzwaan G, van Riel D, et al. Avian H5N1 influenza in cats. Science 2004 Oct 8;306(5694):241 [Abstract - Access requires free registration]

Kuiken T, Taubenberger JK. Pathology of human influenza revisited. Vaccine 2008 Sep 12;26(suppl 4):D59-66 [Full text]

Kung NY, Morris RS, Perkins NR, et al. Risk for infection with highly pathogenic influenza A virus (H5N1) in chickens, Hong Kong, 2002. Emerg Infect Dis 2007 Mar;13(3):412-8 [Full text]

Kuo PC, Huang JH, Liu MD. Avian influenza risk perception and preventive behavior among traditional market workers and shoppers in Taiwan: practical implications for prevention. PLoS ONE 2011 Sep 2;6(9):e24157 [Full text]

Kwon D, Lee JY, Choi W, et al. Avian influenza A (H5N1) virus antibodies in poultry cullers, South Korea, 2003-2004. Emerg Infect Dis 2012 (published online May 9) [Full text]

Kwon YK, Thomas C, Swayne DE. Variability in pathobiology of South Korean H5N1 high-pathogenicity avian influenza virus infection for 5 species of migratory waterfowl. Vet Pathol 2010 May;47(3):495-506 [Abstract]

Lackenby A, Thompson CI, Democratis J. The potential impact of neuraminidase inhibitor resistant influenza. Curr Opin Infect Dis 2008 Dec;21(6):626-38 [Abstract]

Laddy DJ, Yan J, Corbitt N, et al. Immunogenicity of novel consensus-based DNA vaccines against avian influenza. Vaccine 2007 Apr 20;25(16):2984-9 [Abstract]

Laddy DJ, Yan J, Khan AS, et al. Electroporation of synthetic DNA antigens offers protection in nonhuman primates challenged with highly pathogenic avian influenza virus. J Virol 2009 May;83(9):4624-30 [Abstract]

Laddy DJ, Yan J, Kutzler M, et al. Heterosubtypic protection against pathogenic human and avian influenza viruses via in vivo electroporation of synthetic consensus DNA antigens. PLoS ONE 2008 Jun 25;3(6):e2517 [Full text]

Lai JM, Hwang YT, Chou CC. Modeling exotic highly pathogenic avian influenza virus entrance risk through air passenger violations. Risk Analysis 2011 (published online Dec 9) [Abstract]

Lalor PA, Webby RJ, Morrow J, et al. Plasmid DNA-based vaccines protect mice and ferrets against lethal challenge with A/Vietnam/1203/04 (H5N1) influenza virus. J Infect Dis 2008 Jun 15;197(12):1643-52 [Abstract]

Lam PY. Avian influenza and pandemic influenza preparedness in Hong Kong. Ann Acad Med Singapore 2008 Jun;37(6):489-96 [Full text]

Lam TTY, Hon CC, Lemey P, et al. Phylodynamics of H5N1 avian influenza virus in Indonesia. Mol Ecol 2012 (published online May 11) [Abstract]

Lam TTY, Hon CC, Pybus OG, et al. Evolutionary and transmission dynamics of reassortant H5N1 influenza virus in Indonesia. PLoS Pathog 2008 Aug 22;4(8):e1000130 [Full text]

Lam WY, Tang JW, Yeung ACM, et al. Avian influenza virus A/HK/483/97(H5N1) NS1 protein induces apoptosis in human airway epithelial cells. J Virol 2008 Mar;82(6):2741-51 [Abstract]

Lancet Editorial Staff. Asian H5N1 still going strong at 10 years old (Leading Edge). Lancet Infect Dis 2007 Mar;7(3):175 [Full text -- Free registration required]

Landon MR, Amaro RE, Baron R, et al. Novel druggable hot spots in avian influenza neuraminidase H5N1 revealed by computational solvent mapping of a reduced and representative receptor ensemble. Chem Biol Drug Des 2008 Feb;71(2):106-16 [Abstract]

Landry N, Ward BJ, Trepanier S, et al. Preclinical and clinical development of plant-made virus-like particle vaccine against avian H5N1 influenza. PLoS ONE 2010 Dec 22;5(12):e15559 [Full text]

Lang AS, Kelly A, Runstadler JA. Prevalence and diversity of avian influenza viruses in environmental reservoirs. J Gen Virol 2008 Feb;89(2):509-19 [Abstract]

Langley JM, Frenette L, Ferguson L, et al. Safety and cross-reactive immunogenicity of candidate AS03-adjuvanted prepandemic H5N1 influenza vaccines: a randomized controlled phase 1/2 trial in adults. J Infect Dis 2010 Jun 1;201(11):1644-53 [Abstract]

Langley JM, Risi G, Caldwell M, et al. Dose-sparing H5N1 A/Indonesia/05/2005 pre-pandemic influenza vaccine in adults and elderly adults: a phase III, placebo-controlled, randomized study. J Infect Dis 2011 Jun 15;203(12):1729-38 [Abstract]

Lasko B, Reich D, Madan A, et al. Rapid immunization against H5N1: a randomized trial evaluating homologous and cross-reactive immune responses to AS03A- adjuvanted vaccination in adults. J Infect Dis 2011 Aug 15;204(4):574-81 [Abstract]

Latorre-Margalef N, Gunnarsson G, Munster VJ, et al. Effects of influenza A virus infection on migrating mallard ducks. Proc R Soc B 2008 Dec;21(6):626-38 [Abstract]

Lau EHY, Leung YHC, Zhang LJ, et al. Effect of interventions on influenza A (H9N2) isolation in Hong Kong's live poultry markets, 1999-2005. Emerg Infect Dis 2007 Sep;13(9):1340-7 [Full text]

Lau JT, Kim JH, Tsui HY, et al. Perceptions related to bird-to-human avian inlfuenza, influenza vaccination, and use of face mask. Infection 2008 Oct;36(5):434-43 [Abstract]

Lau JTF, Tsui HY, Kim JH, et al. Monitoring of perceptions, anticipated behavioral, and psychological responses related to H5N1 influenza. Infection 2010 Aug;38(4):275-83 [Abstract]

Lau YF, Tang LH, Ooi EE. A TLR3 ligand that exhibits potent inhibition of influenza virus replication and has strong adjuvant activity has the potential for dual applications in an influenza pandemic. Vaccine 2009 Feb 25;27(9):1354-64 [Abstract]

Layton RC, Gigliotti A, Armijo P, et al. Enhanced immunogenicity, mortality protection, and reduced viral brain invasion by alum adjuvant with an H5N1 split-virion vaccine in the ferret. PLoS ONE 2011 Jun 7;6(6):e20641 [Full text]

Le MTQ, Wertheim HFL, Nguyen HD, et al. Influenza A H5N1 clade 2.3.4 virus with a different antiviral susceptibility profile replaced clade 1 virus in humans in northern Vietnam. PLoS ONE 2008 Oct 6;3(10):e3339 [Full text]

Le QM, Kiso M, Someya K, et al. Isolation of drug-resistant H5N1 virus. Nature 2005 Oct 20;437:1108 [Abstract]

Le QM, Sakai-Tagawa Y, Ozawa M, et al. Selection of H5N1 influenza virus PB2 during replication in humans. J Virol 2009 May;83(10):5279-81 [Abstract]

Leask J, Chapman S, Hawe P, et al. What maintains parental support for vaccination when challenged by anti-vaccination messages? A qualitative study. Vaccine 2006 Nov 30;4(49-50):7238-45 [Abstract]

Lebarbenchon C, Feare CJ, Renaud F, et al. Persistence of highly pathogenic avian influenza in natural ecosystems. (Perspective) Emerg Infect Dis 2010 Jul;16(7):1057-62 [Full text]

Lebarbenchon C, Stallknecht DE. Host shifts and molecular evolution of H7 avian influenza virus hemagglutinin. Virol J 2011 Jun 28;8:328 [Abstract]

Ledgerwood JE, Wei CJ, Hu Z, et al. DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomized clinical trials. Lancet Infect Dis 2011 Dec;11(12):916-24 [Full text]

Lednicky JA, Hamilton SB, Tuttle RS, et al. Ferrets develop fatal influenza after inhaling small particle aerosols of highly pathogenic avian influenza virus A/Vietnam/1203/2004 (H5N1). Virol J 2010 Sep 15;7:231 [Abstract]

Lee CW, Suarez DL, Tumpey TM, et al. Characterization of highly pathogenic H5N1 avian influenza A viruses isolated from South Korea. J Virol 2005 Mar;79(6):3692-702 [Full text]

Lee DH, Park JK, Lee YN, et al. H9N2 avian influenza virus-like particle vaccine provides protective immunity and a strategy for the differentiation of infected from vaccinated animals. Vaccine 2011 May 23;29(23):4003-7 [Abstract]

Lee J, Song YJ, Park JH, et al. Emergence of amantadine-resistant H3N2 avian influenza A virus in South Korea. J Clin Microbiol 2008 Nov;46(11):3788-90 [Abstract]

Lee JH, Pascua PNQ, Song MS, et al. Isolation and genetic characterization of H5N2 influenza viruses from pigs in Korea. J Virol 2009 May;83(9):4205-15 [Abstract]

Lee JS, Kim HS, Seo SH. Genetic characterization and protective immunity of cold-adapted attenuated avian H9N2 influenza vaccine. Vaccine 2008 Dec 2;26(51):6569-76 [Abstract]

Lee LHW, Ha DLA, Simmons C, et al. Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals. J Clin Invest 2008 Oct 1;118(10):3478-90 [Full text]

Lee SMY, Cheung CY, Nicholls JM, et al. Hyperinduction of cyclooxygenase-2-mediated proinflammatory cascade: a mechanism for the pathogenesis of avian influenza H5N1 infection. J Infect Dis 2008 Aug 15;198(4):525-35 [Abstract]

Lee SMY, Gardy JL, Cheung CY, et al. Systems-level comparison of host-responses elicited by avian H5N1 and seasonal H1N1 influenza viruses in primary human macrophages. PLoS One 2009 Dec 14;4(12):e8072 [Full text]

Lee YJ, Choi YK, Kim YJ, et al. Highly pathogenic avian influenza virus (H5N1) in domestic poultry and relationship with migratory birds, South Korea. Emerg Infect Dis 2008 Mar;14(3):487-90 [Full text]

Lefrancois T, Hendrikx P, Vachiery N, et al. Interaction between research and diagnosis and surveillance of avian influenza within the Caribbean Animal Health Network (CaribVET). Transbound Emerg Dis 2010 Apr;57(1-2):11-4 [Abstract]

Legastelois I, Garcia-Sastre A, Palese P, et al. Preparation of genetically engineered A/H5N1 and A/H7N1 pandemic vaccine viruses by reverse genetics in a mixture of Vero and chicken embryo cells. Influenza Other Respir Virus 2007 May;1(3):95-104 [Full text]

Leibler JH, Carone M, Silbergeld EK. Contribution of company affiliation and social contacts to risk estimates of between-farm transmission of avian influenza. PLoS ONE 2010 Mar 25;5(3):e9888 [Full text]

Leroux-Roels I, Bernhard R, Gerard P, et al. Broad clade 2 cross-reactive immunity induced by an adjuvanted clade 1 rH5N1 pandemic influenza vaccine. PLoS ONE 2008 Feb 27;3(2):e1665 [Full text]

Leroux-Roels I, Leroux-Roels G. Current status and progress of prepandemic and pandemic influenza vaccine development. Expert Rev Vaccines 2009 Apr;8(4):401-23 [Abstract]

Leroux-Roels K, Borkowski A, Vanwolleghem T, et al. Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial. Lancet 2007 Aug 18;370(9587):580-9 [Abstract]

Leschnik M, Weikel J, Mosti K, et al. Subclinical infection with avian influenza A (H5N1) virus in cats. Emerg Infect Dis 2007 Feb;13(2):243-7 [Full text]

Leslie T, Billaud J, Mofleh J, et al. Knowledge, attitudes, and practices regarding avian influenza (H5N1), Afghanistan. Emerg Infect Dis 2008 Sep;14(9):1459-61 [Full text]

Leung YHC, Zhang LJ, Chow CK, et al. Poultry drinking water used for avian influenza surveillance. Emerg Infect Dis 2007 Sep;13(9):1380-2 [Full text]

Levie K, Leroux-Roels I, Hoppenbrouwers K, et al. An adjuvanted, low-dose, pandemic influenza A (H5N1) vaccine candidate is safe, immunogenic, and induces cross-reactive immune responses in healthy adults. J Infect Dis 2008 Sep 1;198(5):642-9 [Abstract]

Li C, Bankhead A, Eisfeld AJ, et al. Host regulatory network response to infection with highly pathogenic H5N1 avian influenza virus. J Virol 2011 Nov;85(21):10955-67 [Abstract]

Li C, Bankhead A, Eisfeld AJ, et al. Host regulatory network response to infection with highly pathogenic H5N1 avian influenza virus. J Virol 2011 Nov;85(21):10955-67 [Abstract]

Li C, Hatta M, Nidom CA, et al. Reassortment between avian H5N1 and human H3N2 influenza viruses creates hybrid viruses with substantial virulence. Proc Natl Acad Sci 2010 May 9;107(10):4687-92 [Abstract]

Li C, Ping J, Jing B, et al. H5N1 influenza marker vaccine for serological differentiation between vaccinated and infected chickens. Biochem Biophys Res Comm 2008 Jul 25;372(2):293-7 [Abstract]

Li FCK, Choi BCK, Pak AWP. Finding the real case-fatality rate of H5N1 avian influenza. J Epidemiol Comm Health 2008 Jun;62(6):555-9 [Abstract]

Li J, Cai H, Liu Q, et al. Molecular and pathological characterization of two H5N1 avian influenza viruses isolated from wild ducks. Virus Genes 2008 Aug;37(1):88-95 [Abstract]

Li J, Dohna HZ, Cardona CJ, et al. Emergence and genetic variation of neuraminidase stalk deletions in avian influenza viruses. PLoS ONE 2011 Feb 23;6(2):e14722 [Full text]

Li KS, Guan Y, Wang J, et al. Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia. Nature 2004 Jul 8;430:209-13 [Abstract]

Li KS, Xu KM, Peiris JS, et al. Characterization of H9 subtype influenza viruses from the ducks of southern China: a candidate for the next influenza pandemic in humans? J Virol 2003 Jun;77(12):6988-94 [Full text]

Li Y, Liu L, Zhang Y, et al. New avian influenza virus (H5N1) in wild birds, Qinghai, China. Emerg Infect Dis 2011 Feb;17(2):265-7 [Full text]

Li Y, Shi J, Zhong G, et al. Continued evolution of H5N1 influenza viruses in wild birds, domestic poultry, and humans in China from 2004 to 2009. J Virol 2010 Sep;84(17):8389-97 [Abstract]

Li YG, Chittaganpitch M, Waicharoen S, et al. Characterization of H5N1 influenza viruses isolated from humans in vitro. Virol J 2010 Jun 1;7:112 [Abstract]

Li Z, Chen J, Jiao P, et al. Molecular basis of replication of duck H5N1 influenza viruses in a mammalian mouse model. J Virol 2005 Sep;79(18):12058-64 [Abstract]

Li Z, Jiang Y, Jiao P, et al. The NS1 gene contributes to the virulence of H5N1 avian influenza virus. J Virol 2006 Nov;80(22):11115-23 [Abstract]

Liang L, Xu B, Chen Y, et al. Combining spatial-temporal and phylogenetic analysis approaches for improved understanding on global H5N1 transmission. PLoS ONE 2010 Oct 22;5(10):e13575 [Full text]

Liao Q, Cowling BJ, Lam WT, et al. Changing perception of avian influenza risk, Hong Kong, 2006-2010. (Letter) Emerg Infect Dis 2011 Dec;17(12):2379-80 [Full text]

Liem NT, WHO International Avian Influenza Investigation Team - Vietnam, Lim W. Lack of H5N1 avian influenza transmission to hospital employees, Hanoi, 2004. Emerg Infect Dis 2005 Feb;11(2):210-5 [Full text]

Lierz M, Hafez HM, Klopfleisch R, et al. Protection and virus shedding of falcons vaccinated against highly pathogenic avian influenza A virus (H5N1). Emerg Infect Dis 2007 Nov;13(11):1667-74 [Full text]

Liljebjelke KA, Petkov DI, Kapczynski DR. Mucosal vaccination with a codon-optimized hemagglutinin gene expressed by attenuated Salmonella elicits a protective immune response in chickens against highly pathogenic avian influenza. Vaccine 2010 Jun 17;28(27):4430-7 [Full text]

Lim APC, Chan CEZ, Wong SKK, et al. Neutralizing human monoclonal antibody against H5N1 influenza HA selected from a Fab-phage display library. Virol J 2008 Oct 28;5:130 [Abstract]

Lim APC, Wong SKK, Chan AHY, et al. Epitope characterization of the protective monoclonal antibody VN01-2 shows broadly neutralizing activity against highly pathogenic H5N1. Virology J 2008 Jul 11;5:80 [Abstract]

Lim WS, Thomson A, Little P. Preparing for the next flu pandemic. (Editorial) BMJ 2007 Feb 10;334(7588):268-9 [Abstract]

Lin B, Malanoski AP, Wang Z, et al. Universal detection and identification of avian influenza using resequencing microarrays. J Clin Microbiol 2009 Apr;47(4):988-93 [Abstract]

Lin J, Zhang J, Dong X, et al. Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial. Lancet 2006 Sep 16;368(9540):991-7 [Abstract - access requires free registration]

Lin JH, Tseng CP, Chen YJ, et al. Rapid differentiation of influenza A virus subtypes and genetic screening for virus variants by high-resolution melting analysis. J Clin Microbiol 2008 Mar;46(3):1090-7 [Abstract]

Lin JT, Li CG, Wang X, et al. Antibody persistence after 2-dose priming and booster response to a third dose of an inactivated, adjuvanted, whole-virion H5N1 vaccine. J Infect Dis 2009 Jan 15;199(2):184-7 [Abstract]

Lin SC, Huang MH, Tsou PC, et al. Recombinant trimeric HA protein immunogenicity of H5N1 avian influenza viruses and their combined use with inactivated or adenovirus vaccines. PLoS ONE 2011 May 31;6(5):e20052 [Full text]

Lindegardh N, Davies GR, Hien TT, et al. Importance of collection tube during clinical studies of oseltamivir. Antimicrob Agents Chemother 2007 May;51(5):1835-6 [Abstract]

Lipatov AS, Evseenko VA, Yen HL, et al. Influenza (H5N1) viruses in poultry, Russian Federation, 2005-2006. Emerg Infect Dis 2007 Apr 13(4):539-46 [Full text]

Lipatov AS, Govorkova EA, Webby RJ, et al. Influenza: emergence and control. J Virol 2004 Sep;78(17):8951-9 [Full text]

Lipatov AS, Kwon YK, Pantin-Jackwood MJ, et al. Pathogenesis of H5N1 influenza virus infections in mice and ferret models differs according to respiratory tract or digestive system exposure. J Infect Dis 2009 Mar 1;199(5):717-25 [Abstract]

Lipatov AS, Kwon YK, Sarmento LV, et al. Domestic pigs have low susceptibility to H5N1 highly pathogenic avian influenza viruses. PLoS Pathog 2008 Jul 11;4(7):e1000102 [Full text]

Lipatov AS, Webby RJ, Govorkova EA, et al. Efficacy of H5 influenza vaccines produced by reverse genetics in a lethal mouse model. J Infect Dis 2005 Apr 15;191(8):1216-20 [Abstract]

Liu CG, Liu M, Lie F, et al. Evaluation of several adjuvants in avian influenza vaccine to chickens and ducks. Virol J 2011 Jun 26;8:321 [Abstract]

Liu CM, Lin SH, Chen YC, et al. Temperature drops and the onset of severe avian influenza A H5N1 virus outbreaks. PLoS One 2007 Feb 7;2(2):e191 [Full text]

Liu J, Chen P, Jiang Y, et al. A duck enteritis virus-vectored bivalent live vaccine provides fast and complete protection against H5N1 avian influenza virus in ducks. J Virol 2011 Nov;85(21):10989-98 [Abstract]

Liu J, Chen P, Jiang Y, et al. A duck enteritis virus-vectored bivalent live vaccine provides fast and complete protection against H5N1 avian influenza virus infection in ducks. J Virol 2011 Nov;85(21):10989-98 [Abstract]

Liu J, Xiao J, Lei F, et al. Highly pathogenic H5N1 influenza virus infection in migratory birds. (Brevia) Science 2005 Aug 19;309(5738):1206 [Full text]

Lopez P, Caicedo Y, Sierra A, et al. Combined, concurrent, and sequential administration of seasonal influenza and MF59-adjuvanted A/H5N1 vaccines: a phase II randomized, controlled trial of immunogenicity and safety in healthy adults. J Infect Dis 2011 Jun 15;203(12):1719-28 [Abstract]

Loth L, Prijono WB, Wibawa H, et al. Evaluation of two avian influenza type A rapid antigen tests under Indonesian field conditions. J Vet Diagn Invest 2008 Sep;20(5):642-4 [Abstract]

Low DE. Pandemic planning: non-pharmaceutical interventions. Respirology 2008 Mar;13(s1):S44-8 [Full text]

Lu PS. Early Diagnosis of avian influenza. (Editorial) Science 2006 Apr 21;312(5772):337 [Summary]

Lu S. Two is better than one. (Commentary) Lancet Infect Dis 2011 Dec;11(12):889-91 [Extract]

Lucio-Forster A, Bowman DD, Lucio-Martinez B, et al. Inactivation of the avian influenza virus (H5N2) in typical domestic wastewater and drinking water treatment systems. Environ Eng Sci 2006 Nov;23(6):897-903 [Abstract]

Luke TC, Kilbane EM, Jackson JL, et al. Meta-analysis: convalescent blood products for Spanish influenza: a future H5N1 treatment? Ann Intern Med 2006 Oct 17;145(8):599-609 [Abstract - See also Treanor editorial below]

Ly S, Van Kerkhove MD, Holl D, et al. Interaction between humans and poultry, rural Cambodia. Emerg Infect Dis 2007 Jan;13(1):130-2 [Full text]

Lyall J, Irvine RM, Sherman A, et al. Suppression of avian influenza transmission in genetically modified chickens. Science 2011 Jan 14;331(6014):223-6 [Abstract]

Ma W, Vincent AL, Gramer MR, et al. Identification of H2N3 influenza A viruses from swine in the United States. Proc Natl Acad Sci 2007 Dec 26;104(52):20949-54 [Abstract]

Maas R, Tacken M, Ruuls L, et al. Avian influenza (H5N1) susceptibility and receptors in dogs. Emerg Infect Dis 2007 Aug;13(8):1219-21 [Full text]

Mahmood K, Bright RA, Mytle N, et al. H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses. Vaccine 2008 Oct 3;26(42):5393-9 [Abstract]

Maines TR, Chen LM, Belser JA, et al. Multiple genes contribute to the virulent phenotype observed in ferrets of an H5N1 influenza virus isolated from Thailand in 2004. Virology 2011 May 10;413(2):226-30 [Abstract]

Maines TR, Chen LM, Matsuoka Y, et al. Lack of transmission of H5N1 avian-human reassortant influenza viruses in a ferret model. Proc Natl Acad Sci 2006 Aug 8;103(32):1221-6 [Abstract]

Maines TR, Chen LM, Van Hoeven N, et al. Effect of receptor binding domain mutations on receptor binding and transmissibility of avian influenza H5N1 viruses. Virology 2011 Apr 25;413(1):139-47 [Abstract]

Maines TR, Lu XH, Erb SM, et al. Avian influenza (H5N1) viruses isolated from humans in Asia in 2004 exhibit increased virulence in mammals. J Virol 2005 Sep;79(18):11788-800 [Abstract]

Maines TR, Szretter K, Perrone L, et al. Pathogenesis of emerging avian influenza viruses in mammals and the host innate immune response. Immunol Rev 2008 Oct;225(1):68-84 [Abstract]

Majury A, Ash J, Toye B, et al. Laboratory diagnosis of human infection with avian influenza. CMAJ 2006 Nov 21;175(11):1371-2 [Full text]

Mallick AI, Parvizi P, Read LR, et al. Enhancement of immunogenicity of a virosome-based avian influenza vaccine in chickens by incorporating CpG-ODN. Vaccine 2011 Feb 11;29(8):1657-65 [Abstract]

Manabe T, Thuy PTP, Can VV, et al. Impact of educational intervention concerning awareness and behaviors relating to avian influenza (H5N1) in a high-risk population in Vietnam. PLoS ONE 2011 Aug 22;6(8):e23711 [Full text]

Manabe T, Thuy PTP, Kudo K, et al. Impact of education and network for avian influenza H5N1 in human: knowledge, clinical practice, and motivation on medical providers in Vietnam. PLoS ONE 2012 Jan 23;7(1):e30384 [Full text]

Manzoli L, Salanti G, De Vito C, et al. Immunogenicity and adverse events of avian influenza A H5N1 vaccine in healthy adults: multiple-treatments meta-analysis. Lancet Infect Dis 2009 Aug;9(8):482-92 [Abstract]

Marangon S, Cecchinato M, Capua I. Use of vaccination in avian influenza control and eradication. Zoonoses Public Health 2008 Feb;55(1):65-72 [Abstract]

Marcus PI, Girshick T, van der Heide L, et al. Super-sentinel chickens and detection of low-pathogenicity influenza virus. Emerg Infect Dis 2007 Oct;13(10):1608-10 [Full text]

Marsden-Haug N, Foster VB, Gould PL, et al. Code-based syndromic surveillance for influenzalike illness by International Classification of Diseases, Ninth Revision. Emerg Infect Dis 2007 Feb;13(2):207-16 [Full text]

Martell-Moran NK, Mauer WA, Kaneene JB. Assessment of avian influenza surveillance and reporting needs of stakeholders in Michigan, 2007. J Am Vet Med Assoc 2011 Jun 15;238(12):1570-83 [Abstract]

Martin V, Pfeiffer DU, Zhou X, et al. Spatial distribution and risk factors of highly pathogenic avian influenza (HPAI) H5N1 in China. PLoS Pathog 2011 Mar 3;7(3):e1001308 [Full text]

Martinez M, Perez Am, de la Torre A, et al. Association between number of wild birds sampled for identification of H5N1 avian influenza virus and incidence of the disease in the European Union. Transbound Emerg Dis 2008 Dec;55(9-10):393-403 [Abstract]

Martinez M, Perez AM, De La Torre A, et al. Evaluating surveillance in wild birds by the application of risk assessment of avian influenza introduction into Spain. Epidemiol Infect 2011 Jan;139(1):91-8 [Abstract]

Mase M, Tanimura N, Imada T, et al. Recent H5N1 avian Influenza A virus increases rapidly in virulence to mice after a single passage in mice. J Gen Virol 2006 Dec;87(12):3655-9 [Abstract]

Matrosovich M, Matrosovich T, Uhlendorff J, et al. Avian-virus-like receptor specificity of the hemagglutinin impedes influenza virus replication in cultures of human airway epithelium. Virology 2007 May 10;361(2):384-90 [Abstract]

Matrosovich MN, Matrosovich TY, Gray T, et al. Human and avian influenza viruses target different cell types in cultures of human airway epithelium. Proc Natl Acad Sci 2004 Mar 30;101(13):4620-4 [Full text]

McAuley JL, Chipuk JE, Boyd KL, et al. PB1-F2 proteins from H5N1 and 20th century pandemic influenza viruses cause immunopathology. PLoS Pathog 2010 Jul 22;6(7):e1001014 [Full text]

McDermott JE, Shankaran H, Eisfeld AJ, et al. Conserved host response to highly pathogenic avian influenza virus infection in human cell culture, mouse and macaque model systems. BMC Syst Biol 2011 Nov 11;8:190 [Abstract]

McKimm-Breschkin J, Trivedi T, et al. Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir. Antimicrob Agents Chemother. 2003 Jul;47(7):2264-72 [Full text]

McKimm-Breschkin JL, Selleck PW, Usman TB, et al. Reduced sensitivity of influenza A (H5N1) to oseltamivir. Emerg Infect Dis 2007 Sep;13(9):1354-7 [Full text]

McSwiggen JA, Seth S. A potential treatment for pandemic influenza using siRNA targeting conserved regions of influenza A. Expert Opin Biol Ther 2008 Mar;8(3):299-313 [Abstract]

Mehle A, Doudna JA. An inhibitory activity in human cells restricts the function of an avian-like influenza virus polymerase. Cell Host Microbe 2008 Aug 14;4(2):111-22 [Abstract]

Mehle A, Dugan VG, Taubenberger JK, et al. Reassortment and mutation of the avian influenza polymerase PA subunit overcomes species barriers. J Virol 2011 (published online Nov 16) [Abstract]

Mehlmann, M, Bonner AB, Williams JV, et al. Comparison of the MChip to viral culture, reverse transcription-PCR, and the QuickVue influenza A+B test for rapid diagnosis of influenza. J Clin Microbiol 2007 Apr;45(4):1234-7 [Abstract]

Meijer A, Du Ry van Beest Holle M, Fouchier R, et al. Human infection associated with outbreak of fowl plague (avian influenza) in the Netherlands: update 27. Euro Surveill 2003 Mar 27;7(13):pii=2193 [Full text]

Melidou A, Gioula G, Exidari M, et al. Influenza A(H5N1): an overview of the current situation. (Perspectives) Euro Surveill 2009 May 21;14(20):pii=19216 [Full text]

Melnychuk RM, Kenny NP. Pandemic triage: the ethical challenge (Commentary). CMAJ 2006 Nov 21;74(11):1393-4 [Full text]

Meseko CA, Oladokun AT, Ekong PS, et al. Rapid antigen detection in the diagnosis of highly pathogenic avian influenza (H5N1) virus in Nigeria. Diagn Microbiol Infect Dis 2010 Oct;68(2):163-5 [Abstract]

Metzgar D, Myers CA, Russell KL, et al. Single assay for simultaneous detection and differential identification of human and avian influenza virus types, subtypes, and emergent variants. PLoS One 2010 Feb 3;5(2):e8995 [Full text]

Michaelis M, Geiler J, Naczk P, et al. Glycyrrhizin exerts antioxidative effects in H5N1 influenza A virus-infected cells and inhibits virus replication and pro-inflammatory gene expression. PLoS ONE 2011 May 17;6(5):e19705 [Full text]

Middleton D, Bingham J, Selleck P, et al. Efficacy of inactivated vaccines against H5N1 avian influenza infection in ducks. Virol 2007 Mar;359(1):66-71 [Abstract]

Middleton D, Rockman S, Pearse M, et al. Evaluation of vaccines for H5N1 influenza virus in ferrets reveals the potential for protective single-shot immunisation. J Virol 2009 Aug;83(15):7770-8 [Abstract]

Mishra AC, Cherian SS, Chakrabarti AK, et al. A unique influenza A (H5N1) virus causing a focal poultry outbreak in 2007 in Manipur, India. Virol J 2009 Feb 24;6(1):26 [Abstract]

Mok CK, Lee DC, Cheung CY, et al. Differential onset of apoptosis in influenza A virus H5N1- and H1N1-infected human blood macrophages. J Gen Virol 2007 Apr;88(4):1275-80 [Abstract]

Mok KP, Wong CHK, Cheung CY, et al. Viral genetic determinants of H5N1 influenza viruses that contribute to cytokine dysregulation. J Infect Dis 2009 Oct 1;200(7):1104-12 [Abstract]

Molia S, Kamissoko B, Sanogo M, et al. Deficient reporting in avian influenza surveillance, Mali. (Letter) Emerg Infect Dis 2012 (published online Feb 20) [Full text]

Monne I, Fusaro A, Al-Blowi MH, et al. Co-circulation of two sublineages of HPAI H5N1 virus in the Kingdom of Saudi Arabia with unique molecular signatures suggesting separate introductions into the commercial poultry and falconry sectors. J Gen Virol 2008 Nov;89(11):2691-7 [Full text]

Monne I, Joannis TM, Fusaro A, et al. Reassortant avian influenza virus (H5N1) in poultry, Nigeria, 2007. Emerg Infect Dis 2008 Apr;14(4):637-40 [Full text]

Monne I, Ormelli S, Salviato A, et al. Development and validation of a one-step real-time PCR assay for simultaneous detection of subtype H5, H7, and H9 avian influenza viruses. J Clin Microbiol 2008 May;46(5):1769-73 [Abstract]

Monto AS. The threat of an avian influenza pandemic. (Perspective) N Engl J Med 2005 Jan 27;352(4):323-4 [Full text]

Morens DM, Folkers GK, Fauci AS. Emerging infections: a perpetual challenge. Lancet Infect Dis 2008 Nov;8(11):710-9 [Abstract]

Morens DM, Taubenberger JK. An avian outbreak associated with panzootic equine influenza in 1872: an early example of highly pathogenic avian influenza? Influenza Other Respi Viruses 2010 Nov;4(6):373-7 [Full text]

Morgan A. Avian influenza: an agricultural perspective. J Infect Dis 2006 Nov 1;194(suppl 2):S139-46 [Abstract]

Morgan O, Kuhne M, Nair P, et al. Personal protective equipment and risk for avian influenza (H7N3). Emerg Infect Dis 2009 Jan;15(1):59-62 [Full text]

Morse SS, Garwin RL, Olsiewski PJ. Next flu pandemic: What to do until the vaccine arrives? [Policy Forum]. Science 2006 Nov 10;314(5801):929 [Abstract]

Moscona A. Oseltamivir resistance: disabling our influenza defenses. (Perspective) N Engl J Med 2005 Dec 22;353(24):2633-6 [Full text]

Mossialos E, Rudisill C. Knowledge about avian influenza, European region. (Letter) Emerg Infect Dis 2008 Dec;14(12):1956 [Full text]

Mueller M, Renzullo S, Brooks R, et al. Antigenic characterization of recombinant hemagglutinin proteins derived from different avian influenza virus subtypes. PLoS One 2010 Feb 5;5(2):e9097 [Full text]

Munasinghe S, Brown G, Pereira A, et al. Public health response to an avian influenza A (H5N1) poultry outbreak in Suffolk, United Kingdom, in November 2007. Euro Surveill 2008 Jan 31;13(5):pii=8027 [Full text]

Munster VJ, Baas C, Lexmond P, et al. Practical considerations for high-throughput influenza A virus surveillance studies of wild birds by use of molecular diagnostic tests. J Clin Microbiol 2009 Mar 1;47(3):666-73 [Abstract]

Munster VJ, Baas C, Lexmond P, et al. Spatial, temporal, and species variation in prevalence of influenza A viruses in wild migratory birds. PLoS Pathog 2007 May;3(5):e61 [Full text]

Munster VJ, de Wit E, van Riel D, et al. The molecular basis of the pathogenicity of the Dutch highly pathogenic human influenza A H7N7 viruses. J Infect Dis 2007 Jul 15;196(2):258-65 [Abstract]

Munster VJ, Schrauwen EJA, de Wit E, et al. Insertion of a multi basic cleavage motif into the hemagglutinin of a low pathogenic avian influenza H6N1 virus induces a highly pathogenic phenotype. J Virol 2010 Aug;84(16):7953-60 [Abstract]

Munster VJ, Wallensten A, Baas C, et al. Mallards and highly pathogenic avian influenza ancestral viruses, Northern Europe. Emerg Infect Dis 2005 Oct;11(10):1545-51 [Full text]

Munyua PM, Githinji JW, Waiboci LW, et al. Detection of influenza A virus in live bird markets in Kenya, 2009-2011. Influenza Other Respi Viruses 2012 (published online Apr 19) [Abstract]

Murakami S, Horimoto T, Yamada S, et al. Establishment of canine RNA polymerase I-driven reverse genetics for influenza A virus: its application for H5N1 vaccine production. J Virol 2008 Feb;82(3):1605-9 [Abstract]

Murillo LN. Ferret-transmissible influenza A(H5N1) virus: let us err on the side of caution. (Letter) mBio 2012 Mar 6;3(2):e00037 [Full text]

Murray CJ, Lopez AD, Chin B, et al. Estimation of potential global pandemic influenza mortality on the basis of vital registry data from the 1918-20 pandemic: a quantitative analysis. Lancet 2006 Dec 23;368(9554):2211-8 [Full text]

Murray EJ, Morse SS. Seasonal oscillation of human infection with influenza A/H5N1 in Egypt and Indonesia. PLoS ONE 2011 Sep 1;6(9):e24042 [Full text]

Myers KP, Setterquist SF, Capuano AW, et al. Infection due to 3 avian influenza subtypes in United States veterinarians. Clin Infect Dis 2007 Jul 1;45(1):4-9 [Abstract]

Nabel GJ, Wei CJ, Ledgerwood JE. Vaccinate for the next H2N2 pandemic now. (Commentary) Nature 2011 Mar 10;471:157-8 [Full text]

Nagai H, Ikematsu H, Tenjinbaru K, et al. A phase II, open-label, multicentre study to evaluate the immunogenicity and safety of an adjuvanted prepandemic (H5N1) influenza vaccine in health Japanese adults. BMC Infect Dis 2010 Nov 25;10:338 [Abstract]

Nagarajan S, Tosh C, Smith DK, et al. Avian influenza (H5N1) virus of clade 2.3.2 in domestic poultry in India. PLoS ONE 2012 Feb 20;7(2):e31844 [Full text]

Naksupan N, Sanguansermsri D, Wongvilairat R, et al. Whole genome sequences of H5N1 influenza virus isolated from a little grebe in Thailand. Southeast Asian J Trop Med Publ Health 2008 May;39(3):373-8 [Abstract]

Nam JH, Kim EH, Song D, et al. Emergence of mammalian species-infectious and - pathogenic avian influenza H6N5 virus with no evidence of adaption. J Virol 2011 Dec;85(24):13271-7 [Abstract]

Nang NT, Song BM, Kang YM, et al. Live attenuated H5N1 vaccine with H9N2 internal genes protects chickens from infections by both highly pathogenic H5N1 and H9N2 influenza viruses. Influenza Other Respi Viruses 2012 (published online Apr 9) [Abstract]

Nature editorial staff. Facing up to flu. (Editorial) Nature 2012 Feb 9;482(7284):131 [Full text]

Nature editorial staff. The long war against flu. (Editorial) Nature 2008 Jul 10;454(7201):137 [Full text]

Nature editors. Flu papers warrant full publication. Nature 2012 Feb 23;482(7386):439 [Full text]

Nature editors. Publishing risky research. (Editorial) Nature 2012 (published online May 2) [Full text]

Nature Editors. Under surveillance. (Editorial) Nature 2012 Mar 28;483:509-10 [Full text]

Nayak B, Rout SN, Kumar S, et al. Immunization of chickens with Newcastle disease virus expressing H5 hemagglutinin protects against highly pathogenic H5N1 avian influenza viruses. PLoS ONE 2009 Aug 5;4(8):e6509 [Full text]

Needham H, on behalf of the Influenza Project Team, ECDC. H5N1 in wild and domestic birds in Europe--remaining vigilant in response to an ongoing public threat. Eurosurveillance Weekly 2007 Dec 6;12(12):pii=3324 [Full text]

Negovetich NJ, Feeroz MM, Jones-Engel L, et al. Live bird markets of Bangladesh: H9N2 viruses and the near absence of highly pathogenic H5N1 influenza. PLoS ONE 2011 Apr 26;6(4):e19311 [Full text]

Negovetich NJ, Webster RG. Thermostability of subpopulations of H2N3 influenza isolates from mallard ducks. J Virol 2010 Sep;84(18):9369-76 [Abstract]

Negovetich NJ, Webster RG. Thermostability of subpopulations of H2N3 influenza virus isolates from mallard ducks. J Virol 2010 Sep;84(18):9369-76 [Abstract]

Nelson MI, Holmes EC. The evolution of epidemic influenza. Nature Rev Genet 2007 Mar;8(3):196-205 [Abstract]

Neupane D, Khanal V, Ghimire K, et al. Knowledge, attitudes and practices related to avian influenza among poultry workers in Nepal: a cross sectional study. BMC Infect Dis 2012 Mar 30;12:76 [Abstract]

Newman SH, Hill NJ, Spragens KA, et al. Eco-virological approach for assessing the role of wild birds in the spread of avian influenza H5N1 along the central Asian flyway. PLoS ONE 2012 Feb 7;7(2):e30636 [Full text]

Newman SH, Iverson SA, Takekawa JY, et al. Migration of whooper swans and outbreaks of highly pathogenic avian influenza H5N1 in eastern Asia. PLoS ONE 2009 May 29;4(5):e5729 [Full text]

Newton DW, Mellen CF, Baxter BD, et al. Practical and sensitive screening strategy for detection of influenza virus. J Clin Microbiol 2002 Nov;40(11):4353-6 [Full text]

Ng EK, Cheng PK, Ng AY, et al. Influenza A H5N1 detection. Emerg Infect Dis 2005 Aug;11(8):1303-5 [Full text]

Ng LFP, Barr I, Nguyen T, et al. Specific detection of H5N1 avian influenza A virus in field specimens by a one-step RT-PCR assay. BMC Infect Dis 2006;6:40 [Full text]

Nguyen DC, Uyeki TM, Jadhao S, et al. Isolation and characterization of avian influenza viruses, including highly pathogenic H5N1, from poultry in live bird markets in Hanoi, Vietnam, in 2001. J Virol 2005 Apr;79(7):4201-12 [Abstract]

Nguyen HH, Tumpey TM, Park HJ, et al. Prophylactic and therapeutic efficacy of avian antibodies against influenza virus H5N1 and H1N1 in mice. PLoS ONE 2010 Apr 13;5(4):e10152 [Full text]

Nguyen T, Cavis CT, Stembridge W, et al. Characterization of a highly pathogenic avian influenza H5N1 virus sublineage in poultry seized at ports of entry into Vietnam. Virology 2009 May 10;387(2):250-6 [Abstract]

Nguyen TD, Nguyen TV, Vijaykrishna D, et al. Multiple sublineages of influenza A virus (H5N1), Vietnam, 2005-2007. Emerg Infect Dis 2008 Apr;14(4):632-6 [Full text]

NIAID. NIAID announces contracts to develop vaccine against H5N1 avian influenza. May 27, 2004 [Press release]

NIAID. Timeline of human flu pandemics [Web page]

Nichol KL, Treanor JJ. Vaccines for seasonal and pandemic influenza. J Infect Dis 2006 Nov 1;194(suppl 2):S111-8 [Abstract]

Nicholls JM, Bourne AJ, Chen H, et al. Sialic acid receptor detection in the human respiratory tract: evidence for widespread distribution of potential binding sites for human and avian influenza viruses. Respir Res 2007 Oct 25;8:73 [Abstract]

Nicholls JM, Chan MC, Chan WY, et al. Tropism of avian influenza A (H5N1) in the upper and lower respiratory tract. Nature Med 2007 Feb;13(2):147-9 [Abstract]

Nicholson KG, Wood JM, Zambon M. Influenza. Lancet 2003 Nov 22;362(9397):1733-45 [Abstract]

Nicoll A. Children, avian influenza H5N1, and preparing for the next pandemic. Arch Dis Childhood 2008 May;93(5):433-8 [Abstract]

Nicoll A. Human H5N1 infections: so many cases - why so little knowledge? Euro Surveill 2006 May;11(5):pii=619 [Full text]

Nicoll A. Personal (nonpharmaceutical) protective measures for reducing transmission of influenza - ECDC interim recommendations. Eurosurveill Wkly 2006 Oct 12;11(10):pii=3061 [Full text]

Nidom CA, Takano R, Yamada S, et al. Influenza A (H5N1) viruses from pigs, Indonesia. Emerg Infect Dis 2010 Oct;16(10):1515-23 [Full text]

Ninomiya A, Imai M, Tashiro M, et al. Inactivated influenza H5N1 whole-virus vaccine with aluminum adjuvant induces homologous and heterologous protective immunities against lethal challenge with highly pathogenic H5N1 avian influenza viruses in a mouse model. Vaccine 2007 May 4;25(18):3554-60 [Abstract]

NIOSH (National Institute for Occupational Safety and Health). Protecting poultry workers from avian influenza (bird flu). Released Feb 20, 2008 [Full text]

Nolan TM, Richmond PC, Skekjo MV, et al. Phase I and II randomised trials of the safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in healthy adults. Vaccine 2008 Aug 5;26(33):4160-7 [Abstract]

Nomille D. Flu virus research yields results but no magic bullet for pandemic. (News analysis) Science 2008 Feb 29;319(5687):1178-9 [Full text]

Nomura N, Sakoda Y, Endo M, et al. Characterization of avian influenza viruses isolated from domestic ducks in Vietnam in 2009 and 2010. Arch Virol 2011 (published online Nov 9) [Abstract]

NSABB (US National Science Advisory Board for Biosecurity). Adaptations of avian flu virus are a cause for concern. (Commentary) Nature 2012 (published online Jan 31) [Full text]

Obenauer JC, Denson J, Mehta PK, et al. Large-scale sequence analysis of avian influenza isolates. Science 2006 Mar 17;311(5767):1576-80 [Abstract]

Octaviani CP, Ozawa M, Yamada S, et al. High genetic compatibility between swine-origin H1N1 and highly pathogenic avian H5N1 influenza viruses. J Virol 2010 Oct;84(20):10918-22 [Abstract]

Ogata T, Yamazaki Y, Okabe N, et al. Human H5N2 avian influenza infection in Japan and the factors associated with high H5N2-neutralizing antibody titer. J Epidemiol 2008;18(4):160-6 [Abstract]

Oh HLJ, Akerstrom S, Shen S, et al. An antibody against a novel and conserved epitope in the HA1 subunit neutralizes numerous H5N1 influenza viruses. J Virol 2010 Aug;84(16):8275-86 [Abstract]

Ohshima N, Iba Y, Kubota-Koketsu R, et al. Naturally occurring antibodies in a human can neutralize a broad spectrum of influenza strains including H3, H1, H2 and H5. J Virol 2011 Nov;85(21):11048-57 [Abstract]

OIE. Highly pathogenic avian influenza. Technical disease card database. Apr 22, 2002 [Webpage]

OIE. Manual of diagnostic tests and vaccines for terrestrial animals: avian influenza. Chapter 2.3.4. Jul 2008 [Full text]

OIE/FAO. Susceptibility of animal species to the H5N1 Asian strain. Apr 13, 2006 [Full text]

Okamatsu M, Tanaka T, Yamamoto N, et al. Antigenic, genetic, and pathogenic characterization of H5N1 highly pathogenic avian influenza viruses isolated from dead whooper swans (Cygnus cygnus) found in northern Japan in 2008. Virus Genes 2010 Dec;41(3):351-7 [Full text]

Okazaki K, Takada A, Ito T, et al. Precursor genes of future pandemic influenza viruses are perpetuated in ducks nesting in Siberia. Arch Virol 2000;145(5):885-93 [Abstract]

Olsen B, Munster VJ, Wallensten A, et al. Global patterns of influenza A virus in wild birds. Science 2006 Apr 21;312(5772):384-8 [Full text]

Olsen CW, Karasin AI, Carman S, et al. Triple reassortant H3N2 influenza A viruses, Canada, 2005. Emerg Infect Dis 2006 Jul;12(7):1132-5 [Full text]

Olsen SJ, Laosiritaworn Y, Pattanasin S, et al. Poultry-handling practices during avian influenza outbreak, Thailand. Emerg Infect Dis 2005 Oct;11(10):1601-2 [Full text]

Olsen SJ, Ungchusak K, Birmingham M, et al. Surveillance for avian influenza in human beings in Thailand. Lancet Infect Dis 2006 Dec;6(12):757-8 [Full text - Free registration required]

Olsen SJ, Ungchusak K, Sovann L, et al. Family clustering of avian influenza A (H5N1). Emerg Infect Dis 2005 Nov;11(11):1799-801 [Full text]

Oner AF, Bay A, Arslan S, et al. Avian influenza A (H5N1) infection in eastern Turkey in 2006. N Engl J Med 2006 Nov 23;355(21):2179-85 [Full text]

Oner AF, Dogan N, Gasimov V, et al. H5N1 avian influenza in children. Clin Infect Dis 2012 (published online Mar 15) [Abstract]

Ong A, Kindhauser M, Smith I, et al. A global perspective on avian influenza. Ann Acad Med Singapore 2008 Jun;37(6):477-81 [Full text]

Ong AK, Hayden FG. John F. Enders lecture 2006: antivirals for influenza. J Infect Dis 2007 Jul 15;196(2):181-90 [Abstract]

Orozovic G, Orozovic K, Lennerstrand J, et al. Detection of resistance mutations to antivirals oseltamivir and zanamivir in avian influenza A viruses isolated from wild birds. PLoS ONE 2011 Jan 6;6(1):e16028 [Full text]

Ortiz JR, Katz MA, Mahmoud MN, et al. Lack of evidence of avian-to-human transmission of avian influenza A (H5N1) virus among poultry workers, Kano, Nigeria, 2006. J Infect Dis 2007 Dec 1;196(11):1685-91 [Full text]

Ortiz JR, Wallis TR, Katz MA, et al. No evidence of avian influenza A (H5N1) among returning US travelers. Emerg Infect Dis 2007 Feb;13(2):294-7 [Full text]

Osterhaus ADME, Poland GA (eds). Influenza vaccines: research, development and public health challenges. Vaccine 2008 Sep 12;26(suppl 4):D1-174 [Abstract]

Osterholm MT, Kelley NS. Mammalian-transmissible H5N1 influenza: facts and perspective. (Commentary) mBio 2012 Feb 24;3(2):e00045-12 [Full text]

Osterholm MT, Branswell H. Emerging pandemic: costs and consequences of an avian influenza outbreak. Webcast of presentation at Woodrow Wilson International Center for Scholars. Sep 19, 2005 [Web page with links]

Osterholm MT, Henderson DA. Life sciences at a crossroads: respiratory transmissible H5N1. (Commentary) Science 2012 (published online Jan 19) [Full text]

Osterholm MT, Relman DA. Creating a mammalian transmissible A/H5N1 influenza virus: social contracts, prudence, and alternative perspectives. (Perspective) J Infect Dis 2012 (published online Mar 27) [Abstract]

Owen RE, Yamada E, Thompson CI, et al. Alterations in receptor binding properties of recent human influenza H3N2 viruses are associated with reduced natural killer cell lysis of infected cells. J Virol 2007 Oct;81(20):11170-8 [Abstract]

Owoade AA, Gerloff NA, Ducatez MF, et al. Replacement of sublineages of avian influenza (H5N1) by reassortments, sub-Saharan Africa. Emerg Infect Dis 2008 Nov;14(11):1731-5 [Full text]

Oxford JS, Lambkin R, Guralnik M, et al. In vivo prophylactic activity of QR-435 against H3N2 influenza virus infection. Am J Ther 2007 Sep-Oct;14(5):462-8 [Abstract]

Oxford JS, Lambkin R, Guralnik M, et al. Preclinical in vitro activity of QR-435 against influenza A virus as a virucide and in paper masks for prevention of viral transmission. Am J Ther 2007 Sep-Oct;14(5):455-61 [Abstract]

Pachucki CT, Khurshid MA, Nawrocki J. Utility of reverse transcriptase PCR for rapid diagnosis of influenza a virus infection and detection of amantadine-resistant influenza a virus isolates. J Clin Microbiol. 2004 Jun;42(6):2796-8 [Full text]

Palache B, Krause R. Progress with human H5N1 vaccines: a perspective from industry. Expert Rev Vaccines 2009 Apr;8(4):391-400 [Abstract]

Palese P, Wang TT. H5N1 influenza viruses: facts, not fear. (Commentary) Proc Natl Acad Sci 2012 (published online Jan 25) [Full text]

Paltrinieri S, Spagnolo V, Giordano A, et al. Influenza virus type A serosurvey in cats. (Letter) Emerg Infect Dis 2007 Apr;13(4):662-4 [Full text]

Pandemic Flu May 26, 2005 issue of Nature featuring a collection of commentaries and other articles on pandemic and avian influenza [Links to full text]

Pantin-Jackwood MJ, Suarez DL, Spackman E, et al. Age at infection affects the pathogenicity of Asian highly pathogenic avian influenza H5N1 viruses in ducks. Virus Res 2007 Dec;130(1-2):151-61 [Abstract]

Pappaioanou M. Highly pathogenic H5N1 avian influenza virus: cause of the next pandemic? Comp Immunol Microbiol Infect Dis 2009 Jul;32(4):287-300 [Abstract]

Pappas C, Matsuoka Y, Swayne DE, et al. Development and evaluation of an influenza virus subtype H7N2 vaccine candidate for pandemic preparedness. Clin Vaccine Immunol 2007 Nov;14(11):1425-32 [Abstract]

Pareek M, Clark T, Dillon H, et al. Willingness of healthcare workers to accept voluntary stockpiled H5N1 vaccine in advance of pandemic activity. Vaccine 2009 Feb 18;27(8):1242-7 [Abstract]

Park AW, Glass K. Dynamic patterns of avian and human influenza in east and southeast Asia. Lancet Infect Dis 2007 Aug;7(8):543-8 [Abstract]

Park KS, Seo YB, Lee JY, et al. Complete protection against a H5N2 avian influenza virus by a DNA vaccine expressing a fusion protein of H1N1 HA and M2e. Vaccine 2011 Jul 26;29(33):5481-7 [Abstract]

Park MS, Steel J, Garcia-Sastre A, et al. Engineered viral vaccine constructs with dual specificity: avian influenza and Newcastle disease. Proc Natl Acad Sci 2006 May 23;103(21):8203-8 [Abstract]

Parmley EJ, Bastien N, Booth TF, et al. Wild bird influenza survey, Canada, 2005. Emerg Infect Dis 2008 Jan;14(1):84-7 [Full text]

Pasick J, Berhane Y, Embury-Hyatt C, et al. Susceptibility of Canada geese (Branta canadensis) to highly pathogenic avian influenza virus (H5N1). Emerg Infect Dis 2007 Dec;13(12):1821-7 [Full text]

Patel A, Gray M, Li Y, et al. Co-administration of certain DNA vaccine combinations expressing different H5N1 influenza virus antigens can be beneficial or detrimental to immune protection. Vaccine 2012 Jan 11;30(3):626-36 [Abstract]

Patnayak DP, Prasad AM, Malik YS, et al. Efficacy of disinfectants and hand sanitizers against avian respiratory viruses. Avian Dis 2008 Jun;52(2):199-202 [Abstract]

Pavlova SP, Veits J, Keil GM, et al. Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase. Vaccine 2009 Jan 29;27(5):773-85 [Abstract]

Pawar SD, Tandale BV, Raut CG, et al. Avian influenza H9N2 seroprevalence among poultry workers in Pune, India, 2010. PLoS ONE 2012 May 18;7(5):e36374 [Full text]

Pawitan JA. Averting avian influenza pandemic: SOS from a developing country. Lancet Infect Dis 2006;6(12):756-7 [Full text - Free registration required]

Payungporn S, Chuinimitkul S, Chaisingh A, et al. Discrimination between highly pathogenic and low pathogenic H5 avian influenza A viruses. (Letter) Emerg Infect Dis 2006 April;12(4):700-1 [Full text]

Payungporn S, Chutinimitkul S, Chaisingh A, et al. Single step multiplex real-time RT-PCR for H5N1 influenza A virus detection. J Virol Methods 2006 Feb;161(2):143-7 [Abstract]

Pearce JM, Ramey Am, Flint PL, et al. Avian influenza at both ends of a migratory flyway: characterizing viral genomic diversity to optimize surveillance plans for North America. Evol Appl 2009 Apr 15;2(4):457-68 [Full text]

Peiris JS, de Jong MD, Guan Y. Avian influenza virus (H5N1): a threat to human health. Clin Microbiol Rev 2007 Apr;20(2):243-67 [Abstract]

Peiris JS, Guan Y, Markwell D, et al. Cocirculation of avian H9N2 and contemporary "human" H3N2 influenza A viruses in pigs in southeastern China: potential for genetic reassortment? J Virol 2001 Oct;75(20):9679-86 [Full text]

Peiris M, Yuen KY, Leung CW, et al. Human infection with influenza H9N2. Lancet 1999;354:916-7 [Abstract]

Peltz R, Avisar-Shohat G, Bar-Dayan Y. Differences in public emotions, interest, sense of knowledge and compliance between the affected area and the nationwide general population during the first phase of a bird flu outbreak in Israel. J Infect 2007 Dec;55(6):545-50 [Abstract]

Peng F, Wang Z, Zhang S, et al. Development of an immunochromatographic strip for rapid detection of H9 subtype avian influenza viruses. Clin Vaccine Immunol 2008 Mar;15(3):569-74 [Abstract]

Pepin KM, Wang J, Webb CT, et al. Multiannual patterns of influenza A transmission in Chinese live bird market systems. Influenza Other Respi Viruses 2012 (published online Mar 27) [Abstract]

Perdue ML. Molecular diagnostics in an insecure world. Avian Dis 2003;47(3 Suppl):1063-8 [Abstract]

Pereda AJ, Uhart M, Perez AA, et al. Avian influenza virus isolated in waterfowl in Argentina: evidence of a potentially unique phylogenetic lineage in South America. Virology 2008 Sep 1;378(2):363-78 [Abstract]

Perez DR, Webby RJ, Hoffmann E, et al. Land-based birds as potential disseminators of avian mammalian reassortant influenza A viruses. Avian Dis 2003;47(3 Suppl):1114-7 [Abstract]

Perez DR. H5N1 debates: hung up on the wrong questions. (Commentary) Science 2012 (published online Jan 19) [Full text]

Perrone LA, Ahmad A, Veguilla V, et al. Intranasal vaccination with 1918 influenza virus-like particles protects mice and ferrets from lethal 1918 and H5N1 influenza virus challenge. J Virol 2009 Jun;83(11):5726-34 [Abstract]

Perrone LA, Plowden JK, Garcia-Sastre A, et al. H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice. PLoS Pathog 2008 Aug 1;4(8):e1000115 [Full text]

Perrone LA, Szretter KJ, Katz JM, et al. Mice lacking both TNF and IL-1 receptors exhibit reduced lung inflammation and delay in onset of death following infection with a highly virulent H5N1 virus. J Infect Dis 2010 Oct 15;202(8):1161-70 [Abstract]

Peterson AT, Benz BW, Papes M. Highly pathogenic H5N1 avian influenza: entry pathways into North America via bird migration. PLoS One 2007 Feb 28;2(2):e261 [Full text]

Peterson AT, Bush SE, Spackman E, et al. Influenza A virus infections in land birds, People's Republic of China. Emerg Infect Dis 2008 Oct;14(10):1644-6 [Full text]

Peyre M, Fusheng G, Desvaux S, et al. Avian influenza vaccines: a practical review in relation to their application in the field with a focus on the Asian experience. Epidemiol Infect 2009 Jan;137(1):1-21 [Abstract]

Philippa J, Baas C, Beyer W, et al. Vaccination against highly pathogenic avian influenza H5N1 virus in zoos using an adjuvanted inactivated H5N2 vaccine. Vaccine 2007 May 10;25(19):3800-8 [Abstract]

PHS (Poultry Health Services). Fowl plague, avian influenza highly pathogenic. PHS Avian Influenza Forum [Webpage]

Pillai SPS, Saif YM, Lee CW. Detection of influenza A viruses in eggs laid by infected turkeys. Avian Dis 2010 Jun;54(2):830-3 [Abstract]

Pipper J, Inoue M, Ng LFP, et al. Catching bird flu in a droplet. Nature Med 2007 Oct 13;13(10):1259-63 [Abstract]

Pitzer VE, Olsen SJ, Bergstrom CT, et al. Little evidence for genetic susceptibility to influenza A (H5N1) from family clustering data. Emerg Infect Dis 2007 Jul;13(7):1074-6 [Full text]

Poland GA, Jacobson RM, Targonski PV. Avian and pandemic influenza: An overview. Vaccine 2007 Apr 20;25(16):3057-61 [Abstract]

Poland GA. Vaccines against avian influenza--a race against time. (Editorial) N Engl J Med 2006 Mar 30;354(13):1411-3 [Full text]

Polgreen PM, Nelson FD, Neumann GR. Use of prediction markets to forecast infectious disease activity. Clin Infect Dis 2007 Jan 15;44(2):272-9 [Abstract]

Poon LL, Leung YH, Nicholls JM, et al. Vaccinia virus-based multivalent H5N1 avian influenza vaccines adjuvanted with IL-15 confer sterile cross-clade protection in mice. J Immunol 2009 Mar 1;182(5):3063-71 [Abstract]

Pooruk P, Lerdsamran H, et al. Kinetics and longevity of antibody response to influenza A H5N1 virus infection in humans. Clin Vaccine Immunol 2009 Jul;16(7):978-81 [Abstract]

Post J, Burt DW, Cornelissen JBWJ, et al. Systemic virus distribution and host responses in brain and intestine of chickens infected with low pathogenic or high pathogenic avian influenza virus. Virol J 2012 Mar 6;9:61 [Abstract]

Pourmand N, Diamond L, Garten R, et al. Rapid and highly informative diagnostic assay for H5N1 influenza viruses. PLoS One 2006 Dec 20;1(1):e95 [Full text]

Powell TJ, Fox A, Peng Y, et al. Identification of H5N1-specific t-cell responses in a high-risk cohort in Vietnam indicates the existence of potential asymptomatic infections. J Infect Dis 2011 (published online Nov 11) [Abstract]

Prabakaran M, He F, Meng T, et al. Neutralizing epitopes of influenza virus hemagglutinin: target for the development of universal vaccine against H5N1 lineages. J Virol 2010 Nov;84(22):11822-30 [Abstract]

Prabakaran M, Ho HT, Prabhu N, et al. Development of epitope-blocking ELISA for universal detection of antibodies to human H5N1 influenza viruses. PLoS ONE 2009 Feb 24;4(2):e4566 [Abstract]

Prabakaran M, Velumani S, He F, et al. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant. Virology 2008 Oct 25;380(2):412-20 [Abstract]

Prabhu N, Prabakaran M, Ho HT, et al. Monoclonal antibodies against the fusion peptide of hemagglutinin protect mice from lethal influenza A virus H5N1 infection. J Virol 2009 Mar 15;83(6):2553-62 [Abstract]

Price GE, Soboleski MR, Lo CY, et al. Single-dose mucosal immunization with a candidate universal influenza vaccine provides rapid protection from virulent H5N1, H3N2 and H1N1 viruses. PLoS ONE 2010 Oct 4;5(10):e13162 [Full text]

Prosser DJ, Cui P, Takekawa JY, et al. Wild bird migration across the Qinghai-Tibetan Plateau: a transmission route for highly pathogenic H5N1. PLoS ONE 2011 Mar 9;6(3):e17622 [Full text]

Public Health Agency of Canada. Efficiently transmissible engineered influenza A H5N1 viruses. (Biosafety advisory) Feb 1, 2012 [Full text]

Pushko P, Tumpey TM, Van Hoeven N, et al. Evaluation of influenza-like particles and Novasome adjuvant as candidate vaccine for avian influenza. Vaccine 2007 May 22;25(21):4283-90 [Abstract]

Puthavathana P, Sangsiriwut K, Korkusol A, et al. Avian influenza virus (H5N1) in human, Laos. (Letter) Emerg Infect Dis 2009 Jan;15(1):127-9 [Full text]

Puzelli S, De Trani L, Fabiani C, et al. Serological analysis of serum samples from humans exposed to avian H7 influenza viruses in Italy between 1999 and 2004. J Infect Dis 2005 Oct 15;192(8):1318-22 [Full text - See also Hayden above]

Qi X, Li X, Rider P, et al. Molecular characterization of highly pathogenic H5N1 avian influenza A viruses isolated from raccoon dogs in China. PLoS ONE 2009 Mar 9;4(3):e4682 [Abstract]

Quan FS, Huang C, Compans RW, et al. Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus. J Virol 2007 Apr;81(7):3514-24 [Abstract]

Qui YZ, Yin WD. Safety and immunogenicity of Sinovac's prototype pandemic influenza H5N1 vaccines: a review on clinical trials. Influenza Other Resp Viruses 2008 Dec 8;2(6):237-42 [Full text]

Quoilin S, Thomas I, Gerard C, et al. Management of potential human cases of influenza A/H5N1: lessons from Belgium. Eurosurveillance Weekly 2006 Jan 29;11(1):pii=2885 [Full text]

Rabadan R, Levine AJ, Robins H. Comparison of avian and human influenza A viruses reveals a mutational bias on the viral genomes. J Virol 2006 Dec;80(23):11887-91 [Abstract]

Rabinowitz P, Perdue M, Mumford E. Contact variables for exposure to avian influenza H5N1 virus at the human-animal interface. Zoonoses Public Health 2010 Jun;57(4):227-38 [Abstract]

Raleigh PJ, Flynn O, O'Connor M, et al. Phylogenetic analysis of H and N2 genes of avian influenza viruses detected in Ireland between 2003 and 2007. Epidemiol Infect 2010 Oct 18:1-11 [Abstract]

Ramakrishnan MA, Wang P, Abin M, et al. Triple reassortant swine influenza A (H3N2) virus in waterfowl. (Letter) Emerg Infect Dis 2010 Apr;16(4):728-9 [Full text]

Rameix-Welti MA, Agou F, Buchy P, et al. Natural variation can significantly alter the sensitivity of influenza A (H5N1) viruses to oseltamivir. Antimicrob Agents Chemother 2006 Nov;50(11):3809-15 [Abstract]

Ramirez A, Capuano AW, Wellman DA, et al. Preventing zoonotic influenza virus infection. Emerg Infect Dis 2006 Jun;12(6):997-1000 [Full text]

Ranjan P, Jayashankar L, Deyde V, et al. 5'PPP-RNA induced RIG-I activation inhibits drug-resistant avian H5N1 as well as 1918 and 2009 pandemic influenza virus replication. Virol J 2010 May 21;7:102 [Abstract]

Rao SS, Kong WP, Wei CJ, et al. Comparative efficacy of hemagglutinin, nucleoprotein, and matrix 2 protein gene-based vaccination against H5N1 influenza in mouse and ferret. PLoS ONE 2010 Mar 23;5(3):e9812 [Full text]

Rappole JH, Hubalek Z. Birds and influenza H5N1 virus movement to and within North America. (Perspective) Emerg Infect Dis 2006;12(10):1486-92 [Full text]

Raude J, Setbon M. Predicting the lay preventive strategies in response to avian influenza from perceptions of the threat. PLoS ONE 2011 Sep 20;6(9):e24943 [Full text]

Rauw F, Palya V, Van Borm S, et al. Further evidence of antigenic drift and protective efficacy afforded by a recombinant HVT-H5 vaccine against challenge with two antigenically divergent Egyptian clade 2.2.1 HPAI H5N1 strains. Vaccine 2011 Mar 21;29(14):2590-600 [Abstract]

Raviv Y, Blumenthal R, Tompkins SM, et al. Hydrophobic inactivation of influenza viruses confers preservation of viral structure with enhanced immunogenicity. J Virol 2008 May;82(9):4612-9 [Abstract]

Ray K, Potdar VA, Cherian SS, et al. Characterization of the complete genome of influenza A (H5N1) virus isolated during the 2006 outbreak of poultry in India. Virus Genes 2008 Apr;36(2):345-53 [Abstract]

Reemers SS, Jansen C, Koerkamp MJG, et al. Reduced immune reaction prevents immunopathology after challenge with avian influenza virus: a transcriptomics analysis of adjuvanted vaccines. Vaccine 2010 Aug 31;28(38):6351-60 [Abstract]

Reid SM, Shell WM, Barboi G, et al. First reported incursion of highly pathogenic notifiable avian influenza H5N1 viruses from clade 2.3.2 into European poultry. Transbound Emerg Dis 2011 Feb;58(1):76-8 [Abstract]

Reperant LA, Fuckar NS, Osterhaus ADME, et al. Spatial and temporal association of outbreaks of H5N1 influenza virus infection in wild birds with the 0C isotherm. PLoS Pathog 2010 Apr 8;6(4):e1000854 [Full text]

Reperant LA, van Amerongen G, van de Bildt MWG, et al. Highly pathogenic avian influenza virus (H5N1) infection in red foxes fed infected bird carcasses. Emerg Infect Dis 2008 Dec;14(12):1835-41. [Full text]

Reperant LA, van de Bildt MWG, Amerongen GV, et al. Marked endotheliotropism of highly pathogenic avian influenza virus H5N1 following intestinal inoculation in cats. J Virol 2012 Jan;86(2):1158-65 [Abstract]

Reperant LA, van de Bildt MWG, van Amerongen GV, et al. Highly pathogenic avian influenza virus H5N1 infection in a long-distance migrant shorebird under migratory and non-migratory states. PLoS ONE 2011 Nov 22;6(11):e27814 [Full text]

Rice EW, Adcock NJ, Sivaganesan M, et al. Chlorine inactivation of highly pathogenic avian influenza virus (H5N1). Emerg Infect Dis 2007 Oct;13(10):1568-70 [Full text]

Rigoni M, Shinya K, Toffan A, et al. Pneumo- and neurotropism of avian origin Italian highly pathogenic avian influenza H7N1 isolates in experimentally infected mice. Virology 2007 Jul 20;364(1):28-35 [Abstract]

Rimmelzwaan GF, McElhaney JE. Correlates of protection: novel generations of influenza vaccines. Vaccine 2008 Sep 12;26(suppl 4):D41-44 [Full text]

Rimmelzwaan GF, Sutter G. Candidate influenza vaccines based on recombinant modified vaccinia virus Ankara. Expert Rev Vaccines 2009 Apr;8(4):4447-54 [Abstract]

Rimmelzwaan GF, van Riel D, Baars M, et al. Influenza A virus (H5N1) infection in cats causes systemic disease with potential novel routes of virus spread within and between hosts. Am J Pathol 2006 Jan;168(1):176-83 [Abstract]

Risi G, Frenette L, Langley JM, et al. Immunological priming induced by a two-dose series of H5N1 influenza antigen, administered alone or in combination with two different formulations of AS03 adjuvant in adults: results of a randomized single heterologous booster dose study at 15 months. Vaccine 2011 Aug 26;29(37):6408-18 [Abstract]

Rohani P, Breban R, Stallknecht DE, et al. Environmental transmission of low pathogenicity avian influenza viruses and its implications for pathogen invasion. Proc Natl Acad Sci 2009 Jun 23;106(25):10365-9 [Abstract]

Romanova J, Krenn BM, Wolschek M, et al. Preclinical evaluation of a replication-deficient intranasal deltaNS1 H5N1 influenza vaccine. PLoS ONE 2009 Jun 19;4(6):e5984 [Full text]

Rowe T, Abernathy RA, Hu-Primmer J, et al. Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J Clin Microbiol 1999 Apr;37(4):937-43 [Full text]

Roy S, Kobinger GP, Lin J, et al. Partial protection against H5N1 influenza in mice with a single dose of a chimpanzee adenovirus vector expressing nucleoprotein. Vaccine 2007 Sep 28;25(39-40):6845-51 [Abstract]

Ruat C, Caillet C, Bidaut A, et al. Vaccination of macaques with adjuvanted formalin-inactivated influenza A virus (H5N1) vaccines: protection against H5N1 without disease enhancement. J Virol 2008 Mar;82(5):2565-9 [Abstract]

Rudolf M, Poppel M, Frohlich A, et al. Longitudinal 2 years field study of conventional vaccination against highly pathogenic avian influenza H5N1 in layer hens. Vaccine 2010 Oct 4;28(42):6832-40 [Abstract]

Rumke HC, Bayas JM, de Juanes JR, et al. Safety and reactogenicity profile of an adjuvanted H5N1 pandemic candidate vaccine in adults within a phase III safety trial. Vaccine 2008 May 2;26(19):2378-88 [Abstract]

Rungrotmongkol T, Frecer V, De-Eknamkul W, et al. Design of oseltamivir analogs inhibiting neuraminidase of avian influenza virus H5N1. Antiviral Res 2009 Apr;82(1):51-8 [Abstract]

Russell RJ, Haire LF, Stevens DJ, et al. The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design. Nature 2006 Sep 7;443(7107):45-9 [Abstract]

Saad MD, Ahmed LS, Gamal-Eldein MA, et al. Possible avian influenza (H5N1) from migratory bird, Egypt. (Letter) Emerg Infect Dis 2007 Jul;13(7):1120-1 [Full text]

Safdar A, Rodriguez MA, Fayad LE, et al. Dose-related safety and immunogenicity of baculovirus-expressed trivalent influenza vaccine: a double-blind, controlled trial in adult patients with non-Hodgkin B cell lymphoma. J Infect Dis 2006 Nov 15;194(10):1394-97 [Abstract]

Sakabe S, Iwastuki-Horimoto K, Horimoto T, et al. A cross-reactive neutralizing monoclonal antibody protects mice from H5N1 and pandemic (H1N1) 2009 virus infection. Antiviral Res 2010 Dec;88(3):249-55 [Abstract]

Salomon R, Hoffmann E, Webster RG. Inhibition of the cytokine response does not protect against lethal H5N1 influenza infection. Proc Natl Acad Sci 2007 Jul 24;104(30):12479-81 [Abstract]

Salomon R, Webster RG. The influenza virus enigma. Cell 2009 Feb 6;136(3):402-10 [Abstract]

Salzberg S. The contents of the syringe. (Commentary) Nature 2008 Jul 10;454(7201):160-1 [Full text]

Salzberg SL, Kingsford C, Cattoli G, et al. Genome analysis linking recent European and African influenza (H5N1) viruses. Emerg Infect Dis 2007 May;13(5):713-8 [Full text]

Samaan G, Gultom A, Indriani R, et al. Critical control points for avian influenza A H5N1 in live bird markets in low resource settings. Prev Vet Med 2011 Jun 1;100(1):71-8 [Abstract]

Samaan G, Hendrawati F, Taylor T, et al. Application of a healthy food markets guide to two Indonesian markets to reduce transmission of "avian flu." Bull World Health Organ 2012 Apr;90(4):295-300 [Full text]

Samaan G, Patel M, Olowokure B, et al. Rumor surveillance and avian influenza H5N1. Emerg Infect Dis 2005 Mar;11(3):463-6 [Full text]

Sampath R, Russell KL, Massire C, et al. Global surveillance of emerging influenza virus genotypes by mass spectrometry. PLoS One 2007 May 30;2(5):e489 [Full text]

Sandbulte MR, Jimenez GS, Boon AC, et al. Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans. PLoS Med 2007 Feb 13;4(2):e59 [Full text]

Sandman PM, Lanard J. Bird flu: communicating the risk. Perspect Health 2005;19(2) [Full text]

Sandrock C, Kelly T. Clinical review: update of avian influenza A infections in humans. Crit Care 2007 Mar 22;11(2):209 [Full text]

Santhia K, Ramy A, Jayaningsih P, et al. Avian influenza A H5N1 infections in Bali province, Indonesia: a behavioral, virological, and seroepidemiological study. Influenza Other Resp Viruses 2009 May;3(3):81-9 [Abstract]

Santiago FW, Fitzgerald T, Treanor JJ, et al. Vaccination with drifted variants of avian H5 hemagglutinin protein elicits a broadened antibody response that is protective against challenge with homologous or drifted live H5 influenza virus. Vaccine 2011 Nov 8;29(48):8888-97 [Abstract]

Sarikaya O, Erbaydar T. Avian influenza outbreak in Turkey through health personnel's views: a qualitative study. BMC Public Health 2007 Nov 15;7(1):330 [Abstract]

Savill NJ, St Rose SG, Woolhouse MEJ. Detection of mortality clusters associated with highly pathogenic avian influenza in poultry: a theoretical analysis. J R Soc Interface 2008 Dec 6;5(29):1409-19 [Abstract]

Sawai T, Itoh Y, Ozaki H, et al. Induction of cytotoxic T-lymphocytes and antibody responses against highly pathogenic avian influenza virus infection in mice by inoculation of apathogenic H5N1 influenza virus particles inactivated with formalin. Immunology 2008 Jun;124(2):155-65 [Abstract]

Schirmer P, Holodniy M. Oseltamivir for treatment and prophylaxis of influenza infection. Exp Opin Drug Saf 2009 May;8(3):357-71 [Abstract]

Schmolke M, Manicassamy B, Pena L, et al. Differential contribution of PB1-F2 to the virulence of highly pathogenic H5N1 influenza A virus in mammalian and avian species. PLoS Pathog 2011 Aug 11;7(8):e1002186 [Full text]

Schull MA, Gillim-Ross L, Santos C, et al. Avian influenza virus glycoproteins restrict virus replication and spread through human airway epithelium at temperatures of the proximal airways. PLoS Pathog 2009 May 15;5(5):e1000424 [Full text]

Schultsz C, Dong VC, Chau NVV, et al. Avian influenza H5N1 and healthcare workers. (Letter) Emerg Infect Dis 2005 Jul;11(7):1158-9 [Full text]

Schultsz C, Dung NV, Hai LT, et al. Prevalence of antibodies against avian influenza A (H5N1) virus among cullers and poultry workers in Ho Chi Minh City, 2005. PLoS One 2009 Nov 23;4(11):e7948 [Full text]

Schultz-Cherry S, McCukllers JA. A step closer to meeting the threat of avian influenza. PLoS Med 2006 Sep;3(9):e375 [Full text]

Schunemann HJ, Hill SR, Kakad M, et al. Transparent development of the WHO Rapid Advice Guidelines. PLoS Med 2007 May;4(5):e119 [Full text]

Schunemann HJ, Hill SR, Kakad M, et al. WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus. Lancet Infect Dis 2007 Jan;7(1):21-31 [Abstract]

Schwartz JA, Buonocore L, Suguitan A, et al. Vesicular stomatitis virus-based H5N1 avian influenza vaccines induce potent cross-clade neutralizing antibodies in rhesus macaques. J Virol 2011 May;85(9):4602-5 [Abstract]

Schwartz JAl, Buonocore L, Roberts A, et al. Vesicular stomatitis virus vectors expressing avian influenza H5 HA induce cross-neutralizing antibodies and long-term protection. Virology 2007 Sep 15;366(1):166-73 [Abstract]

Security and Prosperity Partnership of North America. North American plan for avian & pandemic influenza. Released Aug 21, 2007 [Full text]

Sedyaningsih ER, Isfandari S, Setiawaty V, et al. Epidemiology of cases of H5N1 virus infection in Indonesia, July 2005-June 2006. J Infect Dis 2007 Aug 15;196(4):522-7 [Abstract]

Sengupta R, Rosenshein L, Gilbert M, et al. Ecoregional dominance in spatial distribution of avian influenza (H5N1) outbreaks. (Letter) Emerg Infect Dis 2007 Aug;13(8):1269-70 [Full text]

Senne DA, Suarez DL, Stallnecht DE, et al. Ecology and epidemiology of avian influenza in North and South America. In Proceedings of OIE/FAO International Scientific Conference on Avian Influenza, Paris, Apr 2005. Dev Biol (Basel). 2006;124:37-44 [Abstract]

Shahid MA, Abubakar M, Hameed S, et al. Avian influenza virus (H5N1): effects of physico-chemical factors on its survival. Virol J 2009 Mar 28;6:38 [Abstract]

Shan S, Ko LS, Collins RA, et al. Comparison of nucleic acid-based detection of avian influenza H5N1 with virus isolation. Biochem Biophys Res Commun 2003 Mar 7;302(2):377-83 [Abstract]

Sharkey KJ, Bowers RG, Morgan KL, et al. Epidemiological consequences of an incursion of highly pathogenic H5N1 avian influenza into the British poultry flock. Proc R Soc B 2008 Jan 7;275(1630):19-28 [Abstract]

Sharpe M, Lynch D, Topham S, et al. Protection of mice from H5N1 influenza challenge by prophylactic DNA vaccination using particle mediated epidermal delivery. Vaccine 2007 Aug 21;25(34):6392-8 [Abstract]

Sharshov K, Silko N, Sousloparov I, et al. Avian influenza (H5N1) outbreak among wild birds, Russia, 2009. (Letter) Emerg Infect Dis 2010 Feb;16(2):349-50 [Full text]

Shelton H, Ayora-Talavera G, Ren J, et al. Receptor binding profiles of avian influenza virus hemagglutinin subtypes on human cells as a predictor of pandemic potential. J Virol 2011 Feb;85(4):1875-80 [Abstract]

Shestopalov AM, Durimanov AG, Evseenko VA, et al. H5N1 influenza virus, domestic birds, Western Siberia, Russia. (Letter) Emerg Infect Dis 2006 Jul;12(7):1167-9 [Full text]

Shi D, Yang J, Yang D, et al. Anti-influenza viral prodrug oseltamivir is activated by carboxylesterase HCE1 and the activation is inhibited by anti-platelet agent clopidogrel. J Pharmacol Exp Ther 2006 Dec;319(3):1477-84 [Abstract]

Shi H, Liu XF, Zhang X, et al. Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses. Vaccine 2007 Oct 16;25(42):7379-84 [Abstract]

Shi W, Lei F, Zhu C, et al A complete analysis of HA and NA genes of influenza A viruses. PLoS ONE 2010 Dec 29;5(12):e14454 [Full text]

Shim E, Galvani AP. Evolutionary repercussions of avian culling on host resistance and influenza virulence. PLoS ONE 2009 May 11;4(5):e5503 [Full text]

Shinde V, Hanshaoworakul W, Simmerman JM, et al. A comparison of clinical and epidemiological characteristics of fatal human infections with H5N1 and human influenza viruses in Thailand, 2004-2006. PLoS ONE 2011 Apr 29;6(4):e14809 [Full text]

Shinya K, Ebina M, Yamada S, et al. Avian flu: influenza virus receptors in the human airway. (Brief Report) Nature 2006 Mar 23;440(7083):435-6 [Full text]

Shinya K, Hatta M, Yamada S, et al. Characterization of a human H5N1 influenza A virus isolated in 2003. J Virol 2005 Aug;79(15):9926-32 [Abstract]

Shinya K, Makino A, Hatta M, et al. Subclinical brain injury caused by H5N1 influenza virus infection. J Virol 2011 May;85(10):5202-7 [Abstract]

Shinya K, Makino A, Tanaka H, et al. Systematic dissemination of H5N1 influenza A viruses in ferrets and hamsters after direct intragastric inoculation. J Virol 2011 May;85(10):4673-8 [Abstract]

Shinya K, Okamura T, Sueta S, et al. Toll-like receptor pre-stimulation protects mice against lethal infection with highly pathogenic influenza viruses. Virol J 2011 Mar 4;8:97 [Abstract]

Shoji Y, Bi H, Musiychuk K, et al. Plant-derived hemagglutinin protects ferrets against challenge infection with the A/Indonesia/05/05 strain of avian influenza. Vaccine 2009 Feb 11;27(7):1087-92 [Abstract]

Shu Y, Li CK, Li Z, et al. Avian influenza A(H5N1) viruses can directly infect and replicate in human gut tissues. J Infect Dis 2010 Apr 15;201(8):1173-7 [Abstract]

Sidwell RW, Barnard DL, Day CW, et al. Efficacy of orally administered T-705 on lethal avian influenza A (H5N1) virus infections in mice. Antimicrob Agents Chemother 2007 Mar;51(3):845-51 [Abstract]

Siembieda J, Johnson CK, Boyce W, et al. Risk for avian influenza virus exposure at human-wildlife interface. Emerg Infect Dis 2008 Jul;14(7):1151-3 [Full text]

Simmons C, Farrar J. Insights into inflammation and influenza. N Engl J Med 2008 Oct 9;359(15):1621-3 [Extract]

Simmons CP, Bernasconi NL, Suguitan AL Jr, et al. Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza. PLoS Med 2007 May;4(5):e178 [Full text]

Skeik N, Jabr FI. Influenza viruses and the evolution of avian influenza virus H5N1. Int J Infect Dis 2008 May;12(3):233-8 [Abstract]

Skowronski DM, Li Y, Tweed SA, et al. Protective measures and human antibody response during an avian influenza H7N3 outbreak in poultry in British Columbia, Canada. CMAJ 2007 Jan 2;176(1):47-53 [Full text]

Slomka MJ, To TL, Tong HH, et al. Evaluation of lateral flow devices for identification of infected poultry by testing swab and feather specimens during H5N1 highly pathogenic avian influenza outbreaks in Vietnam. Influenza Other Respi Viruses 2011 (published online Dec 12) [Abstract]

Smallman-Raynor M, Cliff AD. Avian influenza A (H5N1) age distribution in humans. (Letter) Emerg Infect Dis 2007 Mar;13(3):510-2 [Full text]

Smith BW, Kay VS, Hoyt TV, et al. Predicting the anticipated emotional and behavioral responses to an avian flu outbreak. Am J Infect Control 2009 Jun;37(5):371-80 [Abstract]

Smith GJD, Fan XH, Wang J, et al. Emergence and predominance of an H5N1 influenza variant in China. Proc Natl Acad Sci 2006 Nov 7;103(45):16936-41 [Abstract]

Smith GJD, Vijaykrishna D, Ellis TM, et al. Characterization of avian influenza viruses A (H5N1) from wild birds, Hong Kong, 2004-2008. Emerg Infect Dis 2009 Mar;15(3):402-7 [Full text]

Smith JH, Nagy T, Driskell E, et al. Comparative pathology in ferrets infected with H1N1 influenza A viruses isolated from different hosts. J Virol 2011 Aug;85(15):7572-81 [Abstract]

Smith JR, Wood SC. Travellers need immediate access to Tamiflu when entering areas at risk from avian or seasonal influenza. Travel Med Infect Dis 2007 Nov;5(6):411 [Abstract]

Smith PW, Anderson AO, Christopher GW, et al. Designing a biocontainment unit to care for patients with serious communicable diseases: a consensus statement. Biosecur Bioterror 2006 Dec;4(4):351-5 [Abstract]

Soepandi PZ, Burhan E, Mangunnegoro H, et al. Clinical course of H5N1 avian influenza in patients at the Persahabatan Hospital, Jakarta, Indonesia, 2005-2008. Chest 2010 Sep;138(3):665-73 [Abstract]

Song BM, Kang YM, Kim HS, et al. Induction of inflammatory cytokines and toll-like receptors in human normal respiratory epithelial cells infected with seasonal H1N1, 2009 pandemic H1N1, seasonal H3N2, and highly pathogenic H5N1 influenza virus. Viral Immunol 2011 Jun 13;24(3):179-87 [Abstract]

Song D, Kang B, Lee C, et al. Transmission of avian influenza virus (H3N2) to dogs. Emerg Infect Dis 2008 May;14(5):741-6 [Full text]

Song D, Lee C, Kang B, et al. Experimental infection of dogs with avian-origin canine influenza A virus (H3N2). Emerg Infect Dis 2009 Jan;15(1):56-8 [Full text]

Song H, Nieto GR, Perez DR. A new generation of modified live-attenuated avian influenza viruses using a two-strategy combination as potential vaccine candidates. J Virol 2007 Sep;81(17):9238-48 [Abstract]

Song H, Wan H, Araya Y, et al. Partial direct contact transmission in ferrets of a mallard H7N3 influenza virus with typical avian-like receptor specificity. Virol J 2009 Aug 14;6:126 [Abstract]

Song J, Feng H, Xu J, et al. The PA protein directly contributes to the virulence of H5N1 avian influenza viruses in domestic ducks. J Virol 2011 Mar;85(5):2180-8 [Abstract]

Song JM, Kim YC, Barlow PG, et al. Improved protection against avian influenza H5N1 virus by a single vaccination with virus-like particles in skin using microneedles. Antiviral Res 2010 Nov;88(2):244-7 [Abstract]

Song MS, Oh TK, Moon HJ, et al. Ecology of H3 avian influenza viruses in Korea and assessment of their pathogenic potentials. J Gen Virol 2008 Apr;89(4):949-57 [Abstract]

Songserm T, Amonsin A, Jam-on R, et al. Avian influenza H5N1 in naturally infected domestic cat. Emerg Infect Dis 2006 Apr;12(4):681-3 [Full text]

Songserm T, Amonsin A, Jam-on R, et al. Fatal avian influenza A H5N1 in a dog. Emerg Infect Dis 2006 Nov;12(11):1744-7 [Full text]

Songserm T, Jam-on R, Sae-Heng N, et al. Domestic ducks and H5N1 influenza epidemic, Thailand. Emerg Infect Dis 2006 Apr;12(4):575-81 [Full text]

Southwell BG, Hwang Y, Torres A. Avian influenza and US TV news. (Letter) Emerg Infect Dis 2006 Nov;12(11):1797-8 [Full text]

Spackman E, Gelb J, Preskenis LA, et al. The pathogenesis of low pathogenicity H7 avian influenza viruses in chickens, ducks and turkeys. Virol J 2010 Nov 19;7:331 [Abstract]

Spackman E, Swayne DE, Suarez DL, et al. Characterization of low-pathogenicity H5N1 avian influenza viruses from North America. J Virol 2007 Nov;81(21):11612-9 [Abstract]

Spekreijse D, Bouma A, Koch G, et al. Quantification of dust-borne transmission of highly pathogenic avian influenza virus between chickens. Influenza Other Respi Viruses 2012 (published online Apr 6) [Abstract]

Ssematimba A, Hagenaars TJ, de Jong MCM. Modelling the wind-borne spread of highly pathogenic avian influenza virus between farms. PLoS ONE 2012 Feb 14;7(2):e31114 [Full text]

Steel J, Lowen AC, Mubareka S, et al. Transmission of influenza virus in a mammalian host is increased by PB2 amino acids 627K or 627E/701N. PLoS Pathog 2009 Jan 2;5(1):e1000252 [Full text]

Steel J, Lowen AC, Pena L, et al. Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza. J Virol 2009 Feb;83(4):1742-53 [Abstract]

Stegeman A, Bouma A, Elbers AR, et al. Avian influenza A virus (H7N7) epidemic in the Netherlands in 2004: course of the epidemic and effectiveness of control measures. J Infect Dis 2004 Dec 15;190(12):2088-95 [Abstract]

Stelzer-Braid S, Escott R, Baleriola C, et al. Proficiency of nucleic acid tests for avian influenza viruses, Australasia. Emerg Infect Dis 2008 Jul;14(7):1126-8 [Full text]

Stephenson I, Bugarini R, Nicholson KG, et al. Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A/duck/Singapore/97 (H5N3) vaccine: a potential priming strategy. J Infect Dis 2005 Apr 15;191(8):1210-5 [Abstract]

Stephenson I, Das RG, Wood JM, et al. Comparison of neutralising antibody assays for detection of antibody to influenza A/H3N2 viruses: An international collaborative study. Vaccine 2007 May 16;25(20):4056-63 [Abstract]

Stephenson I, Heath A, Major D, et al. Reproducibility of serologic assays for influenza virus A (H5N1). Emerg Infect Dis 2009 Aug;15(8):1252-9 [Full text]

Stephenson I, Nicholson KG, Hoschler K, et al. Antigenically distinct MF59-adjuvanted vaccine to boost immunity to H5N1. (Letter) N Engl J Med 2008 Oct 9;359(15):1631-3 [Full text]

Stevens J, Blixt O, Chen LM, et al. Recent avian H5N1 viruses exhibit increased propensity for acquiring human receptor specificity. J Mol Biol 2008 Sep 19;381(5):1392-94 [Abstract]

Stevens J, Blixt O, Tumpey TM, et al. Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science 2006 Apr 21;312(5772):404-10 [Full text]

Stittelaar KJ, Lacombe V, Lavieren RB, et al. Cross-clade immunity in cats vaccinated with a canarypox-vectored avian influenza vaccine. Vaccine 2010 Jul 12;28(31):4970-6 [Abstract]

Stohr K. Avian influenza and pandemics: research needs and opportunities. (Editorial) N Engl J Med 2005 Jan 27;352(4):405-7 [Extract]

Stoner TD, Krauss S, DuBois RM, et al. Antiviral susceptibility of avian and swine influenza of the N1 neuraminidase subtype. J Virol 2010 Oct;84(19):9800-9 [Abstract]

Stoops AC, Barbara KA, Indrawan M, et al. H5N1 surveillance in migratory birds in Java, Indonesia. Vector-Borne Zoonotic Dis 2009 Dec 9;9(6):695-702 [Abstract]

Suarez DL, Senne DA, Banks J, et al. Recombination resulting in virulence shift in avian influenza outbreak, Chile. Emerg Infect Dis 2004 Apr;10(4):693-9 [Full text]

Subbarao K, Luke C. H5N1 viruses and vaccines. PLoS Pathog 2007 Mar;3(3):e40 [Full text]

Suder G, Inthavong S. New health risks and sociocultural contexts: bird flu impacts on consumers and poultry businesses in Lao PDR. Risk Analysis 2008 Feb;28(1):1-12 [Abstract]

Suetens C, Snacken R, Hanquet G, et al. Eagles testing positive for H5N1 imported illegally into Europe from Thailand. Eurosurveillance Weekly 2004 Oct 28;8(44):pii=2575 [Full text]

Suguitan AL Jr, McAuliffe J, Mills KL, et al. Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets. PLoS Med 2006 Sep;3(9):e360 [Full text]

Suguitan AL, Cheng X, Wang W, et al. Influenza H5 hemagglutinin DNA primes the antibody response elicited by the live attenuated influenza A/Vietnam/1203/2004 vaccine in ferrets. PLoS ONE 2011 Jul 8;6(7):e21942 [Full text]

Sui J, Hwang WC, Perez S, et al. Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat Struct Mol Biol 2009 Mar;16(3):265-73 [Abstract]

Sun Y, Bi Y, Pu J, et al. Guinea pig model for evaluating the potential public health risk of swine and avian influenza viruses. PLoS ONE 2010 Nov 23;5(11):e15537 [Full text]

Sun Y, Qin K, Wang J, et al. High genetic compatibility and increased pathogenicity of reassortants derived from avian H9N2 and pandemic H1N1/2009 influenza viruses. Proc Natl Acad Sci 2011 Mar 8;108(10):4164-9 [Abstract]

Suptawiwat O, Tantilipikorn P, Boonarkart C, et al. Enhanced susceptibility of nasal polyp tissues to avian and human influenza viruses. PLoS ONE 2010 Sep 24;5(9):e12973 [Full text]

Suwannakarn K, Chutinimitkul S, Payungporn S, et al. Assay to detect H5N1 oseltamivir resistance. (Letter) Emerg Infect Dis 2006 Dec;12(12):1995-6 [Full text]

Suzuki K, Okada H, Itoh T, et al. Association of increased pathogenicity of Asian H5N1 highly pathogenic avian influenza viruses in chickens with highly efficient viral replication accompanied by early destruction of innate immune responses. J Virol 2009 Aug;83(15):7475-86 [Abstract]

Swaminathan A, Martin R, Gamon S, et al. Personal protective equipment and antiviral drug use during hospitalization for suspected avian or pandemic influenza. Emerg Infect Dis 2007 Oct;13(10):1541-7 [Full text]

Swayne D, Beck JR. Experimental study to determine if low-pathogenicity and high-pathogenicity avian influenza viruses can be present in chicken breast and thigh meat following intranasal virus inoculation. Avian Dis 2005 Mar;49(1):81-5 [Abstract]

Swayne DE, Kapczynski D. Strategies and challenges for eliciting immunity against avian influenza virus in birds. Immunol Rev 2008 Oct;225(1):312-31 [Abstract]

Sylte MJ, Hubby B, Suarez DL. Influenza neuraminidase antibodies provide partial protection for chickens against high pathogenic avian influenza infection. Vaccine 2007 May 10;25(19):3763-72 [Abstract]

Sylte MJ, Suarez DL. Vaccination and acute phase mediator production in chickens challenged with low pathogenic avian influenza virus; novel markers for vaccine efficacy? Vaccine 2012 (published online Mar 3) [Abstract]

Szretter KJ, Gangappa S, Lu X, et al. Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice. J Virol 2007 Mar;81(6):2763-44 [Abstract]

Taha SH, Mehrez MA, Sitohy MZ, et al. Effectiveness of esterified whey proteins fractions against Egyptian lethal avian influenza A (H5N1). Virol J 2010 Nov 19;8:330 [Abstract]

Takano R, Nidom CA, Kiso M, et al. A comparison of the pathogenicity of avian and swine H5N1 influenza viruses in Indonesia. Arch Virol 2009 Apr;154(4):677-81 [Abstract]

Takeuchi MT. Avian influenza risk communication, Thailand. (Letter) Emerg Infect Dis 2006 Jul;12(7):1172-3 [Full text]

Talaat KR, Karron RA, Callahan KA, et al. A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a phase I trial in healthy adults. Vaccine 2009 Jun 8;27(28):3744-53 [Abstract]

Tam DKP, Lee S, Lee SS. Impact of SARS on avian influenza preparedness in healthcare workers. Infection 2007 Oct;35(5):320-5 [Abstract]

Tam DKP, Lee SS, Lee S. Impact of severe acute respiratory syndrome and the perceived avian influenza epidemic on the increased rate of influenza vaccination among nurses in Hong Kong. Infect Control Hosp Epidemiol 2008 Mar;39(3):256-61 [Abstract]

Tam JS. Influenza A (H5N1) in Hong Kong: an overview. Vaccine 2002 May 15;20 Suppl 2:S77-81 [Abstract]

Tambyah PA, Wilder-Smith A, Pavlova BG, et al. Safety and immunogenicity of two different doses of a vero cell-derived, whole virus clade 2 H5N1 (A/Indonesia/05/2005) influenza vaccine. Vaccine 2012 Jan 5;30(2):329-35 [Abstract]

Tambyah PA. Update on influenza antivirals. Respirology 2008 Mar;13(s1):S19-21 [Full text]

Tambyah PA. Update on influenza vaccines. Respirology 2008 Mar;13(s1):S41-3 [Full text]

Tang JW, Ngai KLK, Chan PKS. Lack of cross-immune reactivity against influenza H5N1 from seasonal influenza vaccine in humans. J Med Virol 2008 Nov;80(11):1992-6 [Abstract]

Tang JW, Shetty N, Lam TY, et al. Emerging, novel, and known influenza virus infections in humans. Infect Dis Clin North Am 2010 Sep;24(3):603-17 [Abstract]

Tang XC, Lu HR, Ross TM. Hemagglutinin displayed baculovirus protects against highly pathogenic influenza. Vaccine 2010 Oct 4;28(42):6821-31 [Abstract]

Tarantola A, Barboza P, Gauthier V, et al. The influenza A(H5N1) epidemic at six and a half years: 500 notified human cases and more to come. Euro Surveill 2010 Jul 22;15(29):pii=19619 [Full text]

Taubenberger JK, Reid AH, Lourens RM, et al. Characterization of the 1918 influenza virus polymerase genes. (Letter) Nature 2005;Oct 6;437(7060):889-93 [Full text]

Taylor WR, Burhan E, Wertheim H, et al. Avian influenza--a review for doctors in travel medicine. Travel Med Infect Dis 2010 Jan;8(1):1-12 [Abstract]

te Beest DE, van Boven M, Bos MEH, et al. Effectiveness of personal protective equipment and oseltamivir prophylaxis during avian influenza A (H7N7) epidemic, the Netherlands, 2003. Emerg Infect Dis 2010 Oct;16(10):1562-8 [Full text]

Temperton NJ, Hoschler K, Major D, et al. A sensitive retroviral pseudotype assay for influenza H5N1-neutralizing antibodies. Influenza Other Respir Virus 2007 Jul 26;1(3):105-12 [Full text]

Ten Eyck RP. Ability of regional hospitals to meet projected avian flu pandemic surge capacity requirements. J Prehosp Disaster Med 2008 Mar-Apr;23(2):103-12 [Abstract]

Thanawongnuwech R, Amonsin A, Tantilertcharoen R, et al. Probable tiger-to-tiger transmission of avian influenza H5N1. Emerg Infect Dis 2005 May;11(5):699-701 [Full text]

The Global Influenza Programme. Expert consultation on diagnosis of H5N1 avian influenza infections in humans. Influenza Other Resp Viruses 2007 Jul;1(4):131-8 [Full text]

Therkildsen OR, Jensen TH, Handberg KJ et al. Low pathogenic avian influenza (H7N1) transmission between wild ducks and domestic ducks. Zoonoses Public Health 2011 Aug;58(5):312-7 [Abstract]

Thitithanyanont A, Engering A, Ekchariyawat P, et al. High susceptibility of human dendritic cells to avian influenza H5N1 virus infection and protection by IFN-alpha and TLR ligands. J Immunol 2007 Oct 15;179(8):5220-7 [Abstract]

Thomas C, King DJ, Swayne DE. Thermal inactivation of avian influenza and Newcastle disease viruses in chicken meat. J Food Prot 2008 Jun;71(6):1214-222 [Abstract]

Thomas C, Swayne DE. Thermal inactivation of H5N1 high pathogenicity avian influenza virus in naturally infected chicken meat. J Food Prot 2007 Mar;70(3):674-80 [Abstract]

Thorson A, Petzold M, Chuc NTK, et al. Is exposure to sick or dead poultry associated with flulike illness? Arch Intern Med 2006 Jan 9;166(1):119-23 [Abstract]

Tiensin T, Ahmed SSU, Rojanasthien S, et al. Ecologic risk factor investigation of clusters of avian influenza A (H5N1) virus infection in Thailand. J Infect Dis 2009 Jun 15;199(12):1735-43 [Full text]

Tiensin T, Chaitaweesub P, Songserm T, et al. Highly pathogenic avian influenza H5N1, Thailand, 2004. Emerg Infect Dis 2005 Nov;11(11):1664-72 [Full text]

Tiensin T, Nielen M, Vernooij H, et al. Transmission of the highly pathogenic avian influenza virus H5N1 within flocks during the 2004 epidemic in Thailand. J Infect Dis 2007 Dec 1;196(11):1679-84 [Full text]

Toennessen R, Germundsson A, Jonassen CM, et al. Virological and serological surveillance for type A influenza in the black-legged kittiwake (Rissa tridactyla). Virol J 2011 Jan 17;8:21 [Abstract]

Tombari W, Nsiri J, Larbi I, et al. Genetic evolution of low pathogenecity H9N2 avian influenza viruses in Tunisia: acquisition of new mutations. Virol J 2011 Oct 12;8:467 [Abstract]

Tompkins SM, Zhao Z-S, Lo C-Y, et al. Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1. Emerg Infect Dis 2007 Mar;13(3):426-35 [Full text]

Toner ES, Adalja AA. Is H5N1 really highly lethal? (Commentary) Biosecur Bioterror 2012 (published online Mar 6) [Abstract]

Toro H, Tang DC, Suarez DL, et al. Protective avian influenza in ovo vaccination with non-replicating human adenovirus vector. Vaccine 2007 Apr 12;25(15):2886-91 [Abstract]

Tran TH, Nguyen TL, Nguyen TD, et al. Avian influenza (H5N1) in 10 patients in Vietnam. N Engl J Med 2004 Mar 18;350(12):1179-88 [Abstract]

Treanor JJ, Campbell JD, Zangwill KM, et al. Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine. N Engl J Med 2006 Mar 30;354(13):1343-51 [Full text]

Treanor JJ. Avian influenza: exploring all the avenues. (Editorial) Ann Intern Med 2006 Oct 17;145(8)631-2 [Full text - See also Luke above]

Trebbien R, Larsen LE, Viuff BM. Distribution of sialic acid receptors and influenza A virus of avian and swine origin in experimentally infected pigs. Virol J 2011 Sep 8;8:434 [Abstract]

Trevennec K, Chevalier V, Grosbois V, et al. Looking for avian influenza in remote areas: a case study in Northern Vietnam. Acta Trop 2011 Dec;120(3):160-6 [Abstract]

Truscott J, Garske T, Chis-Ster I, et al. Control of a highly pathogenic H5N1 avian influenza outbreak in the GB poultry flock. Proc R Soc B 2007 Sep 22;274(1623):2287-95 [Abstract]

Tseng WC, Li HA, Huang WC, et al. Potential number of human cases of H5N1 avian influenza in Egypt. Public Health 2010 Aug;124(8):452-9 [Abstract]

Tsiodras S, Kelesidis T, Kelesidis I, et al. Human infections associated with wild birds. J Infect 2008 Feb;56(2):83-98 [Abstract]

Tsiodras S, Mooney JD, Hatzakis A. Role of combination antiviral therapy in pandemic influenza and stockpiling implications. BMJ 2007 Feb 10;334(7588):293-4 [Extract]

Tsukamoto K, Ashizawa H, Nakanishi K, et al. Subtyping of avian influenza viruses H1 to H15 on the basis of hemagglutinin genes by PCR assay and molecular determination of pathogenic potential. J Clin Microbiol 2008 Sep;46(9):3048-55 [Abstract]

Tumpey TM, Basler CF, Aguilar PV, et al. Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science 2005 Oct 7;310(5745):77-80 [Abstract]

Tumpey TM, Garcia-Sastre A, Mikulasova A, et al. Existing antivirals are effective against influenza viruses with genes from the 1918 pandemic virus. Proc Natl Acad Sci 2002 Oct 15;99(21):13849-54 [Abstract]

Twu KY, Kuo RL, Marklund J, et al. The H5N1 influenza virus NS genes selected after 1998 enhance virus replication in mammalian cells. J Virol 2007 Aug;81(15):8112-21 [Abstract]

Uchida Y, Mase M, Yoneda K, et al. Highly pathogenic avian influenza virus (H5N1) isolated from whooper swans, Japan. Emerg Infect Dis 2008 Sep;14(9):1427-9 [Full text]

Uiprasertkul M, Kitphati R, Puthavathana P, et al. Apoptosis and pathogenesis of avian influenza A (H5N1) virus in humans. Emerg Infect Dis 2007 May;13(5):708-12 [Full text]

Uiprasertkul M, Puthavathana P, Sangsiriwut K, et al. Influenza A H5N1 replication sites in humans. Emerg Infect Dis 2005 July;11(7):1036-41 [Full text]

UN System Influenza Coordinator & World Bank. Responses to avian influenza and state of pandemic readiness: fourth global progress report. Released Oct 15, 2008 [Full text]

UN System Influenza Coordinator & World Bank. Responses to avian influenza and state of pandemic readiness: third global progress report. Released Nov 29, 2007 [Full text]

UN. Hanoi Declaration sets global framework for avian influenza, pandemic readiness, proposes national steps to detect animal-human transmission, control outbreaks. Apr 21, 2010 [Full text]

Ungchusak K, Auewarakul P, Dowell SF, et al. Probable person-to-person transmission of avian influenza A (H5N1). N Engl J Med 2005 Jan 27;352(4):333-40 [Full text]

US Department of State. Fact Sheet: 2009-H1N1, Pandemic Influenza, and H5N1. Updated Sep 27, 2008 [Full text]

US Department of State. Medical information for Americans traveling abroad [Webpage]

Uscher-Pines L, Omer SB, Barnett DJ, et al. Priority setting for pandemic influenza: an analysis of national preparedness plans. PLoS Med 2006 Oct;3(10):e436 [Full text]

USDA. USDA amends high pathogenicity avian influenza requirements for importing birds, poultry and hatching eggs. Jan 24, 2011, news release [Full text]

USDA. Efforts and response to avian influenza in the United States Transcript of Oct 26, 2005, technical briefing [Press release with links to webcast and transcript]

USDA/APHIS. Agricultural Bioterrorism Protection Act of 2002: Possession, use, and transfer of biological agents and toxins. Final Rule 7 CFR Part 331 and 9 CFR Part 121. Fed Reg 2005 Mar 18;70(52):13242-92 [Full text]

USDA/APHIS. Highly pathogenic avian influenza. Mar 2004 [Full text]

USDA/APHIS. Questions and answers on the Agricultural Bioterrorism Protection Act of 2002: Possession, use, and transfer of select agents and toxins. APHIS factsheet. Aug 2005 [Full text]

USDA/FSIS. Draft interagency risk assessment for the public health impact of highly pathogenic avian influenza virus (HPAIV) in poultry, shell eggs, and egg products. Nov 2008 [Links to report, summary, etc]

USDA/FSIS. FSIS seeks comments on draft risk assessment for the public health impact of highly pathogenic avian influenza virus in poultry, shell eggs, and egg products. Dec 2, 2008, press release [Full text]

Ushirogawa H, Ohuchi M. Novel antiviral activity of neuraminidase inhibitors against an avian influenza A virus. Virol J 2011 Aug 19;8:411 [Abstract]

Uyeki TM, Bresee JS. Detecting human-to-human transmission of avian influenza A (H5N1). (Letter) Emerg Infect Dis 2007 Dec;13(12):1969-70 [Full text]

Uyeki TM, Chong YH, Katz JM, et al. Lack of evidence for human-to-human transmission of avian influenza A (H9N2) viruses in Hong Kong, China, 1999. Emerg Infect Dis 2002 Feb;8(2):154-9 [Full text]

Uyeki TM. Global epidemiology of human infections with highly pathogenic avian influenza A (H5N1) viruses. Respirology 2008 Mar;13(s1):S2-9 [Full text]

Uyeki TM. Human infection with highly pathogenic avian influenza A (H5N1) virus: review of clinical issues. Clin Infect Dis 2009 Jul 15;49(2):279-90 [Abstract]

Vahlenkamp TW, Harder TC, Giese M, et al. Protection of cats against lethal influenza H5N1 challenge infection. J Gen Virol 2008 Apr;89(4):968-74 [Abstract]

Vajo Z, Kosa L, Szilvasy I, et al. Safety and immunogenicity of a prepandemic influenza A (H5N1) vaccine. Pediatr Infect Dis J 2008 Dec;27(12):1052-6 [Abstract]

Vajo Z, Kosa L, Visontay I, et al. Inactivated whole virus influenza A (H5N1) vaccine. (Letter) Emerg Infect Dis 2007 May;13(5):807-8 [Full text]

Vajo Z, Wood J, Kosa L, et al. A single-dose influenza A (H5N1) vaccine safe and immunogenic in adult and elderly patients: an approach to pandemic vaccine development. J Virol 2010 Feb;84(3):1237-42 [Abstract]

Vallat B. Avian influenza epizootie: where do we stand in 2007. 2007 Snowdon Lecture delivered Jul 11, 2007 [Links to slides and video]

Van Beest Holle MD, Meijer A, Koopmans M, et al. Human-to-human transmission of avian influenza A/H7N7, The Netherlands, 2003. Eurosurveillance Monthly 2005 Dec;10(12):pii=584 [Full text]

Van Borm S, Thomas I, Hanquet G, et al. Highly pathogenic H5N1 influenza virus in smuggled Thai eagles, Belgium. Emerg Infect Dis 2005 May 11(5):702-5 [Full text]

van Boven M, Koopmans M, van Beest Holle MD, et al. Detecting emerging human transmissibility of avian influenza virus in human households. PLoS Comp Biol 2007 Jul;3(7):e145 [Full text]

van der Goot JA, Koch G, de Jong MC, et al. Quantification of the effect of vaccination on transmission of avian influenza (H7N7) in chickens. Proc Natl Acad Sci 2005 Dec 13;102(50):18141-6 [Abstract]

van der Goot JA, van Boven M, Stegeman A, et al. Transmission of highly pathogenic avian influenza H5N1 virus in Pekin ducks is significantly reduced by a genetically distant H5N2 vaccine. Virology 2008 Dec 5;382(1):91-7 [Abstract]

van der Laan JW, Herberts C, Lambkin-Williams R, et al. Animals models in influenza vaccine testing. Expert Rev Vaccines 2008 Aug;7(6):783-93 [Abstract]

van Gils JA, Munster VJ, Radersma R, et al. Hampered foraging and migratory performance in swans infected with low-pathogenic avian influenza A virus. PLoS One 2007 Jan 31;2(1):e184 [Full text]

Van Hoeven N, Belser JA, Szretter KJ, et al. Pathogenesis of 1918 pandemic and H5N1 influenza virus infection in a guinea pig model: the antiviral potential of exogenous alpha-interferon to reduce virus shedding. J Virol 2009 Apr;83(7):2851-61 [Abstract]

Van Hoeven N, Pappas C, Belser JA, et al. Human HA and polymerase subunit PB2 proteins confer transmission of an avian influenza virus through the air. Proc Natl Acad Sci 2009 Mar 3;106(9):3366-71 [Abstract]

Van Kerkhove MD, Ly S, Guitian J, et al. Changes in poultry handling behavior and poultry mortality reporting among rural Cambodians in areas affected by HPAI/H5N1. PLoS ONE 2009 Jul 31;4(7):e6466 [Full text]

Van Poucke SGM, Nicholls JM, Nauwynck HJ, et al. Replication of avian, human and swine influenza viruses in porcine respiratory explants and association with sialic acid distribution. Virol J 2010 Feb 16;7:38 [Full text]

van Riel D, Munster VJ, de Wit E, et al. H5N1 virus attachment to lower respiratory tract. Science 2006 Apr 21;312(5772):399 [Full text]

van Riel D, Munster VJ, de Wit E, et al. Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals. Am J Pathol 2007 Oct;171(4):1215-23 [Abstract]

VanDalen KK, Franklin AB, Mooers NL, et al. Shedding light on avian influenza H4N6 infection in mallards: modes of transmission and implications for surveillance. PLoS ONE 2010 Sep 20;5(9):e12851 [Full text]

Veits J, Romer-Oberdorfer A, Helferich D, et al. Protective efficacy of several vaccines against highly pathogenic H5N1 avian influenza virus under experimental conditions. Vaccine 2008 Mar 20;26(13):1688-96 [Abstract]

Veits J, Weber S, Stech O, et al. Avian influenza virus hemagglutinins H2, H4, H8, and H14 support a highly pathogenic phenotype. Proc Natl Acad Sci 2012 Feb 14;109(7):2579-84 [Abstract]

Veits J, Wiesner D, Fuchs W, et al. Newcastle disease virus expressing H5 hemagglutinin gene protects chickens against Newcastle disease and avian influenza. Proc Natl Acad Sci 2006 May 23;103(2):8197-202 [Abstract]

Vela EM, Buccellato MA, Tordoff K, et al. Efficacy of a heterologous vaccine and adjuvant in ferrets challenged with influenza virus H5N1. Influenza Other Respi Viruses 2011 (published online Dec 22) [Abstract]

Veljkovic v, Veljkovic N, Muller CP, et al. Characterization of conserved properties of hemagglutinin of H5N1 and human influenza viruses: possible consequences for therapy and infection control. BMC Struct Biol 2009 Apr 7;9:21 [Full text]

Velumani S, Ho HT, He F, et al. A novel peptide ELISA for universal detection of antibodies to human H5N1 influenza viruses. PLoS ONE 2011 Jun 10;6(6):e20737 [Full text]

Vesikari T, Forsten A, Herbinger KH, et al. Safety and immunogenicity of an MF59-adjuvanted A/H5N1 pre-pandemic influenza vaccine in adults and the elderly. Vaccine 2011 (published online Dec 20) [Abstract]

Vesikari T, Karvonen A, Tilman S, et al. Immunogenicity and safety of MF59-adjuvanted H5N1 influenza vaccine from infancy to adolescence. Pediatrics 2010 Oct;126(4):e762-70 [Abstract]

Vijaykrishna D, Bahl J, Riley S, et al. Evolutionary dynamics and emergence of panzootic H5N1 influenza viruses. PLoS Pathog 2008 Sep 26;4(9):e1000161 [Full text]

Vogel R, Caillet C, Kusters IC, et al. Emulsion-based adjuvants for influenza vaccines. Expert Rev Vaccines 2009 Apr;8(4):483-92 [Abstract]

Vong S, Coghlan B, Mardy S, et al. Low frequency of poultry-to-human H5N1 virus transmission, Southern Cambodia, 2005. Emerg Infect Dis 2006 Oct;12(10):1542-7 [Full text]

Vong S, Ly S, Mardy S, et al. Environmental contamination during influenza A virus (H5N1) outbreaks, Cambodia, 2006. Emerg Infect Dis 2008 Aug;14(8):1303-5 [Full text]

Vong S, Ly S, Van Kerkhove MD, et al. Risk factors associated with subclinical human infection with avian influenza A (H5N1) virus - Cambodia, 2006. J Infect Dis 2009 Jun 15;199(12):1744-52 [Full text]

Wahlgren J, Waldenstrom J, Sahlin S, et al. Gene segment reassortment between American and Asian lineages of avian influenza virus from waterfowl in the Beringia area. Vector-Borne Zoonotic Dis 2008 Dec 15;8(6):783-90 [Abstract]

Walker P, Cauchemez S, Hartemink N, et al. Outbreaks of H5N1 in poultry in Thailand: the relative role of poultry production types in sustaining transmission and the impact of active surveillance in control. J R Soc Interface 2012 (published online Feb 22) [Abstract]

Wallace LA, McAulay KA, Douglas JD, et al. Influenza diagnosis: from dark isolation into the molecular light. West of Scotland Respiratory Virus Study Group. J Infect 1999 Nov;39(3):221-6 [Abstract]

Wallace RG, Fitch WM. Influenza A H5N1 immigration is filtered out at some international borders. PLoS ONE 2008 Feb 27;3(2):e1697 [Full text]

Wallensten A, Munster VJ, Latorre-Margalef N, et al. Surveillance of influenza A virus in migratory waterfowl in northern Europe. Emerg Infect Dis 2007 Mar;13(3):404-11 [Full text]

Wan H, Perez DN. Amino acid 226 in the hemagglutinin of H9N2 influenza viruses determines cell tropism and replication in human airway epithelial cells. J Virol 2007 May;81(10):5181-91 [Abstract]

Wan H, Sorrell EM, Song H, et al. Replication and transmission of H9N2 influenza viruses in ferrets: evaluation of pandemic potential. PLoS ONE 2008 Aug 13;3(8):e2923 [Full text]

Wan XF, Dong L, Lan Y, et al. Indications that live poultry markets are a major source of human H5N1 influenza infection in China. J Virol 2011 Dec;85(24):13432-8 [Abstract]

Wang G, Zhan D, Li L, et al. H5N1 avian influenza re-emergence of Lake Qinghai: phylogenetic and antigenic analyses of the newly isolated viruses and roles of migratory birds in virus circulation. J Gen Virol 2008 Mar;89(3):697-702 [Full text]

Wang H, Feng Z, Shu Y, et al. Probable limited person-to-person transmission of highly pathogenic avian influenza A (H5N1) virus in China. Lancet 2008 Apr 25;371(9622):1427-34 [Abstract]

Wang J, Vijaykrishna D, Duan L, et al. Identification of the progenitors of Indonesian and Vietnamese avian influenza A (H5N1) viruses from southern China. J Virol 2008 Apr;82(7):3405-14 [Abstract]

Wang M, Di B, Zhou D-H, et al. Food markets with live birds as source of avian influenza. Emerg Infect Dis 2006 Nov;12(11):1773-5 [Full text]

Wang M, Fu CX, Zheng BJ. Antibodies against H5 and H9 avian influenza among poultry workers in China. (Letter) N Engl J Med 2009 Jun 11;360(24):2583-4 [Full text]

Wang M, Lamberth K, Harndahl M, et al. CTL epitopes for influenza A including the H5N1 bird flu; genome-, pathogen-, and HLA-wide screening. Vaccine 2007 Apr 12;25(15):2823-31 [Abstract]

Wang TT, Parides MK, Palese P. Seroevidence for H5N1 influenza infections in humans: meta-analysis. Science 2012 (published online Feb 23) [Abstract]

Wang X, Zhao J, Tang S, et al. Viremia associated with fatal outcomes in ferrets infected with avian H5N1 influenza virus. PLoS ONE 2010 Aug 12;5(8):e12099 [Full text]

Ward MP, Maftei D, Apostu C, et al. Estimation of the basic reproductive number (R0) for epidemic, highly pathogenic avian influenza subtype H5N1 spread. Epidemiol Infect 2009 Feb;137(2):219-26 [Abstract]

Ward MP, Maftei DN, Apostu CL, et al. Association between outbreaks of highly pathogenic avian influenza subtype H5N1 and migratory waterfowl (Family Anatidae) populations. Zoonoses Public Health 2009 Feb;56(1):1-9 [Abstract]

Watanabe T, Watanabe S, Kim JH, et al. Novel approach to the development of effective H5N1 influenza A virus vaccines: use of M2 cytoplasmic tail mutants. J Virol 2008 March;82(5):2486-92 [Abstract]

Watanabe Y, Ibrahim MS, Ellakany HF, et al. Acquisition of human-type receptor binding specificity by new H5N1 influenza virus sublineages during their emergence in birds in Egypt. PLoS Pathog 2011 May 26;7(5):e1002068 [Full text]

Watanabe Y, Ibrahim MS, Suzuki Y, et al. The changing nature of avian influenza A virus (H5N1). Trends Microbiol 2012 Jan;20(1):11-20 [Abstract]

Weber TP, Stilianakis NI. Ecologic immunology of avian influenza (H5N1) in migratory birds. Emerg Infect Dis 2007 Aug;13(8):1139-43 [Full text]

Weber TP, Stilianakis NI. Migratory birds, the H5N1 influenza virus and the scientific method. (Commentary) Virol J 2008 May 9;5:57 [Abstract]

Webster R, Peiris M, Chen H, et al. H5N1 outbreaks and enzootic influenza. Emerg Infect Dis 2006 Jan;12(1):3-8 [Full text]

Webster RG, Govorkova EA. H5N1 influenza--continuing evolution and spread. N Engl J Med 2006 Nov 23;355(21):2174-7 [Full text]

Webster RG. Predictions for future human influenza pandemics. J Infect Dis 1997 Aug;176(Suppl 1):S14-9 [Full text]

Wei CJ, Boyington JC, McTamney PM, et al. Induction of broadly neutralizing H1N1 influenza antibodies by vaccination. Science 2010 Aug 27;329(5995):1060-4 [Abstract]

Wei CJ, Xu J, Kong WP, et al. Comparative efficacy of neutralizing antibodies elicited by recombinant hemagglutinin proteins from avian H5N1 influenza virus. J Virol 2008 Jul;82(13):6200-8 [Abstract]

Weinberg A. Evaluation of three influenza a and B rapid antigen detection kits--update. Clin Diagn Lab Immunol 2005 Aug;12(8):1010 [Abstract]

Wetherall NT, Trivedi T, Zeller J, et al. Evaluation of neuraminidase enzyme assays using different substrates to measure susceptibility of influenza virus clinical isolates to neuraminidase inhibitors: report of the neuraminidase inhibitor susceptibility network. J Clin Microbiol 2003 Feb;41(2):742-50 [Full text]

White House. Executive order: amendment to Executive Order 13295 relating to certain influenza viruses and quarantinable communicable diseases. Apr 1, 2005 [Full text - See also CDC Q & A above]

White NJ, Webster RG, Govorkova EA, et al. What is the optimal therapy for patients with H5N1 influenza? PLoS Med 2009 Jun 23;6(6):e1000091 [Full text]

WHO (Writing Committee of the Second WHO Consultation on Clinical Aspects of Human Infection with Avian Influenza A [H5N1] Virus). Update on avian influenza A (H5N1) virus infection in humans. N Engl J Med 2008 Jan 17;358(3):261-73 [Full text]

WHO (Writing Committee of WHO Consultation on Human Influenza A/H5). Avian influenza A (H5N1) infection in humans. N Engl J Med 2005 Sep 29;353(13):1374-85 [Full text]

WHO. A summary of tracking avian influenza A (H5N1) specimens and viruses shared with WHO from 2003 to 2007. Released Jan 21, 2008 [Full text]

WHO. Antigenic and genetic characteristics of influenza A(H5N1) and influenza A(H9N2) viruses and candidate vaccine viruses developed for potential use in human vaccines. September 2010 [Full text]

WHO. Avian influenza ("bird flu"): fact sheet. Apr 2011 [Full text]

WHO. Avian influenza: assessing the pandemic threat. Jan 2005 [Full text]

WHO. Avian influenza: food safety issues. Apr 27, 2007 [Full text]

WHO. Avian influenza: guidelines, recommendations, descriptions: surveillance [Webpage]

WHO. Avian influenza: significance of mutations in the H5N1 virus. Feb 20, 2006 [Full text]

WHO. Checklist for influenza pandemic preparedness planning. 2005 [Full text]

WHO. Clinical management of human infection with avian influenza A (H5N1) virus. Aug 15, 2007 [Full text]

WHO. Continuing progress towards a unified nomenclature system for the highly pathogenic H5N1 avian influenza viruses. Mar 2009 [Full text]

WHO. Development of a vaccine effective against avian influenza H5N1 infection in humans: update 4. Jan 20, 2004 [Webpage]

WHO. Donation of three million treatments of oseltamivir to WHO to help early response to an emerging influenza pandemic. Aug 25, 2005 [Webpage]

WHO. Epidemiology of WHO-confirmed human cases of avian influenza A(H5N1) infection. Wkly Epidemiol Rec 2006 Jun 30;81(26):249-56 [Full text]

WHO. Evolution of H5N1 avian influenza viruses in Asia. Emerg Infect Dis 2005 Oct;11(10):1515-21 [Full text]

WHO. Food safety issues. Nov 2005 [Full text]

WHO. Food safety: avian influenza A(H5N1) in humans and in poultry in Asia. Jan 24, 2004 [Web page]

WHO. Guidelines for global surveillance of influenza A/H5. Feb 6, 2004 [Webpage]

WHO. Inter-country consultation: influenza A/H5N1 in humans in Asia. May 6-7, 2005; Manila, The Phillipines. [Full text]

WHO. Options for the use of human H5N1 influenza vaccines and the WHO H5N1 vaccine stockpile. Released May 16, 2008 [Full text]

WHO. Proposals to finalize remaining elements of the 'Pandemic Influenza Preparedness Framework for sharing influenza viruses and access to vaccines and other benefits.' Sep 18, 2009 [Full text]

WHO. Recommended laboratory tests to identify influenza A/H5 virus in specimens from patients with an influenza-like illness. Feb 19, 2004 [Full text]

WHO. Report on technical consultation on H5N1 research issues. Mar 9, 2012 [Full text]

WHO. Responding to the avian influenza pandemic threat: recommended strategic actions. Released Sep 2, 2005 [Full text]

WHO. Review of latest available evidence on risks to human health through potential transmission of avian influenza (H5N1) through water and sewage. Mar 24, 2006 [Full text]

WHO. Summary of the second WHO consultation on clinical aspects of human infection with avian influenza A(H5N1) virus, 19-21 March, 2007, Antalya, Turkey. Released Apr 19, 2007 [Full text]

WHO. Update: WHO-confirmed human cases of avian influenza A(H5N1) infection, 25 November 2003 - 24 November 2006. Wkly Epidemiol Rec 2007 Feb 9;82(6):41-8 [Full text]

WHO. WHO case definitions for human infections with influenza A(H5N1) virus. Aug 29, 2006 [Full text]

WHO. WHO concerned that new H5N1 influenza research could undermine the 2011 pandemic influenza preparedness framework. Dec 30, 2011 [Full text]

WHO. WHO guidance on public health measures in countries experiencing their first outbreaks of H5N1 avian influenza. Oct 2005 [Full text]

WHO. WHO guidelines for investigation of human cases of avian influenza A(H5N1). Jan 2007 [Full text]

WHO/OIE/FAO H5N1 Evolution Working Group. Toward a unified nomenclature system for highly pathogenic avian influenza virus (H5N1). (Online report) Emerg Infect Dis 2008 Jul;14(7):e1 [Full text]

WHO: INFOSAN. Highly pathogenic H5N1 avian influenza outbreaks in poultry and in humans: food safety implications. Nov 4, 2005 [Webpage]

Wibawa H, Henning J, Wong F, et al. A molecular and antigenic survey of H5N1 highly pathogenic avian influenza virus isolates from smallholder duck farms in Central Java, Indonesia during 2007-2008. Virol J 2011 Sep 7;8:425 [Abstract]

Widjaja L, Krauss SL, Webby RJ, et al. Matrix gene of influenza A viruses isolated from wild aquatic birds: ecology and emergence of influenza A viruses. J Virol 2004 Aug;78(16):8771-9 [Abstract]

Wilcox BR, Knutsen GA, Berdeen J, et al. Influenza-A viruses in ducks in northwestern Minnesota: fine scale spatial and temporal variation in prevalence and subtype diversity. PLoS ONE 2011 Sep 13;6(9):e24010 [Full text]

Wille M, Robertson GJ, Whitney H, et al. Extensive geographic mosaicism in avian influenza viruses from gulls in the northern hemisphere. PLoS ONE 2011 Jun 15;6(6):e20664 [Full text]

Winker K, McCracken KG, Gibson DD, et al. Movements of birds and avian influenza from Asia into Alaska. Emerg Infect Dis 2007 Apr 13(4):547-52 [Full text]

Winker K, Spackman E, Swayne DE. Rarity of influenza A virus in spring shorebirds, southern Alaska. (Letter) Emerg Infect Dis 2008 Aug;14(8):1314-5 [Full text]

Wisedchanwet T, Wongpatcharachai M, Boonyapisitsopa S, et al. Genetic characterization of avian influenza subtype H4N6 and H4N9 from live bird market, Thailand. Virol J 2011 Mar 21;8:131 [Abstract]

Wong JP, Christopher ME, Salazar AM, et al. Nucleic acid-based drugs against seasonal and avian influenza viruses. Vaccine 2007 Apr 20;25(16):4175-8 [Abstract]

Wong SSY, Yuen KY. Avian influenza virus infections in humans. Chest 2006;129(1):156-68 [Full text]

Wong SSY, Yuen KY. Human infection by avian influenza A H5N1. Hong Kong Med J 2005;11(3):189-99 [Full text]

Wood JP, Choi YW, Chappie DJ, et al. Environmental persistence of a highly pathogenic avian influenza (H5N1) virus. Environ Sci Technol 2010 Oct 1;44(19):7515-20 [Abstract]

World Bank. Avian and human influenza: financing needs and gaps. Jan 12, 2006 [Full text]

Worrall EE, Sudarisman, Priadi A. Sialivac: an intranasal homologous inactivated split virus vaccine containing bacterial sialidase for the control of avian influenza in poultry. Vaccine 2009 Jun 24;27(31):4161-8 [Abstract]

Wu B, Wang C, Dong G, et al. New evidence suggests southern China as a common source of multiple clusters of highly pathogenic H5N1 avian influenza virus. J Infect Dis 2010 Aug 1;202(3):452-8 [Abstract]

Wu D, Li G, Qin C, et al. Phage displayed peptides to avian H5N1 virus distinguished the virus from other viruses. PLoS ONE 2011 Aug 22;6(8):e23058 [Full text]

Wu J, Liu SZ, Dong SS, et al. Safety and immunogenicity of adjuvanted inactivated split-virion and whole-virion influenza A (H5N1) vaccines in children: a phase I-II randomized trial. Vaccine 2010 Aug 31;28(38):6221-7 [Abstract]

Wu J, Zhang F, Wang M, et al. Characterization of neuraminidases from the highly pathogenic avian H5N1 and 2009 pandemic H1N1 influenza A viruses. PLoS ONE 2010 Dec 29;5(12):e15825 [Full text]

Wu WL, Chen Y, Wang P, et al. Antigenic profile of avian H5N1 viruses in Asia from 2002 to 2007. J Virol 2008 Feb 15;82(4):1798-807 [Abstract]

Wuethrich B. Infectious disease: an avian flu jumps to people. Science 2003 Mar 7;299(5612):1504 [Full text]

Xiang N, Shi Y, Wu J, et al. Knowledge, attitudes and practices (KAP) relating to avian influenza in urban and rural areas of China. BMC Infect Dis 2010 Feb 21;10:34 [Abstract]

Xu KM, Li KS, Smith GJ, et al. Evolution and molecular epidemiology of H9N2 influenza A viruses from quail in southern China, 2000 to 2005. J Virol 2007 Mar;81(6):2635-45 [Abstract]

Xu KM, Smith GJD, Bahl J, et al. The genesis and evolution of H9N2 influenza viruses in poultry from Southern China, 2000 to 2005. J Virol 2007 Oct;81(19):10389-401 [Abstract]

Xu X, Jin M, Yu Z, et al. Latex agglutination test for monitoring antibodies to avian influenza virus subtype H5N1. J Clin Microbiol 2005 Apr;43(4):1953-5 [Abstract]

Yamada S, Hatta M, Staker BL, et al. Biological and structural characterization of a host-adapting amino acid in influenza virus. PLoS Pathog 2010 Aug 5;6(8):e1001034 [Aug PLoS Pathog article]

Yamada S, Shinya K, Takada A, et al. Adaptation of a duck influenza A virus in quail. J Virol 2011 (published online Nov 16) [Abstract]

Yamada T, Dautry A, Walport M. Ready for avian flu? (Commentary) Nature 2008 Jul 10;454(7201):162 [Full text]

Yamaguchi N, Hupp JW, Higuchi H, et al. Satellite-tracking of northern pintail Anas acuta during outbreaks of the H5N1 virus in Japan: implications for virus spread. Ibis 2010 Apr;152(3):262-71 [Abstract]

Yamamoto N, Sakoda Y, Motoshima M, et al. Characterization of a non-pathogenic H5N1 influenza virus isolated from a migratory duck flying from Siberia in Hokkaido, Japan, in October 2009. Virol J 2011 Feb 11;8:65 [Abstract]

Yamamoto Y, Nakamura K, Okamatsu M, et al. Detecting avian influenza virus (H5N1) in domestic duck feathers. (Letter) Emerg Infect Dis 2008 Oct;14(10):1671 [Full text]

Yamamoto Y, Nakamura K, Okamatsu M, et al. Avian influenza virus (H5N1) replication in feathers of domestic waterfowl. Emerg Infect Dis 2008 Jan;14(1):149-51 [Full text]

Yamamoto Y, Nakamura K, Yamada M, et al. Persistence of avian influenza virus (H5N1) in feathers detached from bodies of infected domestic ducks. Appl Environ Microbiol 2010 Aug;76(16):5496-9 [Abstract]

Yamazaki Y, Doy M, Okabe N, et al. Serological survey of avian H5N2-subtype influenza virus infections in human populations. Arch Virol 2009 Mar;154(3):421-7 [Abstract]

Yan J, Lu Y, Mao H, et al. Pathogenic and molecular characterization of the H5N1 avian influenza virus isolated from the first human case in Zhejiang province, China. Diagn Microbiol Infect Dis 2007 Aug;58(4):399-405 [Abstract]

Yang H, Chen LM, Carney PJ, et al. Structures of receptor complexes of a North American H7N2 influenza hemagglutinin with a loop deletion in the receptor binding site. PLoS Pathog 2010 Sep 2;6(9):e1001081 [Full text]

Yang P, Shi W, Cui S, et al. Infection with multiple avian influenza viruses in a man without poultry-handling practices suggesting an increased probability of emergent pandemic influenza virus in general population. Clin Infect Dis 2011 (published online Dec 5) [Abstract]

Yang Y, Halloran ME, Sugimoto J, et al. Detecting human-to-human transmission of avian influenza A (H5N1). Emerg Infect Dis 2007 Sep;13(9):1348-53 [Full text]

Yang ZY, Wei CJ, Kong WP, et al. Immunization by avian H5 influenza hemagglutinin mutants with altered receptor binding. Science 2007 Aug 10;317(5839):825-8 [Abstract]

Yao L, Korteweg C, Hsueh W, et al. Avian influenza receptor expression in H5N1-infected and noninfected human tissues. FASEB J 2008 Mar;22(3):733-40 [Abstract]

Yee KS, Carpenter TE, Cardona CJ. Epidemiology of H5N1 avian influenza. Comp Immunol Microbiol Infect Dis 2009 Jul;32(4):325-40 [Abstract]

Yen HL, Ilyushina NA, Salomon R, et al. Neuraminidase inhibitor-resistant recombinant A/Vietnam/1203/04 (H5N1) influenza viruses retain their replication efficiency and pathogenicity in vitro and in vivo. J Virol 2007 Nov;81(22):12418-26 [Abstract]

Yen HL, Lipatov AS, Ilyushina NA, et al. Inefficient transmission of H5N1 influenza viruses in a ferret contact model. J Virol 2007 Jul;81(13):6890-8 [Abstract]

Yen HL, Malik Paris JS. Mapping antibody epitopes of the avian H5N1 influenza virus. (Perspective) PLoS Med 2009 Apr 21;6(4):e1000064 [Full text]

Yen HL, Monto AS, Webster RG, et al. Virulence may determine the necessary duration and dosage of oseltamivir treatment for highly pathogenic A/Vietnam/1203/04 influenza virus in mice. J Infect Dis 2005 Aug 15;192(4):665-72 [Abstract]

Yingst SL, Saad MD, Felt SA. Qinghai-like H5N1 from domestic cats, Northern Iraq. (Letter) Emerg Infect Dis 2006 Aug;12(8):1295-7 [Full text]

Yoon KJ, Cooper VL, Schwartz KJ, et al. Influenza virus infection in racing greyhounds. Emerg Infect Dis 2005 Dec;11(12):1974-5 [Full text]

Yu H, Feng Z, Zhang X, et al. Human influenza A (H5N1) cases, urban areas of People's Republic of China, 2005-2006. Emerg Infect Dis 2007 Jul;13(7):1061-4 [Full text]

Yu H, Gao Z, Feng Z, et al. Clinical characteristics of 26 human cases of highly pathogenic avian influenza A (H5N1) virus infection in China. PLoS ONE 2008 Aug;3(8):e2985 [Full text]

Yu Z, Song Y, Zhou H, et al. Avian influenza (H5N1) virus in waterfowl and chickens, central China. Emerg Infect Dis 2007 May;13(5):772-5 [Full text]

Yuan P, Bartlam M, Lou Z, et al. Crystal structure of an avian influenza polymerase PAN reveals an endonuclease active site. Nature 2009 Apr 16;458:909-13 [Abstract]

Yuen KY, Chan PKS, Peiris M, et al. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet 1998;351(9101):467-71 [Abstract]

Yun NE, Linde NS, Zacks MA, et al. Injectable peramivir mitigates disease and promotes survival in ferrets and mice infected with the highly virulent influenza virus A/Vietnam/1203/04 (H5N1). Virology 2008 Apr 25;374(1):198-209 [Abstract]

Yupiana Y, de Vlas SJ, Adnan NM, et al. Risk factors of poultry outbreaks and human cases of H5N1 avian influenza virus infection in West Java Province, Indonesia. Int J Infect Dis 2010 Sep;14(9):e800-5 [Abstract]

Zaman M, Ashraf S, Dreyer NA, et al. Human infection with avian influenza virus, Pakistan, 2007. Emerg Infect Dis 2011 Jun;17(6):1056-9 [Full text]

Zangwill KM, Treanor JJ, Campbell JD, et al. Evaluation of the safety and immunogenicity of a booster (third) dose of inactivated subvirion H5N1 influenza vaccine in humans. J Infect Dis 2008 Feb 15;197(4):580-3 [Abstract]

Zarocostas J. Nations signal support for WHO to stockpile H5N1 vaccine. BMJ 2007 May 5;334(7600):925 [Extract]

Zeng H, Goldsmith C, Thawatsupha P, et al. Highly pathogenic avian influenza H5N1 viruses elicit an attenuated type I interferon response in polarized human bronchial epithelial cells. J Virol 2007 Nov;81(22):12439-49 [Abstract]

Zhang C, Yang Y, Zhou X, et al. Highly pathogenic avian influenza A virus H5N1 NS1 protein induces caspase-dependent apoptosis in human alveolar basal epithelial cells. Virol J 2010 Mar 2;7(1):51 [Abstract]

Zhang G, Shoham D, Gilichinsky D, et al. Evidence of influenza A virus RNA in Siberian lake ice. J Virol 2006 Dec;80(24):12229-35 [Abstract]

Zhang H, Xu B, Chen Q, et al. Characterization of an H10N8 influenza virus isolated from Dongting lake wetland. Virol J 2011 Jan 27;8:42 [Abstract]

Zhang J, Geng X, Ma Y, et al. Fatal avian influenza (H5N1) infection in human, China. Emerg Infect Dis 2010 Nov;16(11):1799-801 [Full text]

Zhang P, Tan Y, Liu X, et al. A novel genotype H9N2 influenza virus possessing human H5N1 internal genomes has been circulating in poultry in eastern China since 1998. J Virol 2009 Sep;83(17):8428-38 [Abstract]

Zhang P, Tang Y, Liu X, et al. Characterization of H9N2 influenza viruses isolated from vaccinated flocks in an integrated broiler chicken operation in eastern China during a 5 year period (1998-2002). J Gen Virol 2008 Dec;89(12):3102-12 [Abstract]

Zhang W, Xue T, Wu X, et al. Increase in viral yield in eggs and MDCK cells of reassortant H5N1 vaccine candidate viruses caused by insertion of 38 amino acids into the NA stalk. Vaccine 2011 Oct 19;29(45):8032-41 [Abstract]

Zhang Y, Lin X, Wang G, Zhou J, Lu J, et al. Neuraminidase and hemagglutinin matching patterns of a highly pathogenic avian and two pandemic H1N1 influenza A viruses. PLoS One 2010 Feb 11;5(2):e9167 [Full text]

Zhang Z, Chen D, Chen Y, et al. Spatio-temporal data comparisons for global highly pathogenic avian influenza (HPAI) H5N1 outbreaks. PLoS ONE 2010 Dec 20;5(12):e15314 [Full text]

Zhao G, Lin Y, Du L, et al. An M2e-based multiple antigenic peptide vaccine protects mice from lethal challenge with divergent H5N1 influenza viruses. Virology J 2010 Jan 18;7:9 [Abstract]

Zhao G, Lu X, Gu X, et al. Molecular evolution of the H6 subtype influenza A viruses from poultry in Eastern China from 2002 to 2010. Virol J 2011 Oct 14;8:470 [Abstract]

Zhao Y, Lu M, Lau LT, et al. Neutrophils may be a vehicle for viral replication and dissemination in human H5N1 avian influenza. Clin Infect Dis 2008 Dec 15;47(12):1575-8 [Abstract]

Zhao ZM, Shortridge KF, Garcia M, et al. Genotypic diversity of H5N1 highly pathogenic avian influenza viruses. J Gen Virol 2008 Sep;89(9):2182-93 [Abstract]

Zhong NS, Zeng GQ. Pandemic planning in China: applying lessons from severe acute respiratory syndrome. Respirology 2008 Mar;13(s1):S33-5 [Full text]

Zhou B, Zhong N, Guan Y. Treatment with convalescent plasma for influenza A (H5N1) infection. (Letter) N Engl J Med 2007 Oct 4;357(14):1450-1 [Extract]

Zhou H, Yu Z, Hu Y, et al. The special neuraminidase stalk-motif responsible for increased virulence and pathogenesis of H5N1 influenza A virus. PLoS ONE 2009 Jul 17;4(7):e6277 [Full text]

Zhou J, Law HK, Cheung CY, et al. Differential expression of chemokines and their receptors in adult and neonatal macrophages infected with human or avian influenza viruses. J Infect Dis 2006 Jul 1;194(1):61-70 [Abstract]

Zhou J, Sun W, Wang J, et al. Characterization of the H5N1 highly pathogenic avian influenza virus derived from wild pikas in China. J Virol 2009 Sep;83(17):8957-64 [Abstract]

Zhou JF, Zou SM, Li Z, et al. Identification of dual receptor-binding specific strains of human H5N1 viruses in China. Biomed Environ Sci 2012 Feb;25(1):104-8 [Abstract]

Zhou L, Liao Q, Dong L, et al. Risk factors for human illness with avian influenza A (H5N1) virus infection in China. J Infect Dis 2009 Jun 15;199(12):1726-34 [Full text]

Zhu H, Zhou B, Fan X, et al. Novel reassortment of Eurasian avian-like and pandemic/2009 influenza viruses in swine: infectious potential to humans. J Virol 2011 Oct;85(20):10432-9 [Abstract]

Zou S, Han J, Wen L, et al. Human influenza A virus (H5N1) detection by a novel multiplex PCR typing method. J Clin Microbiol 2007 Jun;45(6):1889-92 [Abstract]

Zwart OD, Veldhuijzen IK, Richardus JH, et al. Monitoring of risk perceptions and correlates of precautionary behavior related to human avian influenza during 2006 - 2007 in the Netherlands: results of seven consecutive surveys. BMC Infect Dis 2010 May 12;10:114 [Abstract]